Updated on 2024/10/20

写真a

 
OOHASHI Toshitaka
 
Organization
Faculty of Medicine, Dentistry and Pharmaceutical Sciences Professor
Position
Professor
Profile
神経特異的細胞外マトリックス(ECM)分子の発見から、その機能、神経糖鎖生物学に魅せられています。また、軟骨代謝、軟骨プロテオグリカンのイメージング、薬物送達技術にも興味をもっています。
External link

Degree

  • 博士(薬学) ( 岡山大学 )

Research Interests

  • Molecular Biology

  • Matrix Biology

  • Biochemistry

Research Areas

  • Life Science / Neuroscience-general

  • Life Science / Medical biochemistry

  • Life Science / Otorhinolaryngology

  • Life Science / Plastic and reconstructive surgery

  • Life Science / Biomaterials

  • Life Science / Biomedical engineering

  • Life Science / Orthopedics

▼display all

Education

  • Okayama University    

    - 1992

      More details

  • Okayama University   自然科学研究科   生体調節科学

    - 1992

      More details

    Country: Japan

    researchmap

  • Kyoto University    

    - 1987

      More details

  • Kyoto University   薬学部   製薬化学科

    - 1987

      More details

    Country: Japan

    researchmap

Research History

  • - Professor,Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Okayama University

    2014

      More details

  • - 岡山大学医歯薬学総合研究科 教授

    2014

      More details

  • Okayama University   Faculty of Medicine, Dentistry and Pharmaceutical Sciences,   Professor

    2022.4

      More details

    Country:Japan

    researchmap

  • Associate Professor,Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Okayama University

    2012 - 2014

      More details

  • 岡山大学医歯薬学総合研究科 准教授

    2012 - 2014

      More details

  • Max-Planck Research fellow,Max-Planck Institute of Biochemistry

    1997.2 - 1997.9

      More details

  • マックスプランク 生化学研究所 マックスプランク研究員

    1997.2 - 1997.9

      More details

  • Postdoctoral Fellowships of Japan Society for the Promotion of Science,Max-Planck Institute of Biochemistry

    1996 - 1997

      More details

  • マックスプランク 生化学研究所 日本学術振興会特別研究員

    1996 - 1997

      More details

▼display all

Professional Memberships

▼display all

Committee Memberships

  • 日本学術振興会   専門委員  

    2023.11 - 2024.10   

      More details

  • 日本結合組織学会理事   理事  

    2018   

      More details

    Committee type:Academic society

    日本結合組織学会理事

    researchmap

  • 日本軟骨代謝学会理事   理事  

    2017   

      More details

    Committee type:Academic society

    日本軟骨代謝学会理事

    researchmap

  • 日本軟骨代謝学会 評議員   評議員  

    2014   

      More details

    Committee type:Academic society

    日本軟骨代謝学会 評議員

    researchmap

  • 日本生化学会   なし  

    1987   

      More details

    Committee type:Academic society

    日本生化学会

    researchmap

 

Papers

  • The roles of perineuronal nets and the perinodal extracellular matrix in neuronal function. Reviewed International journal

    James W Fawcett, Toshitaka Oohashi, Tommaso Pizzorusso

    Nature reviews. Neuroscience   20 ( 8 )   451 - 465   2019.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Perineuronal nets (PNNs) are extracellular matrix (ECM) chondroitin sulfate proteoglycan (CSPG)-containing structures that surround the soma and dendrites of various mammalian neuronal cell types. PNNs appear during development around the time that the critical periods for developmental plasticity end and are important for both their onset and closure. A similar structure - the perinodal ECM - surrounds the axonal nodes of Ranvier and appears as myelination is completed, acting as an ion-diffusion barrier that affects axonal conduction speed. Recent work has revealed the importance of PNNs in controlling plasticity in the CNS. Digestion, blocking or removal of PNNs influences functional recovery after a variety of CNS lesions. PNNs have further been shown to be involved in the regulation of memory and have been implicated in a number of psychiatric disorders.

    DOI: 10.1038/s41583-019-0196-3

    PubMed

    researchmap

  • O‐<scp>GlcNAcylation</scp> regulates osteoblast differentiation through the morphological changes in mitochondria, cytoskeleton, and endoplasmic reticulum

    Yao Weng, Ziyi Wang, Heriati Sitosari, Mitsuaki Ono, Hirohiko Okamura, Toshitaka Oohashi

    BioFactors   2024.10

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    Abstract

    To explore the potential mechanisms which O‐linked‐N‐acetylglucosaminylation (O‐GlcNAcylation) regulates osteogenesis, a publicly RNA‐seq dataset was re‐analyzed with literature‐mining and showed the primary targets of O‐GlcNAcylation in osteoblasts are mitochondria/cytoskeleton. Although the O‐GlcNAcylation‐regulated mitochondria/cytoskeleton has been extensively studied, its specific role during osteogenesis remains unclear. To address this, we knocked out Ogt (Ogt‐KO) in MC3T3‐E1 osteoblastic cells. Then, significantly reduced osteoblast differentiation, motility, proliferation, mitochondria–endoplasmic reticulum (Mito–ER) coupling, volume of ER, nuclear tubulins, and oxygen metabolism were observed in Ogt‐KO cells. Through artificial intelligence (AI)‐predicted cellular structures, the time‐lapse live cells imaging with reactive‐oxygen‐species/hypoxia staining showed that lower cell proliferation and altered oxygen metabolism in the Ogt‐KO cells were correlated with the Mito–ER coupling. Bioinformatics analysis, combined with correlated mRNA and protein expression, suggested that Ezh2 and its downstream targets (Opa1, Gsk3a, Wnt3a, Hif1a, and Hspa9) may be involved in O‐GlcNAcylation‐regulated Mito–ER coupling, ultimately impacting osteoblast differentiation. In conclusion, our findings indicate that O‐GlcNAcylation‐regulated osteoblast differentiation is linked to morphological changes in mitochondria, cytoskeleton, and ER, with Ezh2 potentially playing a crucial role.

    DOI: 10.1002/biof.2131

    researchmap

  • The cell membrane as biofunctional material for accelerated bone repair. International journal

    Emi Hatano, Nahid Akhter, Risa Anada, Mitsuaki Ono, Toshitaka Oohashi, Takuo Kuboki, Hiroshi Kamioka, Masahiro Okada, Takuya Matsumoto, Emilio Satoshi Hara

    Acta biomaterialia   2024.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The cell (plasma) membrane is enriched with numerous receptors, ligands, enzymes, and phospholipids that play important roles in cell-cell and cell-extracellular matrix interactions governing, for instance, tissue development and repair. We previously showed that plasma membrane nanofragments (PMNFs) act as nucleation sites for bone formation in vivo, and induce in vitro mineralization within 1 day. In this study, we optimized the methods for generating, isolating, and applying PMNFs as a cell-free therapeutic to expedite bone defect repair. The PMNFs were isolated from different mouse cell lines (chondrocytes, osteoblasts, and fibroblasts), pre-conditioned, lyophilized, and subsequently transplanted into 2 mm critical-sized calvarial defects in mice (n = 75). The PMNFs from chondrocytes, following a 3-day pre-incubation, significantly accelerated bone repair within 2 weeks, through a coordinated attraction of macrophages, endothelial cells, and osteoblasts to the healing site. In vitro experiments confirmed that PMNFs enhanced cell adhesion. Comparison of the PMNF efficacy with phosphatidylserine, amorphous calcium phosphate (ACP), and living cells confirmed the unique ability of PMNFs to promote accelerated bone repair. Importantly, PMNFs promoted nearly complete integration of the regenerated bone with native tissue after 6 weeks (% non-integrated bone area = 15.02), contrasting with the partial integration (% non-integrated bone area = 56.10; p < 0.01, Student's test) with transplantation of ACP. Vickers microhardness tests demonstrated that the regenerated bone after 6 weeks (30.10 ± 1.75) exhibited hardness similar to native bone (31.07 ± 2.46). In conclusion, this is the first study to demonstrate that cell membrane can be a promising cell-free material with multifaceted biofunctional properties that promote accelerated bone repair. STATEMENT OF SIGNIFICANCE.

    DOI: 10.1016/j.actbio.2024.07.037

    PubMed

    researchmap

  • The cell membrane as biofunctional material for accelerated bone repair

    Emi Hatano, Nahid Akhter, Risa Anada, Mitsuaki Ono, Toshitaka Oohashi, Takuo Kuboki, Hiroshi Kamioka, Masahiro Okada, Takuya Matsumoto, Emilio Satoshi Hara

    Acta Biomaterialia   2024.7

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.actbio.2024.07.037

    researchmap

  • Local E-rhBMP-2/β-TCP Application Rescues Osteocyte Dendritic Integrity and Reduces Microstructural Damage in Alveolar Bone Post-Extraction in MRONJ-like Mouse Model

    Anh Tuan Dang, Mitsuaki Ono, Ziyi Wang, Ikue Tosa, Emilio Satoshi Hara, Akihiro Mikai, Wakana Kitagawa, Tomoko Yonezawa, Takuo Kuboki, Toshitaka Oohashi

    International Journal of Molecular Sciences   25 ( 12 )   6648 - 6648   2024.6

     More details

    Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    The pathology of medication-related osteonecrosis of the jaw (MRONJ), often associated with antiresorptive therapy, is still not fully understood. Osteocyte networks are known to play a critical role in maintaining bone homeostasis and repair, but the exact condition of these networks in MRONJ is unknown. On the other hand, the local application of E-coli-derived Recombinant Human Bone Morphogenetic Protein 2/β-Tricalcium phosphate (E-rhBMP-2/β-TCP) has been shown to promote bone regeneration and mitigate osteonecrosis in MRONJ-like mouse models, indicating its potential therapeutic application for the treatment of MRONJ. However, the detailed effect of BMP-2 treatment on restoring bone integrity, including its osteocyte network, in an MRONJ condition remains unclear. Therefore, in the present study, by applying a scanning electron microscope (SEM) analysis and a 3D osteocyte network reconstruction workflow on the alveolar bone surrounding the tooth extraction socket of an MRONJ-like mouse model, we examined the effectiveness of BMP-2/β-TCP therapy on the alleviation of MRONJ-related bone necrosis with a particular focus on the osteocyte network and alveolar bone microstructure (microcrack accumulation). The 3D osteocyte dendritic analysis showed a significant decrease in osteocyte dendritic parameters along with a delay in bone remodeling in the MRONJ group compared to the healthy counterpart. The SEM analysis also revealed a notable increase in the number of microcracks in the alveolar bone surface in the MRONJ group compared to the healthy group. In contrast, all of those parameters were restored in the E-rhBMP-2/β-TCP-treated group to levels that were almost similar to those in the healthy group. In summary, our study reveals that MRONJ induces osteocyte network degradation and microcrack accumulation, while application of E-rhBMP-2/β-TCP can restore a compromised osteocyte network and abrogate microcrack accumulation in MRONJ.

    DOI: 10.3390/ijms25126648

    researchmap

  • Exploring the Regulators of Keratinization: Role of BMP-2 in Oral Mucosa

    Xindi Mu, Mitsuaki Ono, Ha Thi Thu Nguyen, Ziyi Wang, Kun Zhao, Taishi Komori, Tomoko Yonezawa, Takuo Kuboki, Toshitaka Oohashi

    Cells   13 ( 10 )   807 - 807   2024.5

     More details

    Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    The oral mucosa functions as a physico-chemical and immune barrier to external stimuli, and an adequate width of the keratinized mucosa around the teeth or implants is crucial to maintaining them in a healthy and stable condition. In this study, for the first time, bulk RNA-seq analysis was performed to explore the gene expression of laser microdissected epithelium and lamina propria from mice, aiming to investigate the differences between keratinized and non-keratinized oral mucosa. Based on the differentially expressed genes (DEGs) and Gene Ontology (GO) Enrichment Analysis, bone morphogenetic protein 2 (BMP-2) was identified to be a potential regulator of oral mucosal keratinization. Monoculture and epithelial–mesenchymal cell co-culture models in the air–liquid interface (ALI) indicated that BMP-2 has direct and positive effects on epithelial keratinization and proliferation. We further performed bulk RNA-seq of the ALI monoculture stimulated with BMP-2 in an attempt to identify the downstream factors promoting epithelial keratinization and proliferation. Analysis of the DEGs identified, among others, IGF2, ID1, LTBP1, LOX, SERPINE1, IL24, and MMP1 as key factors. In summary, these results revealed the involvement of a well-known growth factor responsible for bone development, BMP-2, in the mechanism of oral mucosal keratinization and proliferation, and pointed out the possible downstream genes involved in this mechanism.

    DOI: 10.3390/cells13100807

    researchmap

  • Filamin A mediates embryonical palatal fusion by linking mechanotransduction with β-Catenin/Smad2

    Ziyi Wang, Satoru Hayano, Yao Weng, Xindi Mu, Mitsuaki Ono, Jeremie Oliver Piña, Rena N. D'Souza, Takashi Yamashiro, Toshitaka Oohashi, Hiroshi Kamioka

    2024.2

     More details

    Publisher:Cold Spring Harbor Laboratory  

    To decipher potential mechanisms underlying cleft palate (CP), we used advanced bioinformatic integrated with literature mining and genome-wide association study (GWAS). Re-analysis of RNA-seq data (GSE45568, GSE185279) combined with literature mining highlighted the roles of Filamin A (Flna) and Epithelial-Mesenchymal Transition (EMT) in palatal development. Immunofluorescence of in vivo palatal shelves showed increased Flna in medial edge epithelial (MEE) cells and EMT cells located in an epithelial triangle. Inhibition of TGF-β or RhoA and mechanical stimuli impacted Flna expression in ex vivo cultured palatal shelves. Re-analysis of scRNA-seq data (GSE155928) highlighted a correlation between Flna and Ctnnb1 in EMT cells. Flna knockdown affected β-catenin/Smad2 expression in cultured palatal shelves and HaCaT cells. Epithelium-specific knockout of Flna delayed palatal fusion in female mice but not males. Mendelian randomization analysis suggested that parental habitual physical activity (HPA) was causally associated with lower risk of CP in their offspring. Together, these findings suggested that parental HPA could benefit their offspring's palatal development through Flna by linking mechanotransduction with the Wnt/TGF-β/Smad signaling pathways during palatal fusion.

    DOI: 10.1101/2024.02.16.580664

    researchmap

  • Ten-m4 plays a unique role in the establishment of binocular visual circuits. International journal

    Timothy R Young, Dylan Black, Hannan Mansuri, Toshitaka Oohashi, Xiao-Hong Zhou, Atomu Sawatari, Catherine A Leamey

    Developmental neurobiology   83 ( 3-4 )   104 - 124   2023

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The patterning of binocular vision requires distinct molecular pathways for inputs arising from each side of the nervous system. Recent studies have demonstrated important roles for members of the Ten-m/Odz/teneurin family in the development of ipsilateral retinal projections. Here, we further highlight the significance of this gene family in visual development by identifying a role for Ten-m4 during the formation of the ipsilateral projection in the mouse. Ten-m4 was found to be expressed in the retina, dorsal lateral geniculate nucleus (dLGN), superior colliculus (SC), and primary visual cortex (V1) during development. Anterograde and retrograde tracing experiments in Ten-m4 knockout (KO) mice revealed a specific increase in ipsilateral retinal ganglion cells projecting to dLGN and SC. This increase was most prominent in regions corresponding to temporal retina. Consistent with this, EphB1 expression in the retina around the time of decussation was enhanced in this temporal region for KO mice, suggesting that the increased size of the ipsilateral population arises due to an increased number of retinal ganglion cells remaining ipsilaterally at the optic chiasm due to EphB1-mediated repulsion. The ectopic ipsilaterally targeted retinal ganglion cell projection observed in Ten-m4 KOs was associated with changes in response to ethologically relevant visual stimuli. Together, these data demonstrate a requirement for Ten-m4 in the establishment of ipsilateral projections from the retina, which likely acts in combination with other Ten-m members (Ten-m2 and Ten-m3) to promote the formation of functional binocular circuits.

    DOI: 10.1002/dneu.22912

    PubMed

    researchmap

  • Aggrecan governs intervertebral discs development by providing critical mechanical cues of the extracellular matrix. International journal

    Marta Empere, Xujia Wang, Carina Prein, Anders Aspberg, Markus Moser, Toshitaka Oohashi, Hauke Clausen-Schaumann, Attila Aszodi, Paolo Alberton

    Frontiers in bioengineering and biotechnology   11   1128587 - 1128587   2023

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Aggrecan (ACAN) is localized in the intervertebral disc (IVD) in unique compartment-specific patterns where it contributes to the tissue structure and mechanical function together with collagens. The extracellular matrix (ECM) of the IVD undergoes degenerative changes during aging, misuse or trauma, which inevitably alter the biochemical and biomechanical properties of the tissue. A deeper understanding of these processes can be achieved in genetically engineered mouse models, taking into account the multifaceted aspects of IVD development. In this study, we generated aggrecan insertion mutant mice (Acan iE5/iE5 ) by interrupting exon 5 coding for the G1 domain of ACAN, and analyzed the morphological and mechanical properties of the different IVD compartments during embryonic development. Western blotting using an antibody against the total core protein failed to detect ACAN in cartilage extracts, whereas immunohistochemistry by a G1-specific antibody showed weak signals in vertebral tissues of Acan iE5/iE5 mice. Homozygous mutant mice are perinatally lethal and characterized by short snout, cleft palate and disproportionate dwarfism. Whole-mount skeletal staining and µ-CT analysis of Acan iE5/iE5 mice at embryonic day 18.5 revealed compressed vertebral bodies with accelerated mineralization compared to wild type controls. In Acan iE5/iE5 mice, histochemical staining revealed collapsed extracellular matrix with negligible sulfated glycosaminoglycan content accompanied by a high cellular density. Collagen type II deposition was not impaired in the IVD of Acan iE5/iE5 mice, as shown by immunohistochemistry. Mutant mice developed a severe IVD phenotype with deformed nucleus pulposus and thinned cartilaginous endplates accompanied by a disrupted growth plate structure in the vertebral body. Atomic force microscopy (AFM) imaging demonstrated a denser collagen network with thinner fibrils in the mutant IVD zones compared to wild type. Nanoscale AFM indentation revealed bimodal stiffness distribution attributable to the softer proteoglycan moiety and harder collagenous fibrils of the wild type IVD ECM. In Acan iE5/iE5 mice, loss of aggrecan resulted in a marked shift of the Young's modulus to higher values in all IVD zones. In conclusion, we demonstrated that aggrecan is pivotal for the determination and maintenance of the proper stiffness of IVD and vertebral tissues, which in turn could play an essential role in providing developmental biomechanical cues.

    DOI: 10.3389/fbioe.2023.1128587

    PubMed

    researchmap

  • Cysteinyl leukotriene receptor 1 is dispensable for osteoclast differentiation and bone resorption. International journal

    Hirofumi Fujita, Aoi Ando, Yohei Mizusawa, Mitsuaki Ono, Takako Hattori, Munenori Habuta, Toshitaka Oohashi, Satoshi Kubota, Hideyo Ohuchi

    PloS one   17 ( 11 )   e0277307   2022

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Cysteinyl leukotriene receptor 1 (CysLTR1) is a G protein-coupled receptor for the inflammatory lipid mediators cysteinyl leukotrienes, which are involved in smooth muscle constriction, vascular permeability, and macrophage chemokine release. The Cysltr1 gene encoding CysLTR1 is expressed in the macrophage lineage, including osteoclasts, and the CysLTR1 antagonist Montelukast has been shown to suppress the formation of osteoclasts. However, it currently remains unclear whether CysLTR1 is involved in osteoclast differentiation and bone loss. Therefore, to clarify the role of CysLTR1 in osteoclastogenesis and pathological bone loss, we herein generated CysLTR1 loss-of-function mutant mice by disrupting the cysltr1 gene using the CRISPR-Cas9 system. These mutant mice had a frameshift mutation resulting in a premature stop codon (Cysltr1 KO) or an in-frame mutation causing the deletion of the first extracellular loop (Cysltr1Δ105). Bone marrow macrophages (BMM) from these mutant mice lost the intracellular flux of calcium in response to leukotriene D4, indicating that these mutants completely lost the activity of CysLTR1 without triggering genetic compensation. However, disruption of the Cysltr1 gene did not suppress the formation of osteoclasts from BMM in vitro. We also demonstrated that the CysLTR1 antagonist Montelukast suppressed the formation of osteoclasts without functional CysLTR1. On the other hand, disruption of the Cysltr1 gene partially suppressed the formation of osteoclasts stimulated by leukotriene D4 and did not inhibit that by glutathione, functioning as a substrate in the synthesis of cysteinyl leukotrienes. Disruption of the Cysltr1 gene did not affect ovariectomy-induced osteoporosis or lipopolysaccharide-induced bone resorption. Collectively, these results suggest that the CysLT-CysLTR1 axis is dispensable for osteoclast differentiation in vitro and pathological bone loss, while the leukotriene D4-CysTR1 axis is sufficient to stimulate osteoclast formation. We concluded that the effects of glutathione and Montelukast on osteoclast formation were independent of CysLTR1.

    DOI: 10.1371/journal.pone.0277307

    PubMed

    researchmap

  • Suppression of Bone Necrosis around Tooth Extraction Socket in a MRONJ-like Mouse Model by E-rhBMP-2 Containing Artificial Bone Graft Administration. Reviewed International journal

    Yukie Tanaka, Kyaw Thu Aung, Mitsuaki Ono, Akihiro Mikai, Anh Tuan Dang, Emilio Satoshi Hara, Ikue Tosa, Kei Ishibashi, Aya Ono-Kimura, Kumiko Nawachi, Takuo Kuboki, Toshitaka Oohashi

    International journal of molecular sciences   22 ( 23 )   2021.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Medication-related osteonecrosis of the jaw (MRONJ) is related to impaired bone healing conditions in the maxillomandibular bone region as a complication of bisphosphonate intake. Although there are several hypotheses for the onset of MRONJ symptoms, one of the possible causes is the inhibition of bone turnover and blood supply leading to bone necrosis. The optimal treatment strategy for MRONJ has not been established either. BMP-2, a member of the TGF-β superfamily, is well known for regulating bone remodeling and homeostasis prenatally and postnatally. Therefore, the objectives of this study were to evaluate whether cyclophosphamide/zoledronate (CY/ZA) induces necrosis of the bone surrounding the tooth extraction socket, and to examine the therapeutic potential of BMP-2 in combination with the hard osteoinductive biomaterial, β-tricalcium phosphate (β-TCP), in the prevention and treatment of alveolar bone loss around the tooth extraction socket in MRONJ-like mice models. First, CY/ZA was intraperitoneally administered for three weeks, and alveolar bone necrosis was evaluated before and after tooth extraction. Next, the effect of BMP-2/β-TCP was investigated in both MRONJ-like prevention and treatment models. In the prevention model, CY/ZA was continuously administered for four weeks after BMP-2/β-TCP transplantation. In the treatment model, CY/ZA administration was suspended after transplantation of BMP-2/β-TCP. The results showed that CY/ZA induced a significant decrease in the number of empty lacunae, a sign of bone necrosis, in the alveolar bone around the tooth extraction socket after tooth extraction. Histological analysis showed a significant decrease in the necrotic alveolar bone around tooth extraction sockets in the BMP-2/β-TCP transplantation group compared to the non-transplanted control group in both MRONJ-like prevention and treatment models. However, bone mineral density, determined by micro-CT analysis, was significantly higher in the BMP-2/β-TCP transplanted group than in the control group in the prevention model only. These results clarified that alveolar bone necrosis around tooth extraction sockets can be induced after surgical intervention under CY/ZA administration. In addition, transplantation of BMP-2/β-TCP reduced the necrotic alveolar bone around the tooth extraction socket. Therefore, a combination of BMP-2/β-TCP could be an alternative approach for both prevention and treatment of MRONJ-like symptoms.

    DOI: 10.3390/ijms222312823

    PubMed

    researchmap

  • Imatinib has minimal effects on inflammatory and osteopenic phenotypes in a murine cherubism model. Reviewed International journal

    Tomoyuki Mukai, Takahiko Akagi, Sumie Hiramatsu Asano, Ikue Tosa, Mitsuaki Ono, Mizuho Kittaka, Yasuyoshi Ueki, Ayano Yahagi, Masanori Iseki, Toshitaka Oohashi, Katsuhiko Ishihara, Yoshitaka Morita

    Oral diseases   29 ( 3 )   1089 - 1101   2021.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: Cherubism is a genetic disorder characterised by bilateral jawbone deformation. The associated jawbone lesions regress after puberty, whereas severe cases require surgical treatment. Although several drugs have been tested, fundamental treatment strategies for cherubism have not been established. The effectiveness of imatinib has recently been reported; however, its pharmaceutical mechanism remains unclear. In this study, we tested the effects of imatinib using a cherubism mouse model. METHODS: We used Sh3bp2 P416R cherubism mutant mice, which exhibit systemic organ inflammation and osteopenia. The effects of imatinib were determined using primary bone marrow-derived macrophages. Imatinib was administered intraperitoneally to the mice, and serum tumour necrosis factor-α (TNFα), organ inflammation and bone properties were examined. RESULTS: The cherubism mutant macrophages produced higher levels of TNFα in response to lipopolysaccharide compared to wild-type macrophages, and imatinib did not significantly suppress TNFα production. Although imatinib suppressed osteoclast formation in vitro, administering it in vivo did not suppress organ inflammation and osteopenia. CONCLUSION: The in vivo administration of imatinib had a minimal therapeutic impact in cherubism mutant mice. To establish better pharmaceutical interventions, it is necessary to integrate new findings from murine models with clinical data from patients with a definitive diagnosis of cherubism.

    DOI: 10.1111/odi.14073

    PubMed

    researchmap

  • Assessment of Possible Contributions of Hyaluronan and Proteoglycan Binding Link Protein 4 to Differential Perineuronal Net Formation at the Calyx of Held. Reviewed International journal

    Kojiro Nojima, Haruko Miyazaki, Tetsuya Hori, Lydia Vargova, Toshitaka Oohashi

    Frontiers in cell and developmental biology   9   730550 - 730550   2021.9

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    The calyx of Held is a giant nerve terminal mediating high-frequency excitatory input to principal cells of the medial nucleus of the trapezoid body (MNTB). MNTB principal neurons are enwrapped by densely organized extracellular matrix structures, known as perineuronal nets (PNNs). Emerging evidence indicates the importance of PNNs in synaptic transmission at the calyx of Held. Previously, a unique differential expression of aggrecan and brevican has been reported at this calyceal synapse. However, the role of hyaluronan and proteoglycan binding link proteins (HAPLNs) in PNN formation and synaptic transmission at this synapse remains elusive. This study aimed to assess immunohistochemical evidence for the effect of HAPLN4 on differential PNN formation at the calyx of Held. Genetic deletion of Hapln4 exhibited a clear ectopic shift of brevican localization from the perisynaptic space between the calyx of Held terminals and principal neurons to the neuropil surrounding the whole calyx of Held terminals. In contrast, aggrecan expression showed a consistent localization at the surrounding neuropil, together with HAPLN1 and tenascin-R, in both gene knockout (KO) and wild-type (WT) mice. An in situ proximity ligation assay demonstrated the molecular association of brevican with HAPLN4 in WT and HAPLN1 in gene KO mice. Further elucidation of the roles of HAPLN4 may highlight the developmental and physiological importance of PNN formation in the calyx of Held.

    DOI: 10.3389/fcell.2021.730550

    PubMed

    researchmap

  • Preclinical bioequivalence study of E.coli-derived rhBMP-2/β-TCP and autogenous bone in a canine guided-bone regeneration model. Reviewed

    Shuji Nosho, Mitsuaki Ono, Taishi Komori, Akihiro Mikai, Ikue Tosa, Kei Ishibashi, Yukie Tanaka, Aya Kimura-Ono, Emilio S Hara, Toshitaka Oohashi, Takuo Kuboki

    Journal of prosthodontic research   66 ( 1 )   124 - 130   2021.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: Bone morphogenetic protein (BMP)-2 is a potent growth factor that is widely used in the orthopedic and dental fields for bone regeneration.However, recombinant human BMP-2 (rhBMP-2) products have not been legally approved in Japan. Recently, our research group succeeded in producing GMP-grade rhBMP-2 using the E. coli system (E-rhBMP-2) at the industrial level and developed E-rhBMP-2 adsorbed onto β-TCP (E-rhBMP-2/β-TCP) as an alternative material to autogenous bone grafts. Previous studies on the toxicity, pharmacokinetics, and optimal doses of E-rhBMP-2 have confirmed its safety and efficiency. However, comparative studies with standard treatment therapies are still necessary before clinical application in humans. Therefore, in this preclinical study, we compared the bone regeneration ability of E-rhBMP-2/β-TCP and autogenous bone grafts in a canine guided-bone regeneration model. METHODS: Following extraction of the maxillary third premolar, box-type bone defects (10 mmL × 4 mmW × 9 mmH) were created in the extraction socket area and transplanted with E-rhBMP-2/β-TCP or autogenous bone graft in a canine. After 8 weeks, micro-CT and histological analyses were performed. RESULTS: Transplantation of both E-rhBMP-2/β-TCP and autogenous bone graft significantly promoted bone formation compared to the non-transplantation control group. The bone formation ability of E-rhBMP-2/β-TCP was equal to that of the autogenous bone graft. Histological analysis showed that excessive infiltration of inflammatory cells and residual β-TCP particles mostly were not observed in the E-rhBMP-2/β-TCP transplantation group. CONCLUSIONS: This preclinical study demonstrated that E-rhBMP-2/β-TCP and autogenous bone have equal potential to promote bone regeneration.

    DOI: 10.2186/jpr.JPR_D_20_00226

    PubMed

    researchmap

  • Lack of collagen α6(IV) chain in mice does not cause severe-to-profound hearing loss or cochlear malformation, a distinct phenotype from nonsyndromic hearing loss with COL4A6 missense mutation. Reviewed International journal

    Shaoying Tang, Tomoko Yonezawa, Yukihide Maeda, Mitsuaki Ono, Takahiro Maeba, Toru Miyoshi, Ryusuke Momota, Yasuko Tomono, Toshitaka Oohashi

    PloS one   16 ( 4 )   e0249909   2021.4

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)  

    Congenital hearing loss affects 1 in every 1000 births, with genetic mutations contributing to more than 50% of all cases. X-linked nonsyndromic hereditary hearing loss is associated with six loci (DFNX1-6) and five genes. Recently, the missense mutation (c.1771G>A, p.Gly591Ser) in COL4A6, encoding the basement membrane (BM) collagen α6(IV) chain, was shown to be associated with X-linked congenital nonsyndromic hearing loss with cochlear malformation. However, the mechanism by which the COL4A6 mutation impacts hereditary hearing loss has not yet been elucidated. Herein, we investigated Col4a6 knockout (KO) effects on hearing function and cochlear formation in mice. Immunohistochemistry showed that the collagen α6(IV) chain was distributed throughout the mouse cochlea within subepithelial BMs underlying the interdental cells, inner sulcus cells, basilar membrane, outer sulcus cells, root cells, Reissner's membrane, and perivascular BMs in the spiral limbus, spiral ligament, and stria vascularis. However, the click-evoked auditory brainstem response analysis did not show significant changes in the hearing threshold of Col4a6 KO mice compared with wild-type (WT) mice with the same genetic background. In addition, the cochlear structures of Col4a6 KO mice did not exhibit morphological alterations, according to the results of high-resolution micro-computed tomography and histology. Hence, loss of Col4a6 gene expression in mice showed normal click ABR thresholds and normal cochlear formation, which differs from humans with the COL4A6 missense mutation c.1771G>A, p.Gly591Ser. Therefore, the deleterious effects in the auditory system caused by the missense mutation in COL4A6 are likely due to the dominant-negative effects of the α6(IV) chain and/or α5α6α5(IV) heterotrimer with an aberrant structure that would not occur in cases with loss of gene expression.

    DOI: 10.1371/journal.pone.0249909

    PubMed

    researchmap

  • Distinct Osteogenic Potentials of BMP-2 and FGF-2 in Extramedullary and Medullary Microenvironments. Reviewed International journal

    Shuji Nosho, Ikue Tosa, Mitsuaki Ono, Emilio Satoshi Hara, Kei Ishibashi, Akihiro Mikai, Yukie Tanaka, Aya Kimura-Ono, Taishi Komori, Kenji Maekawa, Takuo Kuboki, Toshitaka Oohashi

    International journal of molecular sciences   21 ( 21 )   2020.10

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)  

    Bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2) have been regarded as the major cytokines promoting bone formation, however, several studies have reported unexpected results with failure of bone formation or bone resorption of these growth factors. In this study, BMP-2 and FGF-2 adsorbed into atellocollagen sponges were transplanted into bone defects in the bone marrow-scarce calvaria (extramedullary environment) and bone marrow-abundant femur (medullary environment) for analysis of their in vivo effects not only on osteoblasts, osteoclasts but also on bone marrow cells. The results showed that BMP-2 induced high bone formation in the bone marrow-scarce calvaria, but induced bone resorption in the bone marrow-abundant femurs. On the other hand, FGF-2 showed opposite effects compared to those of BMP-2. Analysis of cellular dynamics revealed numerous osteoblasts and osteoclasts present in the newly-formed bone induced by BMP-2 in calvaria, but none were seen in either control or FGF-2-transplanted groups. On the other hand, in the femur, numerous osteoclasts were observed in the vicinity of the BMP-2 pellet, while a great number of osteoblasts were seen near the FGF-2 pellets or in the control group. Of note, FCM analysis showed that both BMP-2 and FGF-2 administrated in the femur did not significantly affect the hematopoietic cell population, indicating a relatively safe application of the two growth factors. Together, these results indicate that BMP-2 could be suitable for application in extramedullary bone regeneration, whereas FGF-2 could be suitable for application in medullary bone regeneration.

    DOI: 10.3390/ijms21217967

    PubMed

    researchmap

  • BMP-2/β-TCP Local Delivery for Bone Regeneration in MRONJ-Like Mouse Model. Reviewed International journal

    Mikai A, Ono M, Tosa I, Nguyen HTT, Hara ES, Nosho S, Kimura-Ono A, Nawachi K, Takarada T, Kuboki T, Oohashi T

    Int J Mol Sci.   21 ( 19 )   E7028   2020.9

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)  

    Medication-related osteonecrosis of the jaw (MRONJ) is a severe pathological condition associated mainly with the long-term administration of bone resorption inhibitors, which are known to induce suppression of osteoclast activity and bone remodeling. Bone Morphogenetic Protein (BMP)-2 is known to be a strong inducer of bone remodeling, by directly regulating osteoblast differentiation and osteoclast activity. This study aimed to evaluate the effects of BMP-2 adsorbed onto beta-tricalcium phosphate (β-TCP), which is an osteoinductive bioceramic material and allows space retention, on the prevention and treatment of MRONJ in mice. Tooth extraction was performed after 3 weeks of zoledronate (ZA) and cyclophosphamide (CY) administration. For prevention studies, BMP-2/β-TCP was transplanted immediately after tooth extraction, and the mice were administered ZA and CY for an additional 4 weeks. The results showed that while the tooth extraction socket was mainly filled with a sparse tissue in the control group, bone formation was observed at the apex of the tooth extraction socket and was filled with a dense connective tissue rich in cellular components in the BMP-2/β-TCP transplanted group. For treatment studies, BMP-2/β-TCP was transplanted 2 weeks after tooth extraction, and bone formation was followed up for the subsequent 4 weeks under ZA and CY suspension. The results showed that although the tooth extraction socket was mainly filled with soft tissue in the control group, transplantation of BMP-2/β-TCP could significantly accelerate bone formation, as shown by immunohistochemical analysis for osteopontin, and reduce the bone necrosis in tooth extraction sockets. These data suggest that the combination of BMP-2/β-TCP could become a suitable therapy for the management of MRONJ.

    DOI: 10.3390/ijms21197028

    PubMed

    researchmap

  • The Effect of Hapln4 Link Protein Deficiency on Extracellular Space Diffusion Parameters and Perineuronal Nets in the Auditory System During Aging. Reviewed International journal

    Petra Sucha, Martina Chmelova, Monika Kamenicka, Marcel Bochin, Toshitaka Oohashi, Lydia Vargova

    Neurochemical research   45 ( 1 )   68 - 82   2020.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Hapln4 is a link protein which stabilizes the binding between lecticans and hyaluronan in perineuronal nets (PNNs) in specific brain regions, including the medial nucleus of the trapezoid body (MNTB). The aim of this study was: (1) to reveal possible age-related alterations in the extracellular matrix composition in the MNTB and inferior colliculus, which was devoid of Hapln4 and served as a negative control, (2) to determine the impact of the Hapln4 deletion on the values of the ECS diffusion parameters in young and aged animals and (3) to verify that PNNs moderate age-related changes in the ECS diffusion, and that Hapln4-brevican complex is indispensable for the correct protective function of the PNNs. To achieve this, we evaluated the ECS diffusion parameters using the real-time iontophoretic method in the selected region in young adult (3 to 6-months-old) and aged (12 to 18-months-old) wild type and Hapln4 knock-out (KO) mice. The results were correlated with an immunohistochemical analysis of the ECM composition and astrocyte morphology. We report that the ECM composition is altered in the aged MNTB and aging is a critical point, revealing the effect of Hapln4 deficiency on the ECS diffusion. All of our findings support the hypothesis that the ECM changes in the MNTB of aged KO animals affect the ECS parameters indirectly, via morphological changes of astrocytes, which are in direct contact with synapses and can be influenced by the ongoing synaptic transmission altered by shifts in the ECM composition.

    DOI: 10.1007/s11064-019-02894-2

    PubMed

    researchmap

  • Mechanical strain attenuates cytokine-induced ADAMTS9 expression via transient receptor potential vanilloid type 1. Reviewed International journal

    Takashi Ohtsuki, Akira Shinaoka, Kanae Kumagishi-Shinaoka, Keiichi Asano, Omer Faruk Hatipoglu, Junko Inagaki, Ken Takahashi, Toshitaka Oohashi, Keiichiro Nishida, Keiji Naruse, Satoshi Hirohata

    Experimental cell research   383 ( 2 )   111556 - 111556   2019.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The synovial fluids of patients with osteoarthritis (OA) contain elevated levels of inflammatory cytokines, which induce the expression of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) and of the matrix metalloproteinase (MMP) in chondrocytes. Mechanical strain has varying effects on organisms depending on the strength, cycle, and duration of the stressor; however, it is unclear under inflammatory stimulation how mechanical strain act on. Here, we show that mechanical strain attenuates inflammatory cytokine-induced expression of matrix-degrading enzymes. Cyclic tensile strain (CTS), as a mechanical stressor, attenuated interleukin (IL)-1β and tumor necrosis factor (TNF)-α-induced mRNA expression of ADAMTS4, ADAMTS9, and MMP-13 in normal chondrocytes (NHAC-kn) and in a chondrocytic cell line (OUMS-27). This effect was abolished by treating cells with mechano-gated channel inhibitors, such as gadolinium, transient receptor potential (TRP) family inhibitor, ruthenium red, and with pharmacological and small interfering RNA-mediated TRPV1 inhibition. Furthermore, nuclear factor κB (NF-κB) translocation from the cytoplasm to the nucleus resulting from cytokine stimulation was also abolished by CTS. These findings suggest that mechanosensors such as the TRPV protein are potential therapeutic targets in treating OA.

    DOI: 10.1016/j.yexcr.2019.111556

    Web of Science

    PubMed

    researchmap

  • Type XVIII Collagen Modulates Keratohyalin Granule Formation and Keratinization in Oral Mucosa. Reviewed International journal

    Ha Thi Thu Nguyen, Mitsuaki Ono, Emilio Satoshi Hara, Taishi Komori, Midori Edamatsu, Tomoko Yonezawa, Aya Kimura-Ono, Kenji Maekawa, Takuo Kuboki, Toshitaka Oohashi

    International journal of molecular sciences   20 ( 19 )   2019.9

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)  

    Epithelial keratinization involves complex cellular modifications that provide protection against pathogens and chemical and mechanical injuries. In the oral cavity, keratinized mucosa is also crucial to maintain healthy periodontal or peri-implant tissues. In this study, we investigated the roles of type XVIII collagen, a collagen-glycosaminoglycan featuring an extracellular matrix component present in the basement membrane, in oral mucosal keratinization. Histological analysis of keratinized and non-keratinized oral mucosa showed that type XVIII collagen was highly expressed in keratinized mucosa. Additionally, a 3D culture system using human squamous carcinoma cells (TR146) was used to evaluate and correlate the changes in the expression of type XVIII collagen gene, COL18A1, and epithelial keratinization-related markers, e.g., keratin 1 (KRT1) and 10 (KRT10). The results showed that the increase in COL18A1 expression followed the increase in KRT1 and KRT10 mRNA levels. Additionally, loss-of-function analyses using silencing RNA targeting COL18A1 mRNA and a Col18-knockout (KO) mouse revealed that the absence of type XVIII collagen induces a dramatic decrease in KRT10 expression as well as in the number and size of keratohyalin granules. Together, the results of this study demonstrate the importance of type XVIII collagen in oral mucosal keratinization.

    DOI: 10.3390/ijms20194739

    PubMed

    researchmap

  • Postnatal Runx2 deletion leads to low bone mass and adipocyte accumulation in mice bone tissues. Reviewed International journal

    Ikue Tosa, Daisuke Yamada, Misa Yasumatsu, Eiichi Hinoi, Mitsuaki Ono, Toshitaka Oohashi, Takuo Kuboki, Takeshi Takarada

    Biochemical and biophysical research communications   516 ( 4 )   1229 - 1233   2019.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Global gene deletion studies have established that Runt-related transcription factor-2 (Runx2) is essential during skeletogenesis for osteoblastic differentiation in both intramembranous and endochondral ossification processes. However, the postnatal significance of Runx2 in vivo is poorly understood because a global Runx2 deletion causes perinatal lethality. In this study, we generated tamoxifen-induced Runx2 global deficient mice by crossing Runx2flox mice with ROSA26-CreERT2 mice (Rosa26-CreERT2; Runx2flox/flox). Four-week-old mice were intraperitoneally treated with tamoxifen for five consecutive days, sacrificed, and analyzed six weeks after tamoxifen administration. Deletion of Runx2 led to low bone mass, which is associated with decreased bone formation and bone resorption as well as excessive bone marrow adiposity. Collectively, postnatal Runx2 absolutely plays an important role in maintaining the homeostasis of bone tissues not only in bone mass, but also in the bone marrow environment.

    DOI: 10.1016/j.bbrc.2019.07.014

    PubMed

    researchmap

  • Collagen XVIII Deposition in the Basement Membrane Zone beneath the Newly Forming Epidermis during Wound Healing in Mice. Reviewed

    Takahiro Maeba, Tomoko Yonezawa, Mitsuaki Ono, Yasuko Tomono, Ritva Heljasvaara, Taina Pihlajaniemi, Kiichi Inagawa, Toshitaka Oohashi

    Acta medica Okayama   73 ( 2 )   135 - 146   2019.4

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)  

    The basement membrane (BM) is composed of various extracellular molecules and regulates tissue regeneration and maintenance. Here, we demonstrate that collagen XVIII was spatiotemporally expressed in the BM during skin wound healing in a mouse excisional wound-splinting model. Re-epithelialization was detected at days 3 and 6 post-wounding. The ultrastructure of epidermal BM was discontinuous at day 3, whereas on day 6 a continuous BM was observed in the region proximal to the wound edge. Immunohistochemistry demonstrated that collagen XVIII was deposited in the BM zone beneath newly forming epidermis in day 3 and 6 wounds. Laminin-332, known to be the earliest BM component appearing in wounds, was colocalized with collagen XVIII in the epidermal BM zone at days 3 and 6. The deposition of α1(IV) collagen and nidogen-1 in the epidermal BM zone occurred later than that of collagen XVIII. We also observed the short isoform of collagen XVIII in the epidermal BM zone at day 3 post-wounding. Collectively, our results suggested that collagen XVIII plays a role in the formation of the dermal-epidermal junction during re-epithelialization, and that it is the short isoform that is involved in the early phase of re-epithelialization.

    DOI: 10.18926/AMO/56649

    PubMed

    researchmap

  • Acidic Pre-Conditioning Enhances the Stem Cell Phenotype of Human Bone Marrow Stem/Progenitor Cells. Reviewed International journal

    Yuri Hazehara-Kunitomo, Emilio Satoshi Hara, Mitsuaki Ono, Kyaw Thu Aung, Keiko Komi, Hai Thanh Pham, Kentaro Akiyama, Masahiro Okada, Toshitaka Oohashi, Takuya Matsumoto, Takuo Kuboki

    International journal of molecular sciences   20 ( 5 )   2019.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A deeper understanding of the detailed mechanism of in vivo tissue healing is necessary for the development of novel regenerative therapies. Among several external factors, environmental pH is one of the crucial parameters that greatly affects enzyme activity and cellular biochemical reactions involving tissue repair and homeostasis. In this study, in order to analyze the microenvironmental conditions during bone healing, we first measured the pH in vivo at the bone healing site using a high-resolution fiber optic pH microsensor directly in femur defects and tooth extraction sockets. The pH was shown to decrease from physiological 7.4 to 6.8 during the initial two days of healing (inflammatory phase). In the same initial stages of the inflammatory phase of the bone healing process, mesenchymal stem cells (MSCs) are known to migrate to the healing site to contribute to tissue repair. Therefore, we investigated the effect of a short-term acidic (pH 6.8) pre-treatment on the stemness of bone marrow-derived MSCs (BMSCs). Interestingly, the results showed that pre-treatment of BMSCs with acidic pH enhances the expression of stem cell markers (OCT-4, NANOG, SSEA-4), as well as cell viability and proliferation. On the other hand, acidic pH decreased BMSC migration ability. These results indicate that acidic pH during the initial stages of bone healing is important to enhance the stem cell properties of BMSCs. These findings may enable the development of novel methods for optimization of stem cell function towards tissue engineering or regenerative medicine.

    DOI: 10.3390/ijms20051097

    PubMed

    researchmap

  • Bone Marrow Cells Inhibit BMP-2-Induced Osteoblast Activity in the Marrow Environment. Reviewed International journal

    Ha Thi Nguyen, Mitsuaki Ono, Yasutaka Oida, Emilio Satoshi Hara, Taishi Komori, Kentaro Akiyama, Ha Thi Thu Nguyen, Kyaw Thu Aung, Hai Thanh Pham, Ikue Tosa, Takeshi Takarada, Koichi Matsuo, Toshihide Mizoguchi, Toshitaka Oohashi, Takuo Kuboki

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research   34 ( 2 )   327 - 332   2019.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Bone morphogenetic protein 2 (BMP-2) is widely known as a potent growth factor that promotes bone formation. However, an increasing number of studies have demonstrated side effects of BMP-2 therapy. A deeper understanding of the effect of BMP-2 on cells other than those involved directly in bone remodeling is of fundamental importance to promote a more effective delivery of BMP-2 to patients. In this study, we aimed to investigate the effect of BMP-2 in the marrow environment. First, BMP-2 adsorbed onto titanium implants was delivered at the tooth extraction socket (marrow-absent site) or in the mandible marrow of beagle dogs. BMP-2 could induce marked bone formation around the implant at the tooth extraction socket. Surprisingly, however, no bone formation was observed in the BMP-2-coated titanium implants inserted in the mandible marrow. In C57BL/6 mice, BMP-2 adsorbed in freeze-dried collagen pellets could induce bone formation in marrow-absent calvarial bone. However, similar to the canine model, BMP-2 could not induce bone formation in the femur marrow. Analysis of osteoblast differentiation using Col1a1(2.3)-GFP transgenic mice revealed a scarce number of osteoblasts in BMP-2-treated femurs, whereas in the control group, osteoblasts were abundant. Ablation of femur marrow recovered the BMP-2 ability to induce bone formation. In vitro experiments analyzing luciferase activity of C2C12 cells with the BMP-responsive element and alkaline phosphatase activity of MC3T3-E1 osteoblasts further revealed that bone marrow cells inhibit the BMP-2 effect on osteoblasts by direct cell-cell contact. Collectively, these results showed that the effect of BMP-2 in inducing bone formation is remarkably repressed by marrow cells via direct cell-cell contact with osteoblasts; this opens new perspectives on the clarification of the side-effects associated with BMP-2 application. © 2018 American Society for Bone and Mineral Research.

    DOI: 10.1002/jbmr.3598

    PubMed

    researchmap

  • Under the ECM Dome: The Physiological Role of the Perinodal Extracellular Matrix as an Ion Diffusion Barrier. Reviewed International journal

    Yoko Bekku, Toshitaka Oohashi

    Advances in experimental medicine and biology   1190   107 - 122   2019

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Enriched Na+ channel clustering allows for rapid saltatory conduction at a specialized structure in myelinated axons, the node of Ranvier, where cations are exchanged across the axon membrane. In the extracellular matrix (ECM), highly negatively charged molecules accumulate and wrap around the nodal gaps creating an ECM dome, called the perinodal ECM. The perinodal ECM has different molecular compositions in the central nervous system (CNS) and peripheral nervous system (PNS). Chondroitin sulfate proteoglycans are abundant in the ECM at the CNS nodes, whereas heparan sulfate proteoglycans are abundant at the PNS nodes. The proteoglycans have glycosaminoglycan chains on their core proteins, which makes them electrostatically negative. They associate with other ECM molecules and form a huge stable ECM complex at the nodal gaps. The polyanionic molecular complexes have high affinity to cations and potentially contribute to preventing cation diffusion at the nodes.In this chapter, we describe the molecular composition of the perinodal ECM in the CNS and PNS, and discuss their physiological role at the node of Ranvier.

    DOI: 10.1007/978-981-32-9636-7_8

    PubMed

    researchmap

  • Inhibition of the glutamine transporter SNAT1 confers neuroprotection in mice by modulating the mTOR-autophagy system. Reviewed International journal

    Daisuke Yamada, Kenji Kawabe, Ikue Tosa, Shunpei Tsukamoto, Ryota Nakazato, Miki Kou, Koichi Fujikawa, Saki Nakamura, Mitsuaki Ono, Toshitaka Oohashi, Mari Kaneko, Shioi Go, Eiichi Hinoi, Yukio Yoneda, Takeshi Takarada

    Communications biology   2   346 - 346   2019

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The pathophysiological role of mammalian target of rapamycin complex 1 (mTORC1) in neurodegenerative diseases is established, but possible therapeutic targets responsible for its activation in neurons must be explored. Here we identified solute carrier family 38a member 1 (SNAT1, Slc38a1) as a positive regulator of mTORC1 in neurons. Slc38a1
    flox/flox
    and Synapsin I-Cre mice were crossed to generate mutant mice in which Slc38a1 was selectively deleted in neurons. Measurement of 2,3,5-triphenyltetrazolium chloride (TTC) or the MAP2-negative area in a mouse model of middle cerebral artery occlusion (MCAO) revealed that Slc38a1 deficiency decreased infarct size. We found a transient increase in the phosphorylation of p70S6k1 (pp70S6k1) and a suppressive effect of rapamycin on infarct size in MCAO mice. Autophagy inhibitors completely mitigated the suppressive effect of SNAT1 deficiency on neuronal cell death under in vitro stroke culture conditions. These results demonstrate that SNAT1 promoted ischemic brain damage via mTOR-autophagy system.

    DOI: 10.1038/s42003-019-0582-4

    PubMed

    researchmap

  • DNA Methylation-Based Regulation of Human Bone Marrow-Derived Mesenchymal Stem/Progenitor Cell Chondrogenic Differentiation. Reviewed International journal

    Yu Nomura, Emilio Satoshi Hara, Yuya Yoshioka, Há Thi Nguyen, Shuji Nosho, Taishi Komori, Kei Ishibashi, Toshitaka Oohashi, Mitsuaki Ono, Takuo Kuboki

    Cells, tissues, organs   207 ( 3-4 )   115 - 126   2019

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Stem cells have essential applications in in vitro tissue engineering or regenerative medicine. However, there is still a need to understand more deeply the mechanisms of stem cell differentiation and to optimize the methods to control stem cell function. In this study, we first investigated the activity of DNA methyltransferases (DNMTs) during chondrogenic differentiation of human bone marrow-derived mesenchymal stem/progenitor cells (hBMSCs) and found that DNMT3A and DNMT3B were markedly upregulated during hBMSC chondrogenic differentiation. In an attempt to understand the effect of DNMT3A and DNMT3B on the chondrogenic differentiation of hBMSCs, we transiently transfected the cells with expression vectors for the two enzymes. Interestingly, DNMT3A overexpression strongly enhanced the chondrogenesis of hBMSCs, by increasing the gene expression of the mature chondrocyte marker, collagen type II, more than 200-fold. Analysis of the methylation condition in the cells revealed that DNMT3A and DNMT3B methylated the promoter sequence of early stem cell markers, NANOG and POU5F1(OCT-4). Conversely, the suppression of chondrogenic differentiation and the increase in stem cell markers of hBMSCs were obtained by chemical stimulation with the demethylating agent, 5-azacitidine. Loss-of-function assays with siRNAs targeting DNMT3A also significantly suppressed the chondrogenic differentiation of hBMSCs. Together, these results not only show the critical roles of DNMTs in regulating the chondrogenic differentiation of hBMSCs, but also suggest that manipulation of DNMT activity can be important tools to enhance the differentiation of hBMSCs towards chondrogenesis for potential application in cartilage tissue engineering or cartilage regeneration.

    DOI: 10.1159/000502885

    PubMed

    researchmap

  • Unripe peach (Prunus persica) extract ameliorates damage from UV irradiation and improved collagen XVIII expression in 3D skin model. Reviewed International journal

    Tomoko Yonezawa, Ryusuke Momota, Hideki Iwano, Steven Zhao, Tomohiro Hakozaki, Chieko Soh, Shigetoyo Sawaki, Kazumi Toyama, Toshitaka Oohashi

    Journal of cosmetic dermatology   2018.12

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)  

    INTRODUCTION: Collagen type XVIII regulates cellular activities of adjacent cells at the dermal-epidermal junction (DEJ). To investigate its possible changes during aging, we compared its mRNA levels and protein localization in skin samples from female participants aged 20-70 years old. In addition, we evaluated the beneficial effects of unripe peach extracts in a 3D skin model. METHODS: Sun-exposed or sun-protected female skin samples were compared by DNA array or by immunohistochemistry for basement membrane components. To evaluate protective effects of fresh unripe peach extract, UV-B irradiated human 3D skin models were incubated in the presence or absence of the extract, followed by measurements of mRNA levels by real-time PCR, or by immunohistochemistry. RESULTS: In aged skin samples, COL18A1 mRNA levels were lower and the protein localization exhibited less intensive signal by anti-collagen type XVIII immunostaining. As observed in the skin tissues, collagen type XVIII exists at the DEJ in the 3D skin model. Fresh unripe peach extract significantly improved mRNA levels and partially localizations of collagen type XVIII, suggesting that fresh unripe peach extract ameliorates DEJ damages caused by UV-B irradiation. CONCLUSION: Collagen type XVIII and fresh unripe peach extract can be promising protective cosmetic strategies against skin aging.

    DOI: 10.1111/jocd.12841

    PubMed

    researchmap

  • High molecular weight hyaluronan protects cartilage from degradation by inhibiting aggrecanase expression. Reviewed International journal

    Takashi Ohtsuki, Keiichi Asano, Junko Inagaki, Akira Shinaoka, Kanae Kumagishi-Shinaoka, Mehmet Z Cilek, Omer F Hatipoglu, Toshitaka Oohashi, Keiichiro Nishida, Issei Komatsubara, Satoshi Hirohata

    Journal of orthopaedic research : official publication of the Orthopaedic Research Society   36 ( 12 )   3247 - 3255   2018.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Hyaluronan (HA) is an extracellular matrix (ECM) component of articular cartilage and has been used to treat patients with osteoarthritis (OA). A disintegrin and metalloproteinases with thrombospondin motifs (ADAMTSs) play an important role in cartilage degradation in OA. We have previously reported that ADAMTS4 and ADAMTS9 were induced by cytokine stimulation. However, the effect of HA on the cytokine-inducible ADAMTS9 has never been investigated. Moreover, it is unclear whether HA protects cartilage by suppressing aggrecan degradation. Here, we examined the effects of HA on ADAMTS expression in vitro and on cartilage degradation in vivo. ADAMTS9 expression was higher than that of the other aggrecanases (ADAMTS4 and 5) in human chondrocytes, chondrocytic cells, and rat cartilage. ADAMTS4 and 9 mRNA levels were upregulated in cytokine-stimulated chondrocytes and chondrocytic cells. Pre-incubation with HA significantly inhibited ADAMTS9 mRNA expression in cytokine-stimulated cells. In a rat OA model, Adamts5 and 9 mRNA levels were transiently increased after surgery; intra-articular HA injections attenuated the induction of Adamts5 and 9 mRNA. HA also blocked aggrecan cleavage by aggrecanase in OA rats in a molecular size-dependent manner. These results demonstrate that HA attenuates induced aggrecanases expression in OA and thereby protects articular cartilage degradation by this enzyme. Our findings provide insight into the molecular basis for the beneficial effects of HA in OA. © 2018 The Authors. Journal of Orthopaedic Research® Published by Wiley Periodicals, Inc. on behalf of Orthopaedic Research Society. J Orthop Res 36:3247-3255, 2018.

    DOI: 10.1002/jor.24126

    PubMed

    researchmap

  • Hapln4/Bral2 is a selective regulator for formation and transmission of GABAergic synapses between Purkinje and deep cerebellar nuclei neurons. Reviewed International journal

    Midori Edamatsu, Rinako Miyano, Atsushi Fujikawa, Fuminari Fujii, Tetsuya Hori, Takeshi Sakaba, Toshitaka Oohashi

    Journal of neurochemistry   147 ( 6 )   748 - 763   2018.12

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Purkinje cells (PCs) convey the sole output of the cerebellar cortex to the deep cerebellar nuclei (DCN). DCN neurons are enwrapped in densely organized extracellular matrix structures, known as perineuronal nets (PNNs). PNNs are typically found around fast-spiking GABAergic interneurons expressing parvalbumin but interestingly also exist surrounding other neurons, such as the neurons in the DCN and medial nucleus of the trapezoid body, which are the post-synaptic neurons of large axo-somatic synapses adapted for fast signaling. This characteristic localization prompted the hypothesis that PNNs might play a role in the maintenance and formation of large fast-signaling synapses. To elucidate the role of the PNN at these synapses, we investigated the electrophysiological and morphological properties of DCN synapses in hyaluronan and proteoglycan binding link protein 4 (Hapln4/Bral2) knockout (KO) mice around postnatal day (P)14. Hapln4/Bral2 is important for PNN structure, as it stabilizes the interaction between hyaluronan and proteoglycan. Here, using immunohistochemistry we show that Hapln4/Bral2 localized closely with GABAergic terminals. In DCN neurons of Hapln4/Bral2 KO mice, inhibitory synaptic strengths were reduced as compared to those in wild-type mice, whereas the properties of excitatory synapses were unaffected. The reduced IPSC amplitudes were mainly because of reduced numbers of releasable vesicles. Moreover, Hapln4/Bral2 deficiency reduced the number of PC GABAergic terminals in the DCN. These results demonstrate that Hapln4/Bral2 is a PNN component that selectively contributes to formation and transmission of PC-DCN synapses in the cerebellum. OPEN SCIENCE BADGES: This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at https://cos.io/our-services/open-science-badges/.

    DOI: 10.1111/jnc.14571

    PubMed

    researchmap

  • Host-produced ADAMTS4 Inhibits Early-Stage Tumor Growth. Reviewed

    Keiichi Asano, Midori Edamatsu, Omer F Hatipoglu, Junko Inagaki, Mitsuaki Ono, Takashi Ohtsuki, Toshitaka Oohashi, Satoshi Hirohata

    Acta medica Okayama   72 ( 3 )   257 - 266   2018.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Several research groups demonstrated that 'a disintegrin-like and metalloproteinase with thrombospondin type 1 motifs (ADAMTS)'-family proteases play roles in cancer progression. However, the origins and contributions of these proteases are not known. Here, we demonstrate an association between host-produced ADAMTS4 and early-stage tumor growth. Murine Lewis lung carcinoma (LLC) tumors showed marked expressions of Adamts4 and Adamts5. We examined the contributions and distributions of host-derived Adamts4 and Adamts5 on tumor growth, using Adamts4LacZ/LacZ and Adamts5LacZ/LacZ knockout mice. Interestingly, the Adamts4LacZ/LacZ mice showed enhanced tumor growth compared to wild-type mice at 5-, 10- and 12-days post-inoculation, whereas the Adamts5LacZ/LacZ mice did not show significant differences in tumor growth. We next examined LacZ distribution in LLC tumor-bearing Adamts4LacZ/LacZ mice by β-galactosidase (β-gal) staining. We found that the β-gal-positive signals were strictly localized at the interior areas of the tumor at 10 days post-inoculation. Multiple staining demonstrated that most of the β-gal-positive cells were localized at the tumor vasculature in Adamts4LacZ/LacZ mice. Interestingly, β-gal-positive signals were not co-localized with biglycan after 10 days post-inoculation, excluding the biglycan cleavage by host-derived ADAMTS4. Taken together, these findings illustrate that host-derived ADAMTS4 was expressed at the tumor vessels and was associated with early-stage tumor growth.

    DOI: 10.18926/AMO/56071

    PubMed

    researchmap

  • Physiological role of urothelial cancer-associated one long noncoding RNA in human skeletogenic cell differentiation. Reviewed International journal

    Takanori Ishikawa, Takashi Nishida, Mitsuaki Ono, Takeshi Takarada, Ha Thi Nguyen, Shinnosuke Kurihara, Takayuki Furumatsu, Yurika Murase, Masaharu Takigawa, Toshitaka Oohashi, Hiroshi Kamioka, Satoshi Kubota

    Journal of cellular physiology   233 ( 6 )   4825 - 4840   2018.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A vast number of long-noncoding RNAs (lncRNA) are found expressed in human cells, which RNAs have been developed along with human evolution. However, the physiological functions of these lncRNAs remain mostly unknown. In the present study, we for the first time uncovered the fact that one of such lncRNAs plays a significant role in the differentiation of chondrocytes and, possibly, of osteoblasts differentiated from mesenchymal stem cells, which cells eventually construct the human skeleton. The urothelial cancer-associated 1 (UCA1) lncRNA is known to be associated with several human malignancies. Firstly, we confirmed that UCA1 was expressed in normal human chondrocytes, as well as in a human chondrocytic cell line; whereas it was not detected in human bone marrow mesenchymal stem cells (hBMSCs). Of note, although UCA1 expression was undetectable in hBMSCs, it was markedly induced along with the differentiation toward chondrocytes, suggesting its critical role in chondrogenesis. Consistent with this finding, silencing of the UCA1 gene significantly repressed the expression of chondrogenic genes in human chondrocytic cells. UCA1 gene silencing and hyper-expression also had a significant impact on the osteoblastic phenotype in a human cell line. Finally, forced expression of UCA1 in a murine chondrocyte precursor, which did not possess a UCA1 gene, overdrove its differentiation into chondrocytes. These results indicate a physiological and important role of this lncRNA in the skeletal development of humans, who require more sustained endochondral ossification and osteogenesis than do smaller vertebrates.

    DOI: 10.1002/jcp.26285

    PubMed

    researchmap

  • Type IV collagen α6 chain is a regulator of keratin 10 in keratinization of oral mucosal epithelium. Reviewed International journal

    Taishi Komori, Mitsuaki Ono, Emilio Satoshi Hara, Junji Ueda, Ha Thi Thu Nguyen, Ha Thi Nguyen, Tomoko Yonezawa, Takahiro Maeba, Aya Kimura-Ono, Takeshi Takarada, Ryusuke Momota, Kenji Maekawa, Takuo Kuboki, Toshitaka Oohashi

    Scientific reports   8 ( 1 )   2612 - 2612   2018.2

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)  

    Keratinized mucosa is of fundamental importance to maintain healthy gingival tissue, and understanding the mechanisms of oral mucosa keratinization is crucial to successfully manage healthy gingiva. Previous studies have shown a strong involvement of the basement membrane in the proliferation and differentiation of epithelial cells. Therefore, first, to identify the keratinized mucosa-specific basement membrane components, immunohistochemical analysis for the six alpha chains of type IV collagen was performed in 8-week-old mice. No difference in the expression pattern of type IV collagen α1(IV) and α2(IV) chains was observed in the keratinized and non-keratinized mucosa. Interestingly, however, type IV collagen α5(IV) and α6(IV) chains specifically were strongly detected in the keratinized mucosa. To analyze the functional roles of the type IV collagen isoform α6(IV) in oral mucosa keratinization, we analyzed Col4a6-knockout mice. Epithelial developmental delay and low levels of KRT10 were observed in new-born Col4a6-knockout mice. Additionally, in vitro experiments with loss-of function analysis using human gingival epithelial cells confirmed the important role of α6(IV) chain in epithelial keratinization. These findings indicate that α112:α556 (IV) network, which is the only network that includes the α6(IV) chain, is one regulator of KRT10 expression in keratinization of oral mucosal epithelium.

    DOI: 10.1038/s41598-018-21000-0

    Scopus

    PubMed

    researchmap

  • A deficiency of the link protein Bral2 affects the size of the extracellular space in the thalamus of aged mice. Reviewed International journal

    Michal Cicanic, Midori Edamatsu, Yoko Bekku, Ivan Vorisek, Toshitaka Oohashi, Lydia Vargova

    Journal of neuroscience research   96 ( 2 )   313 - 327   2018.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Bral2 is a link protein stabilizing the binding between lecticans and hyaluronan in perineuronal nets and axonal coats (ACs) in specific brain regions. Using the real-time iontophoretic method and diffusion-weighted magnetic resonance, we determined the extracellular space (ECS) volume fraction (α), tortuosity (λ), and apparent diffusion coefficient of water (ADCW ) in the thalamic ventral posteromedial nucleus (VPM) and sensorimotor cortex of young adult (3-6 months) and aged (14-20 months) Bral2-deficient (Bral2-/- ) mice and age-matched wild-type (wt) controls. The results were correlated with an analysis of extracellular matrix composition. In the cortex, no changes between wt and Bral2-/- were detected, either in the young or aged mice. In the VPM of aged but not in young Bral2-/- mice, we observed a significant decrease in α and ADCW in comparison with age-matched controls. Bral2 deficiency led to a reduction of both aggrecan- and brevican-associated perineuronal nets and a complete disruption of brevican-based ACs in young as well as aged VPM. Our data suggest that aging is a critical point that reveals the effect of Bral2 deficiency on VPM diffusion. This effect is probably mediated through the enhanced age-related damage of neurons lacking protective ACs, or the exhausting of compensatory mechanisms maintaining unchanged diffusion parameters in young Bral2-/- animals. A decreased ECS volume in aged Bral2-/- mice may influence the diffusion of neuroactive substances, and thus extrasynaptic and also indirectly synaptic transmission in this important nucleus of the somatosensory pathway.

    DOI: 10.1002/jnr.24136

    PubMed

    researchmap

  • Stromal Versican Regulates Tumor Growth by Promoting Angiogenesis Reviewed

    Keiichi Asano, Courtney M. Nelson, Sumeda Nandadasa, Noriko Aramaki-Hattori, Daniel J. Lindner, Tyler Alban, Junko Inagaki, Takashi Ohtsuki, Toshitaka Oohashi, Suneel S. Apte, Satoshi Hirohata

    SCIENTIFIC REPORTS   7   2017.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    The proteoglycan versican is implicated in growth and metastases of several cancers. Here we investigated a potential contribution of stromal versican to tumor growth and angiogenesis. We initially determined versican expression by several cancer cell lines. Among these, MDA-MB231 and B16F10 had none to minimal expression in contrast to Lewis lung carcinoma (LLC). Notably, tumors arising from these cell lines had higher versican levels than the cell lines themselves suggesting a contribution from the host-derived tumor stroma. In LLC-derived tumors, both the tumor and stroma expressed versican at high levels. Thus, tumor stroma can make a significant contribution to tumor versican content. Versican localized preferentially to the vicinity of tumor vasculature and macrophages in the tumor. However, an ADAMTS protease-generated versican fragment uniquely localized to vascular endothelium. To specifically determine the impact of host/stroma-derived versican we therefore compared growth of tumors from B16F10 cells, which produced littleversican, in Vcan(hdf/+) mice and wild-type littermates. Tumors in Vcan(hdf/+) mice had reduced growth with a lower capillary density and accumulation of capillaries at the tumor periphery. These findings illustrate the variability of tumor cell line expression of versican, and demonstrate that versican is consistently contributed by the stromal tissue, where it contributes to tumor angiogenesis.

    DOI: 10.1038/s41598-017-17613-6

    Web of Science

    researchmap

  • Monoclonal Suncus Antibodies: Generation of Fusion Partners to Produce Suncus-Suncus Hybridomas. Reviewed

    Yoshikazu Sado, Satoko Inoue, Yasuko Tomono, Makoto Matsuyama, Masaki Fukushima, Toshitaka Oohashi, Takamichi Jogahara, Sen-Ichi Oda

    Acta histochemica et cytochemica   50 ( 2 )   71 - 84   2017.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We used suncus (Suncus murinus; house musk shrew) to generate partner cells for cell fusion to produce suncus monoclonal antibodies. Suncus are insectivores that are genetically distant to rodents, and recognize antigens and epitopes that are not immunogenic in mice and rats, which are the animals most commonly used in basic life science research and from which monoclonal antibodies are usually produced. To date, monoclonal antibodies from suncus have not been generated due to the lack of a plasmacytoma fusion partner. To obtain suncus plasmacytoma cell lines suitable as a cell fusion partner, we injected suncus at both sides of the tail base with antigen emulsion, collected the lymph nodes and spleens, and cultured the cells to obtain immortalized lymphoid cell lines visually resembling mouse SP2/0-Ag14 myeloma cells. Three suncus immunized with the antigen provided 4 cell lines of suncus plasmacytoma, but they did not secrete immunoglobulins. Antibody-producing hybrid cells were generated from these cell lines using a cell fusion technique. Using one of the cell lines as a fusion partner, we obtained six lines of immunoglobulin-producing hybrid cells which secreted an unidentified monoclonal IgG. When these 6 lines were used as new fusion partners, we obtained several hybrid cell lines which secreted immunogen-specific monoclonal antibodies. These hybrid cells can be cloned and cryopreserved. We also obtained another good fusion partner which initially secreted antibody but later stopped doing so. These suncus-suncus hybrid cell lines will be useful for the production of suncus monoclonal antibodies.

    DOI: 10.1267/ahc.17007

    PubMed

    researchmap

  • Modifications of perineuronal nets and remodelling of excitatory and inhibitory afferents during vestibular compensation in the adult mouse. Reviewed International journal

    Alessio Faralli, Federico Dagna, Andrea Albera, Yoko Bekku, Toshitaka Oohashi, Roberto Albera, Ferdinando Rossi, Daniela Carulli

    Brain structure & function   221 ( 6 )   3193 - 209   2016.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Perineuronal nets (PNNs) are aggregates of extracellular matrix molecules surrounding several types of neurons in the adult CNS, which contribute to stabilising neuronal connections. Interestingly, a reduction of PNN number and staining intensity has been observed in conditions associated with plasticity in the adult brain. However, it is not known whether spontaneous PNN changes are functional to plasticity and repair after injury. To address this issue, we investigated PNN expression in the vestibular nuclei of the adult mouse during vestibular compensation, namely the resolution of motor deficits resulting from a unilateral peripheral vestibular lesion. After unilateral labyrinthectomy, we found that PNN number and staining intensity were strongly attenuated in the lateral vestibular nucleus on both sides, in parallel with remodelling of excitatory and inhibitory afferents. Moreover, PNNs were completely restored when vestibular deficits of the mice were abated. Interestingly, in mice with genetically reduced PNNs, vestibular compensation was accelerated. Overall, these results strongly suggest that temporal tuning of PNN expression may be crucial for vestibular compensation.

    DOI: 10.1007/s00429-015-1095-7

    PubMed

    researchmap

  • COL4A6 is dispensable for autosomal recessive Alport syndrome Reviewed

    Tomohiro Murata, Kan Katayama, Toshitaka Oohashi, Timo Jahnukainen, Tomoko Yonezawa, Yoshikazu Sado, Eiji Ishikawa, Shinsuke Nomura, Karl Tryggvason, Masaaki Ito

    SCIENTIFIC REPORTS   6   2016.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Alport syndrome is caused by mutations in the genes encoding alpha 3, alpha 4, or alpha 5 (IV) chains. Unlike X-linked Alport mice, alpha 5 and alpha 6 (IV) chains are detected in the glomerular basement membrane of autosomal recessive Alport mice, however, the significance of this finding remains to be investigated. We therefore generated mice lacking both alpha 3 and alpha 6 (IV) chains and compared their renal function and survival with Col4a3 knockout mice of 129 x 1/Sv background. No significant difference was observed in the renal function or survival of the two groups, or when the mice were backcrossed once to C57BL/6 background. However, the survival of backcrossed double knockout mice was significantly longer than that of the mice of 129 x 1/Sv background, which suggests that other modifier genes were involved in this phenomenon. In further studies we identified two Alport patients who had a homozygous mutation in intron 46 of COL4A4. The alpha 5 and alpha 6 (IV) chains were focally detected in the glomerular basement membrane of these patients. These findings indicate that although a5 and a6 (IV) chains are induced in the glomerular basement membrane in autosomal recessive Alport syndrome, their induction does not seem to play a major compensatory role.

    DOI: 10.1038/srep29450

    Web of Science

    researchmap

  • Human collagen XV is a prominent histopathological component of sinusoidal capillarization in hepatocellular carcinogenesis. Reviewed

    Kouji Kimura, Masaru Nakayama, Ichiro Naito, Takaaki Komiyama, Kouichi Ichimura, Hiroaki Asano, Kazunori Tsukuda, Aiji Ohtsuka, Toshitaka Oohashi, Shinichiro Miyoshi, Yoshifumi Ninomiya

    International journal of clinical oncology   21 ( 2 )   302 - 309   2016.4

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Increased expression of collagen XV has been reported in hepatocellular carcinogenesis in mice. The aim of this study was to confirm the previous murine findings in human hepatocellular carcinoma (HCC) specimens, along with the histopathological distribution of collagen XV in tumoral tissues. METHODS: Sixty-three primary HCC specimens were examined. Immunostaining of collagen XV and quantitative reverse transcriptional PCR of COL15A1, which encodes collagen XV, were performed. RESULTS: Positive staining of collagen XV was observed in all tumoral regions, regardless of differentiation level or pathological type of HCC, along the sinusoid-like endothelium, whereas collagen XV was not expressed in any non-tumoral region. The intensity score of collagen XV immunostaining and the mRNA value of COL15A1 were significantly correlated. COL15A1 expression in tumors was 3.24-fold higher than in non-tumoral regions. Multivariate analysis showed that COL15A1 expression was significantly higher in the absence of hepatitis virus and moderately differentiated HCC. CONCLUSIONS: COL15A1 mRNA was up-regulated in HCC and collagen XV was expressed along the sinusoid-like endothelium of HCC but not in non-tumoral regions, which implies that collagen XV contributes to the capillarization of HCC.

    DOI: 10.1007/s10147-015-0888-2

    PubMed

    researchmap

  • CCN4/WISP-1 positively regulates chondrogenesis by controlling TGF-β3 function. Reviewed International journal

    Yuya Yoshioka, Mitsuaki Ono, Azusa Maeda, Tina M Kilts, Emilio Satoshi Hara, Hany Khattab, Junji Ueda, Eriko Aoyama, Toshitaka Oohashi, Masaharu Takigawa, Marian F Young, Takuo Kuboki

    Bone   83   162 - 170   2016.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The CCN family of proteins plays important roles in development and homeostasis of bone and cartilage. To understand the role of CCN4 in chondrogenesis, human bone marrow stromal cells (hBMSCs) were transduced with CCN4 adenovirus (adCCN4) or siRNA to CCN4 (siCCN4) in the presence or absence of transforming growth factor-β3 (TGF-β3). Overexpression of CCN4 enhanced TGF-β3-induced SMAD2/3 phosphorylation and chondrogenesis of hBMSCs in an in vitro assay using a micromass culture model. On the other hand, knockdown of CCN4 inhibited the TGF-β3-induced SMAD2/3 phosphorylation and synthesis of cartilage matrix in micromass cultures of hBMSCs. Immunoprecipitation-western blot analysis revealed that CCN4 bound to TGF-β3 and regulated the ability of TGF-β3 to bind to hBMSCs. In vivo analysis confirmed there was a significant decrease in the gene expression levels of chondrocyte markers in cartilage samples from Ccn4-knock out (KO) mice, compared to those from wild type (WT) control. In order to investigate the regenerative properties of the articular cartilage in Ccn4-KO mice, articular cartilage defects were surgically performed in the knee joints of young mice, and the results showed that the cartilage was partially repaired in WT mice, but not in Ccn4-KO mice. In conclusion, these results show, for the first time, that CCN4 has a positive influence on chondrogenic differentiation by modulating the effects of TGF-β3.

    DOI: 10.1016/j.bone.2015.11.007

    PubMed

    researchmap

  • The hyaluronan and proteoglycan link proteins: Organizers of the brain extracellular matrix and key molecules for neuronal function and plasticity. Reviewed International journal

    Toshitaka Oohashi, Midori Edamatsu, Yoko Bekku, Daniela Carulli

    Experimental neurology   274 ( Pt B )   134 - 44   2015.12

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    The hyaluronan and proteoglycanbinding link protein (Hapln) is a key molecule in the formation and control of hyaluronan-based condensed perineuronal matrix in the adult brain. This review summarizes the recent advances in understanding the role of Haplns in the formation and control of two distinct types of perineuronal matrices, one for "classical" PNN and the other for the specialized extracellular matrix (ECM) at the node of Ranvier in the central nervous system (CNS). We introduce the structural components of each ECM organization including the basic concept of supramolecular structure named "HLT model". We furthermore summarize the developmental and physiological role of perineuronal ECMs from the studies of Haplns and related molecules. Finally, we also discuss the potential mechanism modulating PNNs in the adult CNS. This layer of organized matrices may exert a direct effect via core protein or sugar moiety from the structure or by acting as a binding site for biologically active molecules, which are important for neuronal plasticity and saltatory conduction.

    DOI: 10.1016/j.expneurol.2015.09.010

    PubMed

    researchmap

  • [Formation and roles of perineuronal extracellular matrices in the adult brain]. Reviewed

    Toshitaka Oohashi, Midori Edamatsu, Yoko Bekku

    Seikagaku. The Journal of Japanese Biochemical Society   87 ( 3 )   393 - 6   2015.6

     More details

    Authorship:Lead author, Corresponding author   Language:Japanese   Publishing type:Research paper (scientific journal)  

    PubMed

    researchmap

  • RXR Partial Agonist Produced by Side Chain Repositioning of Alkoxy RXR Full Agonist Retains Antitype 2 Diabetes Activity without the Adverse Effects Reviewed

    Kohei Kawata, Ken-ichi Morishita, Mariko Nakayama, Shoya Yamada, Toshiki Kobayashi, Yuki Furusawa, Sakae Arimoto-Kobayashi, Toshitaka Oohashi, Makoto Makishima, Hirotaka Naitou, Erika Ishitsubo, Hiroaki Tokiwa, Akihiro Tai, Hiroki Kakuta

    JOURNAL OF MEDICINAL CHEMISTRY   58 ( 2 )   912 - 926   2015.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    We previously reported RXR partial agonist CBt-PMN (1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-1H-benzotriazole-5-carboxylic acid: &lt;bold&gt;5&lt;/bold&gt;, EC50 = 143 nM, E-max = 75%), which showed a potent glucose-lowering effect without causing serious adverse effects. However, it remains important to elucidate the structural requirements for RXR efficacy and the glucose-lowering effect because RXR-permissive heterodimers such as PPAR/RXR or LXR/RXR are reported to be activated differently depending upon the chemical structure of RXR agonists. In this work, we show that an RXR partial agonist, NEt-4IB (6-[ethyl-(4-isobutoxy-3-isopropylphenyl)amino]pyridine-3-carboxylic acid: &lt;bold&gt;8b&lt;/bold&gt;, EC50 = 169 nM, E-max = 55%), can be obtained simply by repositioning the side chains (interchanging the isobutoxy and isopropoxy groups) at the hydrophobic moiety of the RXR full agonist NEt-3IB (6-[ethyl-(3-isobutoxy-4-isopropylphenyl)amino]pyridine-3-carboxylic acid: &lt;bold&gt;7b&lt;/bold&gt;, EC50 = 19 nM). NEt-4IB (&lt;bold&gt;8b&lt;/bold&gt;) showed antitype 2 diabetes activity without the above side effects upon repeated oral administration to mice at 10 mg/kg/day, similarly to &lt;bold&gt;5&lt;/bold&gt;.

    DOI: 10.1021/jm501863r

    Web of Science

    researchmap

  • Eosinophil Cationic Protein Shows Survival Effect on H9c2 Cardiac Myoblast Cells with Enhanced Phosphorylation of ERK and Akt/GSK-3β under Oxidative Stress. Reviewed

    Hiroko Ishii, Shigeshi Kamikawa, Satoshi Hirohata, Akifumi Mizutani, Koji Abe, Masaharu Seno, Toshitaka Oohashi, Yoshifumi Ninomiya

    Acta medica Okayama   69 ( 3 )   145 - 53   2015

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Eosinophil cationic protein (ECP) is well known as a cationic protein contained in the basic granules of activated eosinophils. Recent studies have reported that ECP exhibits novel activities on various types of cells, including rat neonatal cardiomyocytes. Here we evaluated the effects of ECP on rat cardiac myoblast H9c2 cells. Our results showed that ECP enhanced the survival of the cells, in part by promoting the ERK and Akt/GSK-3β signaling pathways. ECP attenuated the cytotoxic effects of H2O2 on H9c2 cells as well as the production of reactive oxygen species, the number of apoptotic cells and caspase 3/7 activity in the cells. In conclusion, ECP activated the ERK and Akt/GSK-3β pathways, resulting in anti-oxidative effects on H9c2 cells that attenuated apoptosis.

    PubMed

    researchmap

  • 肝細胞癌組織におけるXV型コラーゲン発現とその意義

    木村 紘爾, 中山 勝, 小宮山 高明, 市村 浩一, 内藤 一郎, 浅野 博昭, 佃 和憲, 大塚 愛二, 大橋 俊孝, 二宮 善文

    日本結合組織学会学術大会・マトリックス研究会大会合同学術集会プログラム・抄録集   46回・61回   84 - 84   2014.6

     More details

    Language:Japanese   Publisher:日本結合組織学会・マトリックス研究会  

    researchmap

  • Light and electron microscopic detection of inflammation-targeting liposomes encapsulating high-density colloidal gold in arthritic mice. Reviewed International journal

    Ami Maehara, Keiichiro Nishida, Masumi Furutani, Emi Matsumoto, Aiji Ohtsuka, Yoshifumi Ninomiya, Toshitaka Oohashi

    Inflammation research : official journal of the European Histamine Research Society ... [et al.]   63 ( 2 )   139 - 47   2014.2

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: We have previously demonstrated the efficient and time-dependent transvascular localization of Sialyl Lewis X (SLX)-liposomes to inflammatory sites, but the final target of the SLX-liposomes remained uncertain. The aim of this study was to identify the target cells of the liposomes within the inflamed joints of collagen antibody-induced arthritis (CAIA) model mice. METHODS: SLX-liposomes and unlabeled liposomes encapsulating high-density colloidal gold were administered intravenously into the caudal vein of CAIA mice on day 5 after induction of arthritis when the inflammatory score was maximal (n = 6 per group). Six hours or 24 h after liposome administration, animals were euthanized and hind limbs and ankles were excised without perfusion. After fixation, synovial tissues were examined by light microscopy after silver enhancement of colloidal gold or by transmission electron microscopy. RESULTS: Silver-enhanced signals were detected within the cells around E-selectin-positive blood vessels in the synovium of the SLX-liposome group. These cells were positive for the macrophage/monocyte marker F4/80 or neutrophil marker Ly-6G. Transmission electron microscopy detected the colloidal gold signals together with liposome-like structures within the phagosomes of synovial macrophages. Transmission electron microscopy and energy dispersive X-ray spectrometry could determine gold elements in the lysosomes of synovial macrophages. CONCLUSIONS: The results of the current study demonstrate that SLX-liposomes primarily targeting E-selectin in activated endothelial cells could potentially deliver their contents into inflammatory cells around synovial blood vessels in arthritic joints.

    DOI: 10.1007/s00011-013-0682-4

    PubMed

    researchmap

  • Design, synthesis, and preliminary ex vivo and in vivo evaluation of cationic magnetic resonance contrast agent for rabbit articular cartilage imaging Reviewed

    Takayoshi Irie, Kazuhiro Oda, Akihiko Shiino, Mitsuhiko Kubo, Shigehiro Morikawa, Noboru Urushiyama, Shuji Aonuma, Takahide Kimura, Toshiro Inubushi, Toshitaka Oohashi, Naoki Komatsu

    MedChemComm   4 ( 11 )   1508 - 1512   2013.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Since early-stage diagnosis of osteoarthritis (OA) is necessary to retard the progress of the disease, magnetic resonance (MR) and computed tomography (CT) imaging agents have been applied to evaluate the integrity of the extracellular matrix (ECM) in the articular cartilage (AC). Although several negatively charged contrast agents were employed, they provided indirect images of the AC based on the coulombic repulsion with anionic glycosaminoglycans (GAGs) in the ECM. To achieve direct imaging of the ECM, positively charged contrast agents have quite recently been designed for optical and CT imaging. In this paper, we report on a positively charged MR contrast agent, DOTA-Gd-G 2R8, which was applied preliminarily to ex vivo and in vivo imaging of rabbit AC. In the ex vivo imaging, the contrast agent was accumulated in the AC in high concentration due to the strong coulombic attraction between the negative charge of the GAGs and the positive charge of the octaarginine (R8). The thickness of the AC measured in the MR image was found to be comparable to that determined by the histological staining of the slice. The AC was also observed in vivo by MR imaging with the use of DOTA-Gd-G2R8. © 2013 The Royal Society of Chemistry.

    DOI: 10.1039/c3md00229b

    Scopus

    researchmap

  • Ten-m2 is required for the generation of binocular visual circuits. Reviewed International journal

    Timothy R Young, Michael Bourke, Xiaohong Zhou, Toshitaka Oohashi, Atomu Sawatari, Reinhard Fässler, Catherine A Leamey

    The Journal of neuroscience : the official journal of the Society for Neuroscience   33 ( 30 )   12490 - 509   2013.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Functional binocular vision requires that inputs arising from the two retinae are integrated and precisely organized within central visual areas. Previous studies have demonstrated an important role for one member of the Ten-m/Odz/teneurin family, Ten-m3, in the mapping of ipsilateral retinal projections. Here, we have identified a distinct role for another closely related family member, Ten-m2, in the formation of the ipsilateral projection in the mouse visual system. Ten-m2 expression was observed in the retina, dorsal lateral geniculate nucleus (dLGN), superior colliculus (SC), and primary visual cortex (V1) of the developing mouse. Anterograde and retrograde tracing experiments in Ten-m2 knock-out (KO) mice revealed a specific decrease in ipsilateral retinal ganglion cells projecting to dLGN and SC. This reduction was most prominent in regions corresponding to ventral retina. No change in the topography of ipsilateral or contralateral projections was observed. While expression of a critical ipsilateral fate determinant, Zic2, appeared unaltered, a notable reduction in one of its downstream targets, EphB1, was observed in ventral retina, suggesting that Ten-m2 may interact with this molecular pathway. Immunohistochemistry for c-fos, a neural activity marker, revealed that the area of V1 driven by ipsilateral inputs was reduced in KOs, while the ratio of ipsilateral-to-contralateral responses contributing to binocular activation during visually evoked potential recordings was also diminished. Finally, a novel two-alternative swim task revealed specific deficits associated with dorsal visual field. These data demonstrate a requirement for Ten-m2 in the establishment of ipsilateral projections, and thus the generation of binocular circuits, critical for mammalian visual function.

    DOI: 10.1523/JNEUROSCI.4708-12.2013

    PubMed

    researchmap

  • Three mechanisms assemble central nervous system nodes of Ranvier. Reviewed International journal

    Keiichiro Susuki, Kae-Jiun Chang, Daniel R Zollinger, Yanhong Liu, Yasuhiro Ogawa, Yael Eshed-Eisenbach, María T Dours-Zimmermann, Juan A Oses-Prieto, Alma L Burlingame, Constanze I Seidenbecher, Dieter R Zimmermann, Toshitaka Oohashi, Elior Peles, Matthew N Rasband

    Neuron   78 ( 3 )   469 - 82   2013.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Rapid action potential propagation in myelinated axons requires Na⁺ channel clustering at nodes of Ranvier. However, the mechanism of clustering at CNS nodes remains poorly understood. Here, we show that the assembly of nodes of Ranvier in the CNS involves three mechanisms: a glia-derived extracellular matrix (ECM) complex containing proteoglycans and adhesion molecules that cluster NF186, paranodal axoglial junctions that function as barriers to restrict the position of nodal proteins, and axonal cytoskeletal scaffolds (CSs) that stabilize nodal Na⁺ channels. We show that while mice with a single disrupted mechanism had mostly normal nodes, disruptions of the ECM and paranodal barrier, the ECM and CS, or the paranodal barrier and CS all lead to juvenile lethality, profound motor dysfunction, and significantly reduced Na⁺ channel clustering. Our results demonstrate that ECM, paranodal, and axonal cytoskeletal mechanisms ensure robust CNS nodal Na⁺ channel clustering.

    DOI: 10.1016/j.neuron.2013.03.005

    PubMed

    researchmap

  • Bral2 is indispensable for the proper localization of brevican and the structural integrity of the perineuronal net in the brainstem and cerebellum. Reviewed International journal

    Yoko Bekku, Mai Saito, Markus Moser, Maki Fuchigami, Ami Maehara, Masaru Nakayama, Shozo Kusachi, Yoshifumi Ninomiya, Toshitaka Oohashi

    The Journal of comparative neurology   520 ( 8 )   1721 - 36   2012.6

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Perineuronal nets (PNNs) are pericellular coats of condensed matrix that enwrap the cell bodies and dendrites of many adult central nervous system (CNS) neurons. These extracellular matrices (ECMs) play a structural role as well as instructive roles in the control of CNS plasticity and the termination of critical periods. The cartilage link protein Crtl1/Hapln1 was reported to be a trigger for the formation of PNNs in the visual cortex. Bral2/Hapln4 is another link protein that is expressed in PNNs, mainly in the brainstem and cerebellum. To assess the role of Bral2 in PNN formation, we examined the expression of PNN components in targeted mouse mutants lacking Bral2. We show here that Bral2-deficient mice have attenuated PNNs, but the overall levels of chondroitin sulfate proteoglycans, lecticans, are unchanged with the exception of neurocan. Bral2 deficiency markedly affected the localization of brevican in all of the nuclei tested, and neurocan concomitant with Crtl1 in some of the nuclei, whereas no effect was seen on aggrecan even with the attenuation of Crtl1. Bral2 may have a role in the organization of the PNN, in association with brevican, that is independent of aggrecan binding. There was a heterogenous attenuation of PNN components, including glycosaminoglycans, indicating the elaborate molecular organization of the PNN components. Strikingly, a slight decrease in the number of synapses in deep cerebellar nuclei neurons was found. Taken together, these results imply that Bral2-brevican interaction may play a key role in synaptic stabilization and the structural integrity of the PNN.

    DOI: 10.1002/cne.23009

    PubMed

    researchmap

  • RXR Partial Agonist CBt-PMN Exerts Therapeutic Effects on Type 2 Diabetes without the Side Effects of RXR Full Agonists. Reviewed International journal

    Hiroki Kakuta, Nobumasa Yakushiji, Ryosuke Shinozaki, Fuminori Ohsawa, Shoya Yamada, Yui Ohta, Kohei Kawata, Mariko Nakayama, Manabu Hagaya, Chisa Fujiwara, Makoto Makishima, Shigeyuki Uno, Akihiro Tai, Ami Maehara, Masaru Nakayama, Toshitaka Oohashi, Hiroyuki Yasui, Yutaka Yoshikawa

    ACS medicinal chemistry letters   3 ( 5 )   427 - 32   2012.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    Treating insulin resistance and type 2 diabetes in rodents, currently known retinoid X receptor (RXR) agonists induce significant adverse effects. Here we introduce a novel RXR partial agonist CBt-PMN (11b), which shows a potent glucose-lowering effect and improvements of insulin secretion and glucose tolerance without the serious adverse effects caused by RXR full agonists. We suggest that RXR partial agonists may be a new class of antitype 2 diabetes drug candidates.

    DOI: 10.1021/ml300055n

    Web of Science

    PubMed

    researchmap

  • Mechanical stretch enhances COL2A1 expression on chromatin by inducing SOX9 nuclear translocalization in inner meniscus cells. Reviewed International journal

    Tomoko Kanazawa, Takayuki Furumatsu, Motomi Hachioji, Toshitaka Oohashi, Yoshifumi Ninomiya, Toshifumi Ozaki

    Journal of orthopaedic research : official publication of the Orthopaedic Research Society   30 ( 3 )   468 - 74   2012.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    The meniscus plays an important role in controlling the biomechanics of the knee. However, the mechanical stress-related response in meniscus cells remains unclear. We investigated mechanical stretch-regulated gene expression in human meniscus cells. Human inner and outer meniscus cells were prepared from the inner and outer halves of the lateral meniscus. The gene expressions of Sry-type HMG box (SOX) 9 and α1(II) collagen (COL2A1) were assessed by real-time PCR analyses after cyclic tensile strain (CTS) treatment (0.5 Hz, 5% stretch). The localization and phosphorylation of SOX9 were evaluated by immunohistochemical and Western blot (WB) analyses. Chromatin immunoprecipitation (IP) analysis was performed to assess the stretch-related protein-DNA complex formation between SOX9 and the COL2A1 enhancer on chromatin. Type II collagen deposition and SOX9 production were detected only in inner menisci. CTS treatments increased expression of the COL2A1 and SOX9 genes in inner meniscus cells, but not in outer meniscus cells. In addition, CTS treatments stimulated nuclear translocalization and phosphorylation of SOX9 in inner meniscus cells. Chromatin IP analyses revealed that CTS increased the association between SOX9 and its DNA-binding site, included in the COL2A1 enhancer, on chromatin. Our results indicate that inner and outer meniscus cells have different properties in mechanical stretch-induced COL2A1 expression. In inner meniscus cells, mechanical stretch may have an essential role in the epigenetic regulation of COL2A1 expression.

    DOI: 10.1002/jor.21528

    Web of Science

    PubMed

    researchmap

  • [Cutting edge on research of cartilage metabolism. Recent progress in bio-molecular imaging of articular cartilage]. Reviewed

    Toshitaka Oohashi, Keiichiro Nishida

    Clinical calcium   21 ( 6 )   896 - 902   2011.6

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    In the process of cartilage degeneration seen in osteoarthritis, loss of proteoglycan from articular cartilage has been widely accepted as a critical early event, followed by collagen degradation designated as a point of no return. Recent advance in the development of targeted molecular probes and new imaging modalities enabled the detection of qualitative and functional change of articular cartilage. In this paper, we describe the recent progress of bio-molecular imaging of articular cartilage including our fluorescent-labeled glycosaminoglycan-binding octaarginine.

    PubMed

    researchmap

  • Clonal overgrowth of esophageal smooth muscle cells in diffuse leiomyomatosis-Alport syndrome caused by partial deletion in COL4A5 and COL4A6 genes. Reviewed International journal

    Toshitaka Oohashi, Ichiro Naito, Yasuyoshi Ueki, Tomoki Yamatsuji, Rattiya Permpoon, Noriaki Tanaka, Yoshio Naomoto, Yoshifumi Ninomiya

    Matrix biology : journal of the International Society for Matrix Biology   30 ( 1 )   3 - 8   2011.1

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    This is a study of a patient who manifests all of the features of a diffuse leiomyomatosis-Alport syndrome (DL-ATS), and her two-year-old son who has already been diagnosed with Alport syndrome. Fourteen years ago, the patient underwent a partial esophageal resection followed by a replacement with jejunum. Recently, she underwent a surgical resection of the esophagus due to esophageal dysfunction. Genetic analyses of COL4A5 and COL4A6 on the X-chromosome were efficiently performed using the genomic DNA of her son. We have identified a novel deletion of 194-kb in length, encompassing COL4A5-COL4A6 promoters as well as nearly the entire large intron 1 of COL4A5 and intron 2 of COL4A6. To uncover the relationship of the esophagus-specific occurrence of the tumor and the expression of those genes, immunohistochemical analyses of type IV collagen α chains were conducted in the non-affected individuals. The esophageal smooth muscle-specific expression of α5(IV) and α6(IV) chains in the gastrointestinal tract was observed. Moreover, CAG repeat analysis of the androgen receptor gene and an immunohistochemical analysis in the leiomyoma revealed clonal overgrowth of the cells which received X-inactivation on the non-affected allele. These results may suggest that the dominant effect was caused by the partial deletion of the esophageal smooth muscle-specific genes, COL4A5 and COL4A6.

    DOI: 10.1016/j.matbio.2010.09.003

    Web of Science

    PubMed

    researchmap

  • Development of an active targeting liposome encapsulated with high-density colloidal gold for transmission electron microscopy. Reviewed

    Hideki Minematsu, Takayuki Otani, Toshitaka Oohashi, Masahiko Hirai, Kazunori Oie, Koichi Igarashi, Aiji Ohtsuka

    Journal of electron microscopy   60 ( 1 )   95 - 9   2011

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:OXFORD UNIV PRESS  

    Active targeting of the liposome is an attractive strategy for drug delivery and in vivo bio-imaging. We previously reported the specific accumulation of Sialyl Lewis X (SLX) liposome to inflamed tissue in arthritic model mice or tumor-bearing mice. SLX-liposome encapsulation with fluorescent substances allows for the visualization of these liposomes by the time-dependent transvascular accumulation of fluorescent signals in the histological sections. In the present study, we developed a new SLX-liposome encapsulated with colloidal gold for transmission electron microscopic observation. We herein describe the characterization of the colloidal gold-loaded SLX-liposomes and demonstrate its specific targeting to the endothelial cells of tumor blood vessels in tumor-bearing mice.

    DOI: 10.1093/jmicro/dfq071

    Web of Science

    PubMed

    researchmap

  • Bral1: its role in diffusion barrier formation and conduction velocity in the CNS. Reviewed International journal

    Yoko Bekku, Lýdia Vargová, Yoshinobu Goto, Ivan Vorísek, Lesia Dmytrenko, Masahiro Narasaki, Aiji Ohtsuka, Reinhard Fässler, Yoshifumi Ninomiya, Eva Syková, Toshitaka Oohashi

    The Journal of neuroscience : the official journal of the Society for Neuroscience   30 ( 8 )   3113 - 23   2010.2

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:SOC NEUROSCIENCE  

    At the nodes of Ranvier, excitable axon membranes are exposed directly to the extracellular fluid. Cations are accumulated and depleted in the local extracellular nodal region during action potential propagation, but the impact of the extranodal micromilieu on signal propagation still remains unclear. Brain-specific hyaluronan-binding link protein, Bral1, colocalizes and forms complexes with negatively charged extracellular matrix (ECM) proteins, such as versican V2 and brevican, at the nodes of Ranvier in the myelinated white matter. The link protein family, including Bral1, appears to be the linchpin of these hyaluronan-bound ECM complexes. Here we report that the hyaluronan-associated ECM no longer shows a nodal pattern and that CNS nerve conduction is markedly decreased in Bral1-deficient mice even though there were no differences between wild-type and mutant mice in the clustering or transition of ion channels at the nodes or in the tissue morphology around the nodes of Ranvier. However, changes in the extracellular space diffusion parameters, measured by the real-time iontophoretic method and diffusion-weighted magnetic resonance imaging (MRI), suggest a reduction in the diffusion hindrances in the white matter of mutant mice. These findings provide a better understanding of the mechanisms underlying the accumulation of cations due to diffusion barriers around the nodes during saltatory conduction, which further implies the importance of the Bral1-based extramilieu for neuronal conductivity.

    DOI: 10.1523/JNEUROSCI.5598-09.2010

    Web of Science

    PubMed

    researchmap

  • Neurocan contributes to the molecular heterogeneity of the perinodal ECM. Reviewed

    Yoko Bekku, Toshitaka Oohashi

    Archives of histology and cytology   73 ( 2 )   95 - 102   2010

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:INT SOC HISTOLOGY & CYTOLOGY  

    Neurocan is a central nervous tissue-specific chondroitin sulfate proteoglycan of the lectican family. Mainly expressed during modeling and remodeling stages of this tissue, it is thought to play an important role via binding to various extracellular matrix and cellular components. In adults, neurocan expression is associated with the perineuronal net structures. This study shows the neurocan immunolocalization at the node of Ranvier in mouse central nervous tissues. The N-terminal fragment of neurocan (Ncan130) was the predominant form detected in the optic nerve. The expression of neurocan in the white matter of brain tissue and nerve tracts revealed differential expression profiles compared with those of versican V2 and brevican, other perinodal extracellular matrix molecules. Double immunolabeling for neurocan and a nodal marker, Bral1, or a paranodal marker, caspr, demonstrated that neurocan was localized at the node of Ranvier. Neurocan expression was found at many--not all--nodal regions, and neurocan-positive nodes outnumbered brevican-positive nodes. The nodal localization of neurocan was diminished in Bral1-deficient mice. Taken together, these findings indicate that neurocan contributes to the molecular heterogeneity of the perinodal matrix, and its nodal expression is dependent on Bral1.

    DOI: 10.1679/aohc.73.95

    Web of Science

    PubMed

    researchmap

  • Optical imaging of mouse articular cartilage using the glycosaminoglycans binding property of fluorescent-labeled octaarginine. Reviewed International journal

    K Inagawa, T Oohashi, K Nishida, J Minaguchi, T Tsubakishita, K O Yaykasli, A Ohtsuka, T Ozaki, T Moriguchi, Y Ninomiya

    Osteoarthritis and cartilage   17 ( 9 )   1209 - 18   2009.9

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: The aim of the current study was to examine the cartilage-specific binding property of polyarginine peptides (R4, 8, 12, and 16) and specifically to test octaarginine peptides for the optical imaging of articular cartilage in experimentally induced arthritis in mice. METHODS: Four rhodamine-labeled polyarginine peptides each with a different-length arginine chain (R4, 8, 12, or 16) were injected into the knee joints of C57BL/6J mice (n=20). The joints were excised 1h later and the fluorescent signal intensity in cartilage cryosections was compared for the four peptides. To examine the substrate of R8 in cartilage, femoral condyles obtained from another set of mice were treated with chondroitinase ABC (Ch'ase ABC), keratanase or heparitinase then immersed in R8-rhodamine. Fluorescent signals were examined by fluorescent microscopy. Next, R8-rhodamine was injected into the right knee joints of three control and three collagen antibody-induced arthritis (CAIA) mice, and fluorescent intensity in normal and degenerative cartilage was semi-quantitatively analysed on the histological sections using image software. Finally, femoral condyles from normal mice (n=2) and CAIA mice (n=2) were immersed in R8-rhodamine and calcein, then imaged using optical projection tomography (OPT). RESULTS: Fluorescent signals were specifically detected in the cartilage pericellular matrix from the surface to the tide mark but were completely absent in the calcified layer or bone marrow. The number of arginine residues significantly influenced peptide accumulation in articular cartilage, with R8 accumulating the most. The fluorescent signal in the femoral condylar cartilage diminished when it was treated with Ch'ase ABC. R8 accumulation was significantly decreased in the degenerative cartilage of CAIA mice, and this was demonstrated both histologically and in three-dimensional (3D)-reconstruction image by OPT. CONCLUSION: R8 may be a useful new experimental probe for optical imaging of normal and arthritic articular cartilage.

    DOI: 10.1016/j.joca.2009.03.010

    PubMed

    researchmap

  • The 3'-untranslated region of ADAMTS1 regulates its mRNA stability. Reviewed

    Omer Faruk Hatipoglu, Satoshi Hirohata, Kursat Oguz Yaykasli, Mehmet Zeynel Cilek, Kadir Demircan, Ryoko Shinohata, Tomoko Yonezawa, Toshitaka Oohashi, Shozo Kusachi, Yoshifumi Ninomiya

    Acta medica Okayama   63 ( 2 )   79 - 85   2009.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    ADAMTS1 (a disintegrin and metalloproteinase with thrombospondin motifs 1) is an inflammatory-induced gene. We have previously reported that ADAMTS1 was strongly but transiently expressed in the infarcted heart. In this study, we investigated whether a 3'-untranslated region (UTR) affects the mRNA stability of this gene. When stimulated with tissue necrosis factor (TNF)-alpha, the expression level of ADAMTS1 mRNA rapidly increased, but the induction of ADAMTS1 mRNA peaked at 6h after stimulation, after which the expression levels of ADAMTS1 mRNA decreased. The 3'-UTR ADAMTS1 mRNA contains multiple adenine and uridine-rich elements, suggesting that the 3'-UTR may regulate gene stability. The addition of actinomycin D, an RNA synthesis inhibitor, demonstrated the decay of induced ADAMTS1 mRNA by TNF-alpha. Furthermore, a region containing multiple AUUUA motifs within the ADAMTS1 3'-UTR destabilized transfected Enhanced Green Fluorescence Protein (EGFP) mRNA expression. These results demonstrated that the ADAMTS1 3'-UTR may regulate the expression of ADAMTS1 mRNA.

    DOI: 10.18926/AMO/31831

    PubMed

    researchmap

  • Brevican distinctively assembles extracellular components at the large diameter nodes of Ranvier in the CNS. Reviewed International journal

    Yoko Bekku, Uwe Rauch, Yoshifumi Ninomiya, Toshitaka Oohashi

    Journal of neurochemistry   108 ( 5 )   1266 - 76   2009.3

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Brevican is known to be an abundant extracellular matrix component in the adult brain and a structural constituent of perineuronal nets. We herein show that brevican, tenascin-R (TN-R) and phosphacan are present at the nodes of Ranvier on myelinated axons with a particularly large diameter in the central nervous system. A brevican deficiency resulted in a reorganization of the nodal matrices, which was characterized by the shift of TN-R, and concomitantly phosphacan, from an axonal diameter-dependent association with nodes to an axonal diameter independent association. Supported by the co-immunoprecipitation results, these observations indicate that the presence of TN-R and phosphacan at nodes is normally brevican-dependent, while in the absence of brevican these molecules can also be recruited by versican V2. The versican V2 and Bral1 distribution was not affected, thus indicating a brevican-independent role of these two molecules for establishing hyaluronan-binding matrices at the nodes. Our results revealed that brevican plays a crucial role in determining the specialization of the hyaluronan-binding nodal matrix assemblies in large diameter nodes.

    DOI: 10.1111/j.1471-4159.2009.05873.x

    PubMed

    researchmap

  • ADAMTS9 activation by interleukin 1 beta via NFATc1 in OUMS-27 chondrosarcoma cells and in human chondrocytes. Reviewed International journal

    Kursat Oguz Yaykasli, Toshitaka Oohashi, Satoshi Hirohata, Omer Faruk Hatipoglu, Kiichi Inagawa, Kadir Demircan, Yoshifumi Ninomiya

    Molecular and cellular biochemistry   323 ( 1-2 )   69 - 79   2009.3

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    ADAMTS9 is a member of the disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) genes, with aggrecan-degrading activity. It has also been characterized to be reactive and highly activated ADAMTS by IL-1 beta in both chondrosarcoma cells and human chondrocytes (Demircan et al. Arthritis Rheum 52:1451-1460, 2005). In order to understand the regulation of ADAMTS9 gene expression a functional 3.0 kb human ADAMTS9 promoter has been cloned and characterized. A sequence analysis of the promoter revealed the presence of putative binding sites for Nuclear Factor of Activated T cells (NFAT), which is commonly found in the ADAMTS4 and ADAMTS5 promoters. NFATc1 was up-regulated in an activated form by IL-1 beta in human chondrocytes. The IL-1 beta inducible ADAMTS9 expression was inhibited by NFAT inhibitors, FK506 and 11Arg (11R)-VIVIT. Furthermore, direct binding of NFATc1 on distal and proximal promoters of ADAMTS9 was demonstrated by a chromatin immunoprecipitation assay. Promoter-reporter assays supported those results. These findings may provide a better understanding of the regulation of ADAMTS9 expression induced by inflammatory cytokines.

    DOI: 10.1007/s11010-008-9965-4

    PubMed

    researchmap

  • THE ION-DIFFUSION BARRIER MODEL AT THE NODE OF RANVIER: FROM THE EXTRACELLULAR ION DIFFUSION ANALYSIS IN BRAL1-DEFICIENT MICE Reviewed

    Yoko Bekku, Lydia Vargova, Yoshinobu Goto, Yoshifumi Ninomiya, Eva Sykova, Toshitaka Oohashi

    JOURNAL OF PHYSIOLOGICAL SCIENCES   59   292 - 292   2009

     More details

    Language:English   Publisher:SPRINGER TOKYO  

    Web of Science

    researchmap

  • Target-tropic accumulation of SLX-liposome in arthritis mouse Reviewed

    Minaguchi JA, Minematsu H, Oohashi T, Otani T, Inagawa K, Oie K, Nishida K, Ohtsuka A, Ninomiya Y, Igarashi K

    Matrix Biology   27   43 - 43   2008.12

     More details

    Language:English  

    researchmap

  • Transvascular accumulation of Sialyl Lewis X conjugated liposome in inflamed joints of collagen antibody-induced arthritic (CAIA) mice. Reviewed

    Jun Minaguchi, Toshitaka Oohashi, Kiichi Inagawa, Aiji Ohtsuka, Yoshifumi Ninomiya

    Archives of histology and cytology   71 ( 3 )   195 - 203   2008.11

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    The aim of the current study was to investigate the specific accumulation of the Sialyl Lewis X (SLX) liposome in inflammation in the collagen-antibody induced arthritic (CAIA) model mice. The SLX-liposome encapsulating fluorescent substance (Cy5.5 or Cy3) was prepared for this study. The SLX-liposome was administered intravenously via the mouse caudal vein. After 1 to 24 h, the accumulation of SLX-liposome was observed using in vivo fluorescent imaging equipment (eXplore Optix), or the knee joints were removed for histological analysis. The in vivo fluorescent imaging showed that the signal was confined to the inflammatory site in the CAIA mice in an inflammatory dependent manner. The signal intensity was stronger at 24 h than at 1 h after injection. In the histological sections, the fluorescent signals were detected in the periarticular soft-tissue, especially in the hyperplastic synovium, including a pannus invasion with inflammatory cells in the CAIA. Intense signals were observed in vessel-like structures 1 h after injection; these were co-labeled with the vascular endothelial cell marker (CD31) and E-selectin, a ligand of the SLX-liposome expressed on activated endothelial cells. The diffused signals from the vessels increased time-dependently at 6 to 24 h after injection. This is the first report to examine the exact localization of the SLXliposome by encapsulated fluorescence in hyperplastic synovial tissue of CAIA mice. These results suggest the feasibility and potential use of SLX-liposome as a vehicle for the active targeting of drug delivery to inflammatory tissue.

    DOI: 10.1679/aohc.71.195

    PubMed

    researchmap

  • Molecular cloning and developmental expression of a hyaluronan and proteoglycan link protein gene, crtl1/hapln1, in zebrafish. Reviewed

    Jeong Suk Kang, Yasuhiko Kawakami, Yoko Bekku, Yoshifumi Ninomiya, Juan Carlos Izpisúa Belmonte, Toshitaka Oohashi

    Zoological science   25 ( 9 )   912 - 8   2008.9

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    The proteoglycan aggregate of the cartilage is composed of aggrecan, link protein (LP), and hyaluronan, providing resistance to compression in joints and cartilage structures. To further understand the function of LP during the process of chondrogenesis and bone formation in zebrafish, we cloned the zebrafish cDNA for hyaluronan and proteoglycan link protein 1 (crtl1/hapln1) and examined the expression of the gene during embryogenesis using in-situ hybridization. crtl1/hapln1 expression is first observed in the adaxial cells at the bud- stage. Throughout somitogenesis, crtl1/hapln1 is expressed in the sclerotomes, floor plate, and hypochord. In addition, crtl1/hapln1 is expressed in rhombomeres 3 and 5, pharyngeal arches, telecephalon, otic vesicles, and pectral fins. During chondrocranial/skull formation, crtl1/hapln1 expression is highest at around 4 dpf and is colocalized with aggrecan in the cartilaginous arches and with dermacan in the dermal bones.

    DOI: 10.2108/zsj.25.912

    PubMed

    researchmap

  • Ten_m3 regulates eye-specific patterning in the mammalian visual pathway and is required for binocular vision. Reviewed International journal

    Catherine A Leamey, Sam Merlin, Paul Lattouf, Atomu Sawatari, Xiaohong Zhou, Natasha Demel, Kelly A Glendining, Toshitaka Oohashi, Mriganka Sur, Reinhard Fässler

    PLoS biology   5 ( 9 )   e241 - 2092   2007.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PUBLIC LIBRARY SCIENCE  

    Binocular vision requires an exquisite matching of projections from each eye to form a cohesive representation of the visual world. Eye-specific inputs are anatomically segregated, but in register in the visual thalamus, and overlap within the binocular region of primary visual cortex. Here, we show that the transmembrane protein Ten_m3 regulates the alignment of ipsilateral and contralateral projections. It is expressed in a gradient in the developing visual pathway, which is consistently highest in regions that represent dorsal visual field. Mice that lack Ten_m3 show profound abnormalities in mapping of ipsilateral, but not contralateral, projections, and exhibit pronounced deficits when performing visually mediated behavioural tasks. It is likely that the functional deficits arise from the interocular mismatch, because they are reversed by acute monocular inactivation. We conclude that Ten_m3 plays a key regulatory role in the development of aligned binocular maps, which are required for normal vision.

    DOI: 10.1371/journal.pbio.0050241

    Web of Science

    PubMed

    researchmap

  • ADAMTS-9 is synergistically induced by interleukin-1beta and tumor necrosis factor alpha in OUMS-27 chondrosarcoma cells and in human chondrocytes. Reviewed International journal

    Kadir Demircan, Satoshi Hirohata, Keiichiro Nishida, Omer F Hatipoglu, Toshitaka Oohashi, Tomoko Yonezawa, Suneel S Apte, Yoshifumi Ninomiya

    Arthritis and rheumatism   52 ( 5 )   1451 - 60   2005.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-LISS  

    OBJECTIVE: To compare induction of the aggrecanases (ADAMTS-1, ADAMTS-4, ADAMTS-5, ADAMTS-8, ADAMTS-9, and ADAMTS-15) by interleukin-1beta (IL-1beta) and tumor necrosis factor alpha (TNFalpha) in chondrocyte-like OUMS-27 cells and human chondrocytes, and to determine the mechanism of induction of the most responsive aggrecanase gene. METHODS: OUMS-27 cells were stimulated for different periods of time and with various concentrations of IL-1beta and/or TNFalpha. Human chondrocytes obtained from osteoarthritic joints and human skin fibroblasts were also stimulated with IL-1beta and/or TNFalpha. Total RNA was extracted, reverse transcribed, and analyzed by quantitative real-time polymerase chain reaction and Northern blotting. ADAMTS-9 protein was examined by Western blotting, and the role of the MAPK signaling pathway for ADAMTS9 induction in IL-1beta-stimulated OUMS-27 cells was investigated. RESULTS: IL-1beta increased messenger RNA (mRNA) levels of ADAMTS4, ADAMTS5, and ADAMTS9 but not ADAMTS1 and ADAMTS8. The fold increase for ADAMTS9 mRNA was greater than that for mRNA of the other aggrecanase genes. The increase of ADAMTS9 mRNA by IL-1beta stimulation was greater in chondrocytes than in fibroblasts. The combination of IL-1beta and TNFalpha had a synergistic effect, resulting in a considerable elevation in the level of ADAMTS9 mRNA. ADAMTS-9 protein was also induced in IL-1beta-stimulated OUMS-27 cells. The MAPK inhibitors SB203580 and PD98059 decreased ADAMTS9 up-regulation in OUMS-27 cells. CONCLUSION: ADAMTS9 is an IL-1beta- and TNFalpha-inducible gene that appears to be more responsive to these proinflammatory cytokines than are other aggrecanase genes. Furthermore, these cytokines had a synergistic effect on ADAMTS9. Together with the known ability of ADAMTS-9 to proteolytically degrade aggrecan and its potential to cleave other cartilage molecules, the data suggest that ADAMTS-9 may have a pathologic role in arthritis.

    DOI: 10.1002/art.21010

    Web of Science

    PubMed

    researchmap

  • Suppression of chondrosarcoma cells by 15-deoxy-Delta 12,14-prostaglandin J2 is associated with altered expression of Bax/Bcl-xL and p21. Reviewed International journal

    Zheng-Nan Shen, Keiichiro Nishida, Hideyuki Doi, Toshitaka Oohashi, Satoshi Hirohata, Toshifumi Ozaki, Aki Yoshida, Yoshifumi Ninomiya, Hajime Inoue

    Biochemical and biophysical research communications   328 ( 2 )   375 - 82   2005.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    We previously reported that 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)), the most potent agonist for peroxisome proliferator-activated receptor gamma (PPAR gamma), induces apoptosis of human chondrosarcoma cell line OUMS-27. The current study aimed to explore the mechanism of 15d-PGJ(2)-induced apoptosis and inhibition of cell proliferation in OUMS-27 cells. The preliminary results of cDNA microarray analysis showed the down-regulation of anti-apoptotic Bcl-xL and up-regulation of pro-apoptotic Bax in the process of 15d-PGJ(2)-induced apoptosis. These changes were further confirmed at mRNA and protein levels by RT-PCR and Western blot analysis, respectively. Among cyclin-dependent kinase inhibitors, p21 was induced and up-regulated by 15d-PGJ(2), but p16 and p27 were not changed, suggesting that the involvement of p21 in inhibition of cell proliferation. Activation of caspase-3 by 15d-PGJ(2) was partly, but not completely, blocked by PPAR gamma antagonist (GW9662) suggesting the 15d-PGJ(2) exerted its effect by PPAR gamma-dependent and -independent pathways. Interestingly, immunohistochemical study on human chondrosarcoma samples revealed that Bcl-xL is frequently expressed by tumor cells. The results of the current study suggest that the potential ability of 15d-PGJ(2) in regulation of cell cycle and inhibition of Bcl-xL expression might be beneficial in the development of novel pharmacological agents for chondrosarcoma.

    DOI: 10.1016/j.bbrc.2004.12.186

    Web of Science

    PubMed

    researchmap

  • [Bral1, Bral2: the novel brain specific-hyaluronan and protoglycan link protein genes]. Reviewed

    Toshitaka Oohashi, Yoko Bekku, Yoshifumi Ninomiya

    Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme   49 ( 15 Suppl )   2354 - 61   2004.11

     More details

    Authorship:Lead author, Corresponding author   Language:Japanese   Publishing type:Research paper (scientific journal)  

    PubMed

    researchmap

  • Dynamic induction of ADAMTS1 gene in the early phase of acute myocardial infarction. Reviewed International journal

    Keigo Nakamura, Satoshi Hirohata, Takashi Murakami, Toru Miyoshi, Kadir Demircan, Toshitaka Oohashi, Hiroko Ogawa, Kazuya Koten, Kenichi Toeda, Shozo Kusachi, Yoshifumi Ninomiya, Yasushi Shiratori

    Journal of biochemistry   136 ( 4 )   439 - 46   2004.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:JAPANESE BIOCHEMICAL SOC  

    Extracellular matrix (ECM)-degrading enzymes such as matrix metalloproteases (MMPs) play an essential role in the repair of infarcted tissue, which affects ventricular remodeling after myocardial infarction. ADAMTS1 (A disintegrin and metalloprotease with thrombospondin motifs), a newly discovered metalloprotease, was originally cloned from a cancer cell line, but little is known about its contribution to disease. To test the hypothesis that ADAMTS1 appears in infarcted myocardial tissue, we examined ADAMTS1 mRNA expression in a rat myocardial infarction model by Northern blotting, real-time RT-PCR and in situ hybridization. Normal endothelium expressed little ADAMTS1 mRNA, while normal myocardium expressed no detectable ADAMTS1 mRNA. Up-regulation of ADAMTS1 was demonstrated by Northern blot analysis and real-time RT-PCR at 3 h after coronary artery ligation. In situ hybridization revealed strong ADAMTS1 mRNA signals in the endothelium and myocardium in the infarcted heart, mainly in the infarct zone, at 3 h after myocardial infarction. The rapid and transient up-regulation of the ADAMTS1 gene in the ischemic heart was distinct from the regulatory patterns of other MMPs. Our study demonstrated that the ADAMTS1 gene is a new early immediate gene expressed in the ischemic endothelium and myocardium.

    DOI: 10.1093/jb/mvh138

    Web of Science

    PubMed

    researchmap

  • Lp3/Hapln3, a novel link protein that co-localizes with versican and is coordinately up-regulated by platelet-derived growth factor in arterial smooth muscle cells. Reviewed International journal

    Hiroko Ogawa, Toshitaka Oohashi, Masataka Sata, Yoko Bekku, Satoshi Hirohata, Keigo Nakamura, Tomoko Yonezawa, Shozo Kusachi, Yasushi Shiratori, Yoshifumi Ninomiya

    Matrix biology : journal of the International Society for Matrix Biology   23 ( 5 )   287 - 98   2004.8

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    Link proteins (LPs) belong to the link-module superfamily, which can stabilize and enhance the binding of lecticans to hyaluronan. We report here the identification and characterization of a novel rat link protein gene (Lp3/Hapln3). The deduced protein sequence shares the typical modular elements of link proteins and has an estimated mass of 39 kDa. Examination of the rat genomic DNA sequence revealed that Lp3/Hapln3 and aggrecan genes were paired on chromosome 1q31. Another LP gene and the lectican gene were also paired at a different locus, as they are in the human and mouse genomes. Immunohistochemical analysis showed the prominent expression of Lp3/Hapln3 in the smooth muscle tissues of the vascular wall and gastrointestinal tract. Further comparative studies revealed that Lp3/Hapln3 was well co-localized with versican around the smooth muscle cells of blood vessels but not around endothelial cells. In vitro experiments using primary cultured rat arterial smooth muscle cells (ASMCs) demonstrated the coordinated up-regulation of Lp3/Hapln3 and versican by platelet-derived growth factor (PDGF). These data were supported by in vivo studies of a mechanical vascular injury model in mice. Altogether, our results suggest that Lp3/Hapln3 is involved, together with versican and hyaluronan, in the formation of the pericellular matrix of vascular smooth muscle cells.

    DOI: 10.1016/j.matbio.2004.07.001

    Web of Science

    PubMed

    researchmap

  • Characterization of dermacan, a novel zebrafish lectican gene, expressed in dermal bones. Reviewed International journal

    Jeong Suk Kang, Toshitaka Oohashi, Yasuhiko Kawakami, Yoko Bekku, Juan Carlos Izpisúa Belmonte, Yoshifumi Ninomiya

    Mechanisms of development   121 ( 3 )   301 - 12   2004.3

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    We report here the isolation and characterization of a cDNA encoding zebrafish dermacan, a novel member of hyaluronan (HA)-binding proteoglycans, which was termed after its characteristic expression in the zebrafish dermal bones. The deduced protein sequence shares the typical modular elements of lecticans. Sequence comparison covering the C-terminal globular domain demonstrated that dermacan shows high homology with zebrafish versican but is distinct from any other identified lecticans. Genomic DNA analysis demonstrated that dermacan and versican were encoded by distinct genes in the zebrafish genome. The expression of dermacan is initiated in the sclerotome and cephalic paraxial mesoderm at 16 h postfertilization. During the pharyngular period, dermacan transcripts were detected in the sclerotome, tail fin bud, pharyngular arch primordial region, and otic vesicle. In the development of craniofacial bones, dermacan expression was detected typically in the opercle and dentary. These regions belong to the craniofacial dermal bones. aggrecan expression, in contrast, was observed in the elements of craniofacial cartilage bones. In the dermacan-morpholino-injected embryos, dermal bones, e.g. opercle, dentary, and branchiostegal rays, as well as axial skeleton in the trunk, showed decreased ossification. We conclude that dermacan is a novel lectican gene, and that zebrafish lectican genes have genetically diverged. In addition, our data suggest the involvement of dermacan in zebrafish dermal bone development.

    DOI: 10.1016/j.mod.2004.01.007

    Web of Science

    PubMed

    researchmap

  • Cartilage link protein interacts with neurocan, which shows hyaluronan binding characteristics different from CD44 and TSG-6. Reviewed International journal

    Uwe Rauch, Satoshi Hirakawa, Toshitaka Oohashi, Joachim Kappler, Gunnel Roos

    Matrix biology : journal of the International Society for Matrix Biology   22 ( 8 )   629 - 39   2004.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    The interaction of neurocan with hyaluronan was qualitatively characterized with alkaline phosphatase fusion proteins secreted by mammalian cells. The wild type neurocan hyaluronan binding domain fused to alkaline phosphatase bound to immobilized hyaluronan under physiological as well as moderately hypertonic conditions, whereas its ability to bind to immobilized chondroitin sulfate dropped rapidly with increasing salt concentration. Strong hyaluronan binding ability was still evident when in both link modules within the hyaluronan binding domain a basic amino acid was mutated, which is well conserved among link modules of hyaluronan binding proteins. A strong enhancement of the binding of neurocan to immobilized hyaluronan was observed after preincubation of the immobilized hyaluronan with cartilage link protein. Moreover, this preincubation mediated also the binding of a fusion protein representing only the immunoglobulin module of neurocan linked to alkaline phosphatase, which showed no binding to immobilized hyaluronan alone. The interaction of the neurocan immunoglobulin module with link protein could also be shown by overlay blot analysis. These observations suggest that the hyaluronan binding characteristics of paired link modules are different from those of single link modules, and that the reported temporal co-expression of cartilage link protein and of neurocan in developing brain implicates the possibility of a cooperative function of these molecules.

    DOI: 10.1016/j.matbio.2003.11.007

    Web of Science

    PubMed

    researchmap

  • Molecular cloning of Bral2, a novel brain-specific link protein, and immunohistochemical colocalization with brevican in perineuronal nets. Reviewed International journal

    Yoko Bekku, Wei-Dong Su, Satoshi Hirakawa, Reinhard Fässler, Aiji Ohtsuka, Jeong Suk Kang, Jennifer Sanders, Takuro Murakami, Yoshifumi Ninomiya, Toshitaka Oohashi

    Molecular and cellular neurosciences   24 ( 1 )   148 - 59   2003.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The hyaluronan binding chondroitin sulphate proteoglycans, called lecticans, are the abundant extracellular matrix molecules in the developing and/or adult brain. The link proteins (LPs) are also known to be coordinately present in brain. We report here the molecular cloning and expression analysis of a novel member of LPs: Bral2, predominantly expressed in brain. The Bral2 mRNA expression is first detected at P20 and continued through adulthood, suggesting its functional importance and association with adult-type lecticans. The substantial immunoreactivity of Bral2 is found in several nuclei throughout the midbrain and hindbrain in a perineuronal net pattern. In situ hybridization revealed that Bral2 is synthesized by these neurons themselves, especially by the GABAergic neurons in the cerebellar cortex. Interestingly, the colocalization and synergic importance of Bral2 and brevican in the perineuronal nets is indicated by the comparative immunohistochemical analysis using wild-type and brevican-deficient mouse brain. Our results suggest that Bral2 is involved in the formation of extracellular matrix contributing to perineuronal nets and facilitate the understanding of a functional role of these extracellular matrices.

    PubMed

    researchmap

  • Molecular cloning of a novel transmembrane protein MOLT expressed by mature oligodendrocytes. Reviewed International journal

    Hiroyuki Nomoto, Tomoko Yonezawa, Kouichi Itoh, Katsuhiko Ono, Kiyotaka Yamamoto, Toshitaka Oohashi, Fumio Shiraga, Hiroshi Ohtsuki, Yoshifumi Ninomiya

    Journal of biochemistry   134 ( 2 )   231 - 8   2003.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A novel oligodendrocyte (OL)-specific cDNA was isolated from brain capillary endothelial cells and characterized. The cDNA encodes a protein of 1099 amino acids that contains a signal peptide and a transmembrane domain. The protein was expressed in mature OLs in vivo and in vitro cell cultures and was thus designated as mature OL transmembrane protein (MOLT). RT-PCR analysis showed that MOLT mRNA was expressed in brain, lung, pancreas, and testis. A polyclonal antibody raised against a part of the mouse MOLT reacted specifically with multipolar OLs possessing radially oriented processes that penetrated into the gray matter. More cells were detected in the white matter, and these had longitudinally oriented processes. In a rat OL lineage culture system, oligodendrocyte precursor cells did not initially produce MOLT mRNA and protein, but when they begun to differentiate into mature OLs, they started expressing MOLT. Consequently, MOLT may function as OLs become mature and may serve as a cell-surface marker for OL differentiation.

    PubMed

    researchmap

  • The murine Ten-m/Odz genes show distinct but overlapping expression patterns during development and in adult brain. Reviewed International journal

    Xiao-Hong Zhou, Oliver Brandau, Kang Feng, Toshitaka Oohashi, Yoshifumi Ninomiya, Uwe Rauch, Reinhard Fässler

    Gene expression patterns : GEP   3 ( 4 )   397 - 405   2003.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The mouse TEN-M/ODZ proteins belong to a new family of type II transmembrane proteins with unknown function. The family consists of four members, which are expressed highly in brain and less in many other tissues. In the present study we have generated specific RNA probes and antibodies to characterize the expression of the 4 Ten-m/Odz genes in the developing and adult central nervous system (CNS) of mice. Ten-m/Odz3 and Ten-m/Odz4 mRNAs were first detectable at E7.5, Ten-m/Odz2 expression started at the 37 somite (E 10.5) stage, while Ten-m/Odz1 mRNA is not found before E15.5. In the adult mouse CNS mRNAs of the 4 Ten-m/Odzs were expressed in distinct patterns, which partially overlapped. Immunostaining and in situ hybridization localized proteins and mRNAs of Ten-m/Odzs in adjacent areas suggesting that TEN-M/ODZ proteins might be transported from the cell body along the axon or that they are shed from the cell surface and diffuse into distant regions.

    PubMed

    researchmap

  • Vascular endothelial growth factor principally acts as the main angiogenic factor in the early stage of human osteoblastogenesis. Reviewed International journal

    Takayuki Furumatsu, Zheng Nan Shen, Akira Kawai, Keiichiro Nishida, Hironori Manabe, Toshitaka Oohashi, Hajime Inoue, Yoshifumi Ninomiya

    Journal of biochemistry   133 ( 5 )   633 - 9   2003.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Vascular endothelial growth factor (VEGF)-mediated angiogenesis is essential for bone formation. However, the effect of VEGF on osteoblastic cells during osteoblastogenesis is still controversial. The aim of this study was to clarify the relationship between osteoblastic cells derived from human mesenchymal stem cells (MSCs) and VEGF in the early stage of osteoblastic differentiation. Continuous dexamethasone treatment with a low concentration stimulated osteoblastogenesis of MSCs and the expression of VEGF121 mRNA. The VEGF secretion from osteoblastic cells also increased along with osteoblastogenesis. Neuropilin-1, which mainly binds VEGF165, was detected at all stages during early osteoblastogenesis, but VEGF receptor-1 and -2 were not detected on RT-PCR analyses. In this study, VEGF had no direct effect on the proliferation of osteoblastic cells. However, the secreted VEGF in the conditioned medium of osteoblastic cells exhibited high angiogenic power as to endothelial cell proliferation. Our findings indicated that VEGF121 principally acts as the main angiogenic factor in the early stage of human osteoblastogenesis. The present study also demonstrated the differential expression of VEGF121 during osteoblastogenesis. The increase of VEGF in the early stage might be a useful marker of induction of bone formation due to human MSCs.

    PubMed

    researchmap

  • All four members of the Ten-m/Odz family of transmembrane proteins form dimers. Reviewed International journal

    Kang Feng, Xiao-Hong Zhou, Toshitaka Oohashi, Matthias Mörgelin, Ariel Lustig, Satoshi Hirakawa, Yoshifumi Ninomiya, Jürgen Engel, Uwe Rauch, Reinhard Fässler

    The Journal of biological chemistry   277 ( 29 )   26128 - 35   2002.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Ten-m/Odz/teneurins are a new family of four distinct type II transmembrane molecules. Their extracellular domains are composed of an array of eight consecutive EGF modules followed by a large globular domain. Two of the eight modules contain only 5 instead of the typical 6 cysteine residues and have the capability to dimerize in a covalent, disulfide-linked fashion. The structural properties of the extracellular domains of all four mouse Ten-m proteins have been analyzed using secreted, recombinant molecules produced by mammalian HEK-293 cells. Electron microscopic analysis supported by analytical ultracentrifugation data revealed that the recombinant extracellular domains of all Ten-m proteins formed homodimers. SDS-PAGE analysis under nonreducing conditions as well as negative staining after partial denaturation of the molecules indicated that the globular COOH-terminal domains of Ten-m1 and -m4 contained subdomains with a pronounced stability against denaturing agents, especially when compared with the homologous domains of Ten-m2 and -m3. Cotransfection experiments of mammalian cells with two different extracellular domains revealed that Ten-m molecules have also the ability to form heterodimers, a property that, combined with alternative splicing events, allows the formation of a multitude of molecules with different characteristics from a limited set of genes.

    PubMed

    researchmap

  • Human BRAL1 and BCAN genes that belong to the link-module superfamily are tandemly arranged on chromosome 1q21-23. Reviewed

    Hiroyuki Nomoto, Toshitaka Oohashi, Satoshi Hirakawa, Yasuyoshi Ueki, Hiroshi Ohtsuki, Yoshifumi Ninomiya

    Acta medica Okayama   56 ( 1 )   25 - 9   2002.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We herein determined by fluorescence in situ hybridization the chromosomal localization of 2 human genes, BRAL1 and BCAN, both of which belong to the link-module superfamily, i.e. to the same band of chromosome 1q21-23. Further analysis of the genomic organization of BRAL1 and BCAN revealed that the BRAL1 gene was located 20-kb upstream of the BCAN start site. We isolated a polymorphic dinucleotide (CA) repeat sequence from a genomic clone containing the BCAN gene. High heterozygosity (0.79) makes this polymorphism a useful marker in the study of genetic disorders. Knowledge of the structure of the genes and the marker provides essential information for further analysis of the gene locus at chromosome 1q21-23.

    PubMed

    researchmap

  • Bral1, a brain-specific link protein, colocalizing with the versican V2 isoform at the nodes of Ranvier in developing and adult mouse central nervous systems. Reviewed International journal

    Toshitaka Oohashi, Satoshi Hirakawa, Yoko Bekku, Uwe Rauch, Dieter R Zimmermann, Wei-Dong Su, Aiji Ohtsuka, Takuro Murakami, Yoshifumi Ninomiya

    Molecular and cellular neurosciences   19 ( 1 )   43 - 57   2002.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Bral1, a brain-specific hyaluronan-binding protein, has been cloned recently. To gain insight into the role of Bral1, we generated a specific antibody against this protein. We have examined the detailed localization pattern of Bral1 protein and compared it with that of other members of the lectican proteoglycan family, such as brevican and versican, with which Bral1 is predicted to interact. The immunoreactivity of Bral1 antibody was predominantly observed in myelinated fiber tracts in the adult brain and could be detected at P20 in the white matter of the developing cerebellum, suggesting that expression starts when axonal myelination takes place. Furthermore, immunostaining demonstrated that Bral1 colocalized with the versican V2 isoform at the nodes of Ranvier. The present data suggest that Bral1 may play a pivotal role in the formation of the hyaluronan-associated matrix in the CNS that facilitates neuronal conduction by forming an ion diffusion barrier at the nodes.

    PubMed

    researchmap

  • Neurocan is dispensable for brain development. Reviewed International journal

    X H Zhou, C Brakebusch, H Matthies, T Oohashi, E Hirsch, M Moser, M Krug, C I Seidenbecher, T M Boeckers, U Rauch, R Buettner, E D Gundelfinger, R Fässler

    Molecular and cellular biology   21 ( 17 )   5970 - 8   2001.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Neurocan is a component of the extracellular matrix in brain. Due to its inhibition of neuronal adhesion and outgrowth in vitro and its expression pattern in vivo it was suggested to play an important role in axon guidance and neurite growth. To study the role of neurocan in brain development we generated neurocan-deficient mice by targeted disruption of the neurocan gene. These mice are viable and fertile and have no obvious deficits in reproduction and general performance. Brain anatomy, morphology, and ultrastructure are similar to those of wild-type mice. Perineuronal nets surrounding neurons appear largely normal. Mild deficits in synaptic plasticity may exist, as maintenance of late-phase hippocampal long-term potentiation is reduced. These data indicate that neurocan has either a redundant or a more subtle function in the development of the brain.

    PubMed

    researchmap

  • The brain link protein-1 (BRAL1): cDNA cloning, genomic structure, and characterization as a novel link protein expressed in adult brain. Reviewed International journal

    S Hirakawa, T Oohashi, W D Su, H Yoshioka, T Murakami, J Arata, Y Ninomiya

    Biochemical and biophysical research communications   276 ( 3 )   982 - 9   2000.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We report here molecular cloning and expression analysis of the gene for a novel human brain link protein-1 (BRAL1) which is predominantly expressed in brain. The predicted open reading frame of human brain link protein-1 encoded a polypeptide of 340 amino acids containing three protein modules, the immunoglobulin-like fold and proteoglycan tandem repeat 1 and 2 domains, with an estimated mass of 38 kDa. The brain link protein-1 mRNA was exclusively present in brain. When analyzed during mouse development, it was detected solely in the adult brain. Concomitant expression pattern of mRNAs for brain link protein-1 and various lectican proteoglycans in brain suggests a possibility that brain link protein-1 functions to stabilize the binding between hyaluronan and brevican. The human BRAL1 gene contained 7 exons and spanned approximately 6 kb. The entire immunoglobulin-like fold was encoded by a single exon and the proteoglycan tandem repeat 1 and 2 domains were encoded by a single and two exons, respectively. The deduced amino acid sequence of human brain link protein-1 exhibited 45% identity with human cartilage link protein-1 (CRTL1), previously reported as link protein to stabilize aggregates of aggrecan and hyaluronan in cartilage. These results suggest that brain link protein-1 may have distinct function from cartilage link protein-1 and play specific roles, especially in the adult brain.

    PubMed

    researchmap

  • Differential expression of mouse alpha5(IV) and alpha6(IV) collagen genes in epithelial basement membranes. Reviewed International journal

    K Saito, I Naito, T Seki, T Oohashi, E Kimura, R Momota, Y Kishiro, Y Sado, H Yoshioka, Y Ninomiya

    Journal of biochemistry   128 ( 3 )   427 - 34   2000.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We first completed the primary structure of the mouse alpha5(IV) and alpha6(IV) chains, from which synthetic peptides were produced and a chain-specific monoclonal antibodies were raised. Expression of collagen IV genes in various basement membranes underlying specific organ epithelia was analyzed by immunohistochemical staining using these monoclonal antibodies and other antibodies from human and bovine sequences. It was possible to predict the presence of the three collagen IV molecules: [alpha1(IV)](2) alpha2(IV), alpha3(IV)alpha4(IV)alpha5(IV), and [alpha5(IV)](2)alpha6(IV). In skin basement membrane two of the three forms, [alpha1(IV)](2)alpha2(IV) and [alpha5(IV)](2)alpha6(IV), were detected. The alpha3(IV)alpha4(IV)alpha5(IV) molecule was observed as the major form in glomerulus, alveolus, and choroid plexus, where basement membranes function as filtering units. The molecular form [alpha5(IV)](2)alpha6(IV) was present in basement membranes in tubular organs such as the epididymis, where the tubes need to expand in diameter. Thus, the distribution of the basement membranes with different molecular composition is consistent with tissue-specific function.

    PubMed

    researchmap

  • Peri-implantation lethality in mice lacking the Sm motif-containing protein Lsm4. Reviewed International journal

    E Hirsch, T Oohashi, M Ahmad, S Stamm, R Fässler

    Molecular and cellular biology   20 ( 3 )   1055 - 62   2000.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Small nuclear ribonucleoproteins (snRNPs) are particles present only in eukaryotic cells. They are involved in a large variety of RNA maturation processes, most notably in pre-mRNA splicing. Several of the proteins typically found in snRNPs contain a sequence signature, the Sm domain, conserved from yeast to mammals. By using a promoter trap strategy to target actively transcribed loci in murine embryonic stem cells, a new murine gene encoding an Sm motif-containing protein was identified. Database searches revealed that it is the mouse orthologue of Lsm4p, a protein found in yeast and human cells and putatively associated with U6 snRNA. Introduction of the geo reporter gene cassette under the control of the murine Lsm4 (mLsm4) endogenous promoter showed that the gene was ubiquitously transcribed in embryonic and adult tissues. The insertion of the geo cassette disrupted the mLsm4 allele, and homozygosity for the mutation led to a recessive embryonic lethal phenotype. mLsm4-null zygotes survived to the blastocyst stages, implanted into the uterus, but died shortly thereafter. The early death of mLsm4p-null mice suggests that the role of mLsm4p in splicing is essential and cannot be compensated by other Lsm proteins.

    PubMed

    researchmap

  • The extracellular matrix in the mouse brain: its reactions to endo-alpha-N-acetylgalactosaminidase and certain other enzymes. Reviewed

    T Murakami, A Ohtsuka, W D Su, T Taguchi, T Oohashi, T Murakami, K Abe, Y Ninomiya

    Archives of histology and cytology   62 ( 3 )   273 - 81   1999.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    As our previous studies have indicated, the cingulate cortex of the adult mouse brain contains many neurons with rich cell surface glycoproteins which are linked by collagenous ligands to perineuronal proteoglycans. The present study demonstrated that exclusive incubation with endo-alpha-N-acetylgalactosaminidase abolished the lectin Vicia villosa or Wisteria floribunda agglutinin (VVA or WFA) labeling of the nerve cell surface glycoproteins, while it neither interfered with the cationic iron colloid or aldehyde fuchsin stainings of the perineuronal proteoglycans nor abolished the Gömöri's ammoniacal silver impregnation of the collagenous ligands. Double incubations with endo-alpha-N-acetylgalactosaminidase and collagenase did not eliminate the lectin VVA or WFA labeling of the nerve cell surface glycoproteins, though they did eliminate the cationic iron colloid and aldehyde fuchsin stainings of the perineuronal proteoglycans as well as the Gömöri's ammoniacal silver impregnation of the collagenous ligands. Triple incubations with endo-alpha-N-acetylgalactosaminidase, collagenase, and endo-alpha-N-acetylgalactosaminidase abolished the lectin VVA or WFA labeling of the nerve cell surface glycoproteins, and also eliminated the cationic iron colloid and aldehyde fuchsin stainings of the perineuronal proteoglycans and the Gömöri's ammoniacal silver impregnation of the collagenous ligands. These findings indicate that: the nerve cell surface glycoproteins or their terminal N-acetylgalactosamines are digested by endo-alpha-N-acetylgalactosaminidase; these galactosamines associated with the collagenous ligands or perineuronal proteoglycans are not digested by endo-alpha-N-acetylgalactosaminidase; and the terminal N-acetylgalactosamines newly exposed by collagenase incubation are digested by this galactosaminidase. It was further demonstrated that hyaluronidase incubation neither digests the collagenous ligands nor revives the lectin VVA or WFA labeling of the nerve cell surface proteoglycans.

    PubMed

    researchmap

  • Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. Reviewed International journal

    T Oohashi, X H Zhou, K Feng, B Richter, M Mörgelin, M T Perez, W D Su, R Chiquet-Ehrismann, U Rauch, R Fässler

    The Journal of cell biology   145 ( 3 )   563 - 77   1999.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The Drosophila gene ten-m/odz is the only pair rule gene identified to date which is not a transcription factor. In an attempt to analyze the structure and the function of ten-m/odz in mouse, we isolated four murine ten-m cDNAs which code for proteins of 2,700-2, 800 amino acids. All four proteins (Ten-m1-4) lack signal peptides at the NH2 terminus, but contain a short hydrophobic domain characteristic of transmembrane proteins, 300-400 amino acids after the NH2 terminus. About 200 amino acids COOH-terminal to this hydrophobic region are eight consecutive EGF-like domains. Cell transfection, biochemical, and electronmicroscopic studies suggest that Ten-m1 is a dimeric type II transmembrane protein. Expression of fusion proteins composed of the NH2-terminal and hydrophobic domain of ten-m1 attached to the alkaline phosphatase reporter gene resulted in membrane-associated staining of the alkaline phosphatase. Electronmicroscopic and electrophoretic analysis of a secreted form of the extracellular domain of Ten-m1 showed that Ten-m1 is a disulfide-linked dimer and that the dimerization is mediated by EGF-like modules 2 and 5 which contain an odd number of cysteines. Northern blot and immunohistochemical analyses revealed widespread expression of mouse ten-m genes, with most prominent expression in brain. All four ten-m genes can be expressed in variously spliced mRNA isoforms. The extracellular domain of Ten-m1 fused to an alkaline phosphatase reporter bound to specific regions in many tissues which were partially overlapping with the Ten-m1 immunostaining. Far Western assays and electronmicroscopy demonstrated that Ten-m1 can bind to itself.

    PubMed

    researchmap

  • Differential tissular expression and localization of type IV collagen alpha1(IV), alpha2(IV), alpha5(IV), and alpha6(IV) chains and their mRNA in normal breast and in benign and malignant breast tumors. Reviewed International journal

    S Nakano, K Iyama, M Ogawa, H Yoshioka, Y Sado, T Oohashi, Y Ninomiya

    Laboratory investigation; a journal of technical methods and pathology   79 ( 3 )   281 - 92   1999.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Type IV collagen, the major component of basement membrane (BM), is composed of six genetically distinct alpha chains. We investigated the cellular regulation and origin of these alpha(IV) chains in normal and neoplastic breast tissues by immunohistochemistry by using alpha(IV) chain-specific antibodies and by in situ hybridization. In normal breast, alpha1(IV) and alpha2(IV) chains were stained in all BM, whereas alpha5(IV) and alpha6(IV) chains were restrictively localized in a linear pattern in the BM of the mammary gland. Similar immunostaining profiles were observed in benign breast tumors and in the intraductal components of invasive ductal carcinoma. However, in invasive ductal carcinoma, alpha1(IV) and alpha2(1V) chains were discontinuously or negatively stained in the cancer cell nests, and the assembly of alpha5(IV) and alpha6(IV) chains into the BM was completely inhibited. Coexpression of alpha5(IV) and alpha6(IV) chains was related to the localization of alpha-smooth muscle actin (alpha-SMA)-positive myoepithelial cells. By in situ hybridization, in fibroadenoma and invasive ductal carcinoma, the signals for alpha1(IV) and alpha2(IV) mRNA were abundant in stromal cells. However, the signals for alpha5(IV) and alpha6(IV) mRNA were not seen in any of these cells. In contrast, in intraductal papilloma, coexpression of alpha1 (IV)/alpha2(IV) mRNA and alpha5(IV)/alpha6(IV) mRNA was identified in epithelial cells. The results indicate that the mammary gland forms a second network of BM composed of alpha5(IV)/alpha6(IV) chains, in addition to the classic network of alpha1(IV)/alpha2(IV) chains. The expression of type IV collagen alpha chains seems to be differentially regulated by the epithelial-myoepithelial interaction and to be associated with the invasive potential of breast cancer.

    PubMed

    researchmap

  • Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Reviewed International journal

    A J Coffey, R A Brooksbank, O Brandau, T Oohashi, G R Howell, J M Bye, A P Cahn, J Durham, P Heath, P Wray, R Pavitt, J Wilkinson, M Leversha, E Huckle, C J Shaw-Smith, A Dunham, S Rhodes, V Schuster, G Porta, L Yin, P Serafini, B Sylla, M Zollo, B Franco, A Bolino, M Seri, A Lanyi, J R Davis, D Webster, A Harris, G Lenoir, G de St Basile, A Jones, B H Behloradsky, H Achatz, J Murken, R Fassler, J Sumegi, G Romeo, M Vaudin, M T Ross, A Meindl, D R Bentley

    Nature genetics   20 ( 2 )   129 - 35   1998.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    X-linked lymphoproliferative syndrome (XLP or Duncan disease) is characterized by extreme sensitivity to Epstein-Barr virus (EBV), resulting in a complex phenotype manifested by severe or fatal infectious mononucleosis, acquired hypogammaglobulinemia and malignant lymphoma. We have identified a gene, SH2D1A, that is mutated in XLP patients and encodes a novel protein composed of a single SH2 domain. SH2D1A is expressed in many tissues involved in the immune system. The identification of SH2D1A will allow the determination of its mechanism of action as a possible regulator of the EBV-induced immune response.

    PubMed

    researchmap

  • Differential expression of type IV collagen isoforms, alpha5(IV) and alpha6(IV) chains, in basement membranes surrounding smooth muscle cells. Reviewed International journal

    T Seki, I Naito, T Oohashi, Y Sado, Y Ninomiya

    Histochemistry and cell biology   110 ( 4 )   359 - 66   1998.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Smooth muscle is composed of cigar-shaped, non-striated cells, each of which is encapsulated by a basement membrane and forms the contractile portion of tubular organs such as the gastrointestinal tract, pulmonary tract, genitourinary tract, and vasculature, in which slow and sustained contractions are needed. We examined basement membranes produced by smooth muscle cells and, using alpha(IV) chain-specific monoclonal antibodies, analyzed type IV collagens in these organs. Detailed distribution analysis of the alpha chains in normal and Alport cases by use of specific antibodies indicated that there are at least three molecular forms of type IV collagen, [alpha1(IV)]2alpha2(IV),alpha3(IV)alpha4(IV)alpha5+ ++(IV), and alpha5(IV)/alpha6(IV). Smooth muscle cells in the urinary bladder and uterus were enclosed by basement membranes composed of alpha1, alpha2, alpha5, and alpha6 chains. The same alpha chains were present around smooth muscle cells in the muscular layer of the fundus of the stomach, whereas those in the antrum and further distal side of the gastrointestinal tract expressed mostly alphal and alpha2 chains. In addition, immunostaining analysis of the vasculature also showed that most of the smooth muscle cells were positive for alpha1 and alpha2 chains; however, alpha5 and alpha6 chains were also expressed by smooth muscle cells in the aorta and some arteries where blood pressure changes significantly. These results suggest that the smooth muscle cells enclosed by alpha5/alpha6-containing basement membranes might have some particular function related to mechanical stress or tensile strength during the characteristic contractile activity of tubular organs.

    PubMed

    researchmap

  • Differential expression of type IV collagen isoforms, alpha 5(IV) and alpha 6(IV) chains, in basement membranes surrounding smooth muscle cells Reviewed

    T Seki, Naito, I, T Oohashi, Y Sado, Y Ninomiya

    HISTOCHEMISTRY AND CELL BIOLOGY   110 ( 4 )   359 - 366   1998.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SPRINGER VERLAG  

    Smooth muscle is composed of cigar-shaped, non-striated cells, each of which is encapsulated by a basement membrane and forms the contractile portion of tubular organs such as the gastrointestinal tract, pulmonary tract, genitourinary tract, and vasculature, in which slow and sustained contractions are needed. We examined basement membranes produced by smooth muscle cells and, using alpha(IV) chain-specific monoclonal antibodies, analyzed type IV collagens in these organs. Detailed distribution analysis of the alpha chains in normal and Alport cases by use of specific antibodies indicated that there are at least three molecular forms of type IV collagen, [alpha 1(IV)](2)alpha 2(IV), alpha 3(IV)alpha 4(IV)alpha 5(IV), and alpha 5(IV)/alpha 6(IV). Smooth muscle cells in the urinary bladder and uterus were enclosed by basement membranes composed of alpha 1, alpha 2, alpha 5, and alpha 6 chains. The same alpha chains were present around smooth muscle cells in the muscular layer of the fundus of the stomach, whereas those in the antrum and further distal side of the gastrointestinal tract expressed mostly alpha 1 and alpha 2 chains. In addition, immunostaining analysis of the vasculature also showed that most of the smooth muscle cells were positive for alpha 1 and alpha 2 chains; however, alpha 5 and alpha 6 chains were also expressed by smooth muscle cells in the aorta and some arteries where blood pressure changes significantly. These results suggest that the smooth muscle cells enclosed by alpha 5/alpha 6-containing basement membranes might have some particular function related to mechanical stress or tensile strength during the characteristic contractile activity of tubular organs.

    Web of Science

    researchmap

  • Organization and expression of basement membrane collagen IV genes and their roles in human disorders. Reviewed International journal

    Y Sado, M Kagawa, I Naito, Y Ueki, T Seki, R Momota, T Oohashi, Y Ninomiya

    Journal of biochemistry   123 ( 5 )   767 - 76   1998.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Six distinct genes have been identified as belonging to the type IV collagen gene family. They can be organized into three sets, i.e., COL4A1/COL4A2, COL4A3/COL4A4, and COL4A5/COL4A6, which are localized on three different chromosomes in humans, 13, 2, and X, respectively. Within each set the genes are aligned head-to-head and their expression is regulated by bidirectional promoters between the genes. Transcriptional regulation of the COL4A1/COL4A2 set has been well characterized. The transcription of COL4A6 seems to be controlled by two alternative promoters. While collagen IV molecules composed of alpha1 and alpha2 chains are broadly distributed, molecules comprising combinations of the other four chains, alpha3-alpha6, are important components of specialized basement membranes. The precise chain composition of triple-helical molecules assembled from the alpha3-alpha6 chains is not entirely clear, but it is hypothesized that alpha3-alpha5 chains and alpha5 and alpha6 chains form heterotrimeric molecules. Several pieces of evidence indicate that alpha3/alpha4/alpha5 molecules and alpha5/alpha6 molecules are components of the basement membrane network. This helps explain the observation that the kidney and skin basement membranes from patients with Alport syndrome caused by mutations in the alpha5 coding gene, COL4A5, are defective in the alpha3, alpha4, and alpha6 chains together with the alpha5 chain. Large deletions involving the COL4A5 and COL4A6 genes have been found in rare cases of diffuse leiomyomatosis associated with Alport syndrome.

    PubMed

    researchmap

  • Two genes, COL4A3 and COL4A4 coding for the human alpha3(IV) and alpha4(IV) collagen chains are arranged head-to-head on chromosome 2q36. Reviewed International journal

    R Momota, M Sugimoto, T Oohashi, K Kigasawa, H Yoshioka, Y Ninomiya

    FEBS letters   424 ( 1-2 )   11 - 6   1998.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We first isolated and characterized genomic DNA fragments that cover the 5' flanking sequences of COL4A3 and COL4A4 encoding the human basement membrane alpha3(IV) and alpha4(IV) collagen chains, respectively. Nucleotide sequence analysis indicated that the two genes are arranged head-to-head. To determine transcription start site for COL4A4 gene, we performed RACE and RNase protection assays, indicating that there are two alternative transcripts presumably derived from two different promoters. Interestingly, one transcription start site (from exon 1') of COL4A4 is only 5 bp away from the reported transcription start site of COL4A3, whereas the other transcript (from exon 1) starts 373 nucleotides downstream from the first one, generating the two kinds of transcripts that differ in the 5' UTR regions. Expression of these two transcripts appears tissue-specific; exon 1 transcript was expressed predominantly in epithelial cells, while exon 1' transcript showed rather ubiquitous and low expression. The nucleotide sequence of the promoter region is composed of dense CpG dinucleotides, GC boxes, CTC boxes and a CCAAT box but no TATA box. These results provide information to delineate the promoter activity for the tissue-specific expression of the six type IV collagen genes and basement membrane assembly in different tissues and organs.

    DOI: 10.1016/S0014-5793(98)00128-8

    PubMed

    researchmap

  • Expression of type XVII collagen alpha 1 chain mRNA in the mouse heart. Reviewed

    J Kondo, S Kusachi, Y Ninomiya, H Yoshioka, T Oohashi, M Doi, T Murakami, H Moritani, H Kumashiro, T Tsuji

    Japanese heart journal   39 ( 2 )   211 - 20   1998.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The type XVII collagen alpha 1 chain has been identified as a component of the type I hemidesmosome, and is thus thought to play a role in extracellular matrix (ECM) maintenance and signal transduction between the cell and the ECM. We examined the expression of type XVII collagen alpha 1 chain mRNA in the mouse heart by Northern blot analysis and determined the sequential changes of its expression in different developmental stages of the heart using the reverse transcriptase-polymerase chain reaction (RT-PCR) method. Northern blotting: Total RNA was extracted from 10 adult mouse hearts by the guanidine/cesium method. Hybridization was performed with mouse cDNA for alpha 1 (XVII) collagen. RT-PCR: Total RNA was extracted from 7 embryos, 4 neonates and 8 adult mice. Reverse transcription was performed using oligo-dT primer and MMLV. Amplification was carried out in alpha 1 (XVII) collagen and glyceraldehyde 3-phosphate dehydrogenase (GAPDH). GAPDH served as an internal control. Northern blotting revealed a 5.6 kb signal that was identical to that of the alpha 1 (XVII) of skin and transformed keratinocyte reported previously. The sequences of the PCR products were also identical to those reported. The normalized expression ratios of alpha 1 (XVII) were 0.91 +/- 0.20 in the embryonic heart, 0.36 +/- 0.20 in the neonatal heart and 0.96 +/- 0.21 in the adult heart. In conclusion, we identified the expression of type XVII collagen alpha 1 chain mRNA in the mouse heart, suggesting that the type I hemidesmosome is located in the heart. The results of the RT-PCR at different developmental stages of the heart suggest that type XVII collagen contributes not only to cardiogenesis in the embryonic stage but also to maintenance of architecture and function in the adult heart.

    DOI: 10.1536/ihj.39.211

    PubMed

    researchmap

  • Topoisomerase I and II consensus sequences in a 17-kb deletion junction of the COL4A5 and COL4A6 genes and immunohistochemical analysis of esophageal leiomyomatosis associated with Alport syndrome. Reviewed International journal

    Y Ueki, I Naito, T Oohashi, M Sugimoto, T Seki, H Yoshioka, Y Sado, H Sato, T Sawai, F Sasaki, M Matsuoka, S Fukuda, Y Ninomiya

    American journal of human genetics   62 ( 2 )   253 - 61   1998.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Diffuse esophageal leiomyomatosis (DL), a benign smooth-muscle-cell tumor, is characterized by abnormal cell proliferation. DL is sometimes associated with X-linked Alport syndrome (AS), an inherited nephropathy caused by COL4A5 gene mutations. COL4A5 is tightly linked, in a head-to-head fashion, to the functionally related and coordinately regulated COL4A6 gene. No X-linked AS cases are due to COL4A6 mutations, but all DL/AS cases are always associated with deletions spanning the 5' regions of the COL4A5/COL4A6 cluster. Unlike the COL4A5 breakpoints, those of COL4A6 are clustered within intron 2 of the gene. We identified a DL/AS deletion and the first characterization of the breakpoint sequences. We show that a deletion eliminates the first coding exon of COL4A5 and the first two coding exons of COL4A6. The breakpoints share the same sequence, which, in turn, is closely homologous to the consensus sequences of topoisomerases I and II. Additional DNA evidence suggested that the male patient is a somatic mosaic for the mutation. Immunohistochemical analysis using alpha-chain-specific monoclonal antibodies supported this conclusion, since it revealed the absence of the alpha5(IV) and alpha6(IV) collagen chains in most but not all of the basement membranes of the smooth-muscle-cell tumor. We also documented a similar segmental staining pattern in the glomerular basement membranes of the patient's kidney. This study is particularly relevant to the understanding of DL pathogenesis and its etiology.

    DOI: 10.1086/301703

    PubMed

    researchmap

  • There is temporal and spatial expression of alpha1 (IV), alpha2 (IV), alpha5 (IV), alpha6 (IV) collagen chains and beta1 integrins during the development of the basal lamina in an "in vitro" skin model. Reviewed International journal

    R Fleischmajer, K Kühn, Y Sato, E D MacDonald 2nd, J S Perlish, T C Pan, M L Chu, Y Kishiro, T Oohashi, S M Bernier, Y Yamada, Y Ninomiya

    The Journal of investigative dermatology   109 ( 4 )   527 - 33   1997.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Temporal and spatial expression of alpha1 (IV), alpha2 (IV), alpha3 (IV), alpha4 (IV), alpha5 (IV), and alpha6 (IV) collagen chains was studied during the formation of the basal lamina in an "in vitro" skin model. A sequential study was performed at 7-d and 14-d cultures (lamina densa absent) and at 28-, 36-, and 56-d cultures (lamina densa present). Expression of beta1, beta4, alpha1, alpha2, alpha3, alpha5, alpha6 integrin subunits and co-localization with collagen IV was studied by regular and laser confocal indirect immunofluorescence microscopy. mRNA expression of alpha2 (IV) and alpha6 (IV) chains was estimated by northern blots. The earliest expression of alpha1 (IV) and alpha2 (IV) collagen chains was noted in 7-d cultures restricted to basal keratinocytes. At 14-d cultures, alpha1 (IV) and alpha2 (IV) chains were noted in basal keratinocytes and as a broad band (10 microm) in the adjacent dermis. At this stage 80% of the alpha2 (IV) mRNA was expressed in the dermis and 20% in the epidermis. At 28-, 36-, and 56-d cultures the alpha1 (IV) and alpha2 (IV) chains were present in a linear distribution at the epidermo-dermal junction and in the upper dermis. The alpha6 (IV) collagen chains were expressed much later at 36-d cultures and the alpha5 (IV) at 56 d, both mostly in a linear distribution but also in the adjacent dermis. Alpha6 (IV) mRNA was demonstrated in the dermis of 36-d cultures. There was co-localization of collagen IV and beta1 integrin subunits in 14-d cultures at the matrix site of keratinocytes. Functional perturbation studies with AIIB2 monoclonal antibody (anti-beta1 subunits) and competitive inhibition with a collagen cyanogen bromide digestion derived fragment (CB3[IV]) that contains the collagen IV ligand for alpha1beta1, alpha2beta1 integrins, altered the pattern of collagen IV deposition.

    PubMed

    researchmap

  • Differential expression of alpha 1(IV), alpha 2(IV), alpha 5(IV) and alpha 6(IV) collagen chains in the basement membrane of basal cell carcinoma. Reviewed International journal

    K Tanaka, K Iyama, M Kitaoka, Y Ninomiya, T Oohashi, Y Sado, T Ono

    The Histochemical journal   29 ( 7 )   563 - 70   1997.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Type IV collagen, the major component of basement membrane, consists primarily of alpha 1(IV) and alpha 2(IV) chains. Recently, other types of collagen IV chains, i.e. alpha 3(IV), alpha 4(IV), alpha 5(IV) and alpha 6(IV) chains, have been identified by protein chemistry and molecular cloning. We have examined the diversity of the assembly of alpha (IV) chains of the basement membrane surrounding tumour nests of basal cell carcinomas, in tissues from 11 patients, by immunohistochemical analysis using specific monoclonal antibodies to six alpha (IV) chain. The immunostaining profile of each chain differed with respect to the histological subtypes of basal cell carcinoma. In the morphea-like subtype, which was more invasive, alpha 1(IV) and alpha 2(IV) chains were discontinuously stained, and alpha 5(IV) and alpha 6(IV) chains were entirely absent. However, in the superficial subtype, which was non-aggressive, alpha 1(IV), alpha 2(IV), alpha 5(IV) and alpha 6(IV) chains were well stained compared with the other subtypes of basal cell carcinoma. In addition, in the solid subtype, which showed slow growth and ulceration, alpha 1(IV) and alpha 2(IV) chains were continuously stained, and alpha 5(IV) and alpha 6(IV) chains were discontinuous or absent. The assembly of alpha 5(IV) and alpha 6(IV) chains into the basement membrane was inhibited in the solid and morphea subtypes of BCC. This differential expression of type IV collagen chains seems to be associated with the invasive potential of basal cell carcinoma.

    DOI: 10.1023/A:1026428010104

    PubMed

    researchmap

  • The primary structure of the Cl(-)-translocating ATPase, b subunit of Acetabularia acetabulum, which belongs to the F-type ATPase family. Reviewed International journal

    C Moritani, T Ohhashi, H Kadowaki, M Tagaya, T Fukui, F Lottspeich, D Oesterhelt, M Ikeda

    Archives of biochemistry and biophysics   339 ( 1 )   115 - 24   1997.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The genes possibly encoding the b subunit (50 kDa) of the Cl(-)-translocating ATPase of Acetabularia acetabulum were cloned from total RNA and from poly(A)+ RNA and sequenced. The deduced amino acid sequence of the open reading frame consisted of 478 amino acids and showed high similarity to the beta subunit of chloroplast F1-ATPase. Gene fragments encoding the putative beta subunit of chloroplast F1- (273 bp) and mitochondrial F1-ATPases (332 bp) were also cloned from A. acetabulum and sequenced, respectively. The deduced amino acid sequence of the chloroplast F1-ATPase showed 92.5% identity to be primary structure of the b subunit of the Cl(-)-translocating ATPase, while the nucleotide sequences were 79.9% identical. The deduced amino acid sequence of the latter was 77.3% identical to that of the b subunit of the Cl(-)-translocating ATPase and the nucleotide sequences were 67.5% identical. By Northern analysis, these three beta-like genes were demonstrated to be transcribed with different sizes of RNA species. A putative chloroplast F1-beta fragment also hybridized with chloroplast DNA isolated from the organism.

    PubMed

    researchmap

  • Absence of alpha 6(IV) collagen in kidney and skin of X-linked Alport syndrome patients. Reviewed International journal

    S Hino, T Takemura, Y Sado, M Kagawa, T Oohashi, Y Ninomiya, K Yoshioka

    Pediatric nephrology (Berlin, Germany)   10 ( 6 )   742 - 4   1996.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    To identify the abnormalities of the type IV collagen alpha 6 chain, alpha 6(IV), in Alport syndrome, we examined renal and skin tissue using rat monoclonal antibodies against non-consensus amino acid sequences of alpha 6(IV). Immunofluorescence of normal human kidney and skin tissue revealed linear alpha 6(IV) staining in the basement membrane (BM) of Bowman's capsule, in some tubules, and also in the epidermal BM. Renal specimens from five male patients of four families with X-linked Alport syndrome showed no reactivity for alpha 6(IV) in Bowman's capsules and tubules. In these patients, alpha 1(IV) and alpha 2(IV) were normal, whereas alpha 3(IV), alpha 4(IV), and alpha 5(IV) were absent from the BMs of the kidney. In skin tissue of male patients, neither alpha 5(IV) nor alpha 6(IV) were detected. The epidermal BM of female heterozygotes with X-linked Alport syndrome showed a mosaic staining for alpha 5(IV) and alpha 6(IV). These findings indicate that, in addition to a disturbed alpha 3(IV)-alpha 4(IV)-alpha 5(IV) network, patients with X-linked Alport syndrome have abnormalities in alpha 6(IV) of the renal and epidermal BMs at the protein level.

    DOI: 10.1007/s004670050206

    PubMed

    researchmap

  • Nephritogenicity and alpha-chain composition of NC1 fractions of type IV collagen from bovine renal basement membrane. Reviewed International journal

    S Rauf, M Kagawa, Y Kishiro, S Inoue, I Naito, T Oohashi, M Sugimoto, Y Ninomiya, Y Sado

    Virchows Archiv : an international journal of pathology   428 ( 4-5 )   281 - 8   1996.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Nephritogenicity (anti-GBM-nephritis-inducing activity) and alpha-chain composition of globular-do-main (NCI) fractions of type IV collagen from bovine renal, pulmonary, and placental basement membranes (BMs) was examined by injecting these fractions with adjuvant into WKY/NCrj rats and by Western blotting using epitope-defined monoclonal antibodies to the six different alpha chains of type IV collagen. A purified nephritogenic fraction from renal BM contained alpha 1-alpha 6(IV)NCI, whereas a non-nephritogenic fraction contained only alpha 1-alpha 2(IV)NCI. Renal and pulmonary NCI had strong nephritogenic activity: placental NCI had weak activity. The renal and pulmonary fractions contained alpha 1-alpha 6(IV)NCI, and the placental fraction had a large amount of alpha 1-alpha 2(IV)NCI and a very small amount of alpha 3-alpha 6(IV)NCI. Immunohistochemical study of bovine renal BM with the monoclonal antibodies revealed that bovine glomerular BM contained alpha 1-alpha 5(IV) chains, but not the alpha 6(IV) chain. The absence of alpha 6(IV) chain in glomerular BM in bovine and in humans indicates that alpha 6(IV) chain is not a target antigen of anti-GBM nephritis. Nephritogenicity is apparently a property of alpha 3-alpha 5(IV)NCI.

    PubMed

    researchmap

  • Isolation and structure of the COL4A6 gene encoding the human alpha 6(IV) collagen chain and comparison with other type IV collagen genes. Reviewed International journal

    T Oohashi, Y Ueki, M Sugimoto, Y Ninomiya

    The Journal of biological chemistry   270 ( 45 )   26863 - 7   1995.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The genes COL4A5 and COL4A6, coding for the basement membrane collagen chains, alpha 5(IV) and alpha 6(IV), respectively, are located head-to-head in close proximity on human chromosome Xq22, and COL4A6 is transcribed from two alternative promoters in a tissue-specific fashion (Sugimoto M., Oohashi T., and Ninomiya Y. (1994) Proc. Natl. Acad. Sci. U.S.A. 91, 11679-11683). Immunofluorescence studies using alpha chain-specific antibodies demonstrated that the two genes are expressed in a tissue-specific manner (Ninomiya, Y., Kagawa, M., Iyama, K., Naito, L., Kishiro, Y., Seyer, J. M., Sugimoto, M., Oohashi, T., and Sado, Y. (1995) J. Cell Biol. 130, 1219-1229). We report here for the first time the isolation and the structural organization of the human COL4A6 gene. The entire gene presumably exceeds 200 kilobase pairs and contains 46 exons. Exons 1' and 1 encode the two different 5'-UTRs and the two amino-terminal parts of of the signal peptide. The carboxyl part of the signal peptide and the 7 S domain are coded for by the following 6 different exons, 2-7, whereas the exons 7-42 encode the central COL 1 domain, which contains the Gly-X-Y repeats. The last three exons, 43-45, encode the carboxyl-terminal NC1 domain. Sizes of more than a half of the exons of the gene are the same as those of Col4a2 but quite different from those of COL4A5. Within the COL4A6 gene we found three CA repeat markers that can be used for allele detection. The detailed structure of the COL4A6 gene and the high heterozygosity microsatellite markers located within the gene will be useful for linkage analysis and familial diagnosis of diseases caused by mutations of this gene.

    PubMed

    researchmap

  • ESTABLISHMENT BY THE RAT LYMPH-NODE METHOD OF EPITOPE-DEFINED MONOCLONAL-ANTIBODIES RECOGNIZING THE 6 DIFFERENT ALPHA-CHAINS OF HUMAN TYPE-IV COLLAGEN Reviewed

    Y SADO, M KAGAWA, Y KISHIRO, K SUGIHARA, NAITO, I, JM SEYER, M SUGIMOTO, T OOHASHI, Y NINOMIYA

    HISTOCHEMISTRY AND CELL BIOLOGY   104 ( 4 )   267 - 275   1995.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SPRINGER VERLAG  

    A group of rat monoclonal antibodies recognizing the six different alpha chains of human type IV collagen have been established by our novel method. The method is designated the rat lymph node method in which enlarged medial iliac lymph nodes of a rat injected with an antigen emulsion via hind footpads are used as a source of B cells for cell fusion to produce hybridomas. The immunogens used were synthetic peptides having non-consensus amino acid sequences near the carboxyl termini of type IV collagen alpha chains. Hybridomas were screened both by ELISA with synthetic peptides and by indirect immunofluorescence with cryostat sections of human kidneys. Because the epitopes of all antibodies were determined by multipin-peptide scanning, they were confirmed to be isoform-specific. They are useful for identification of alpha chains of type IV collagen at the protein level in normal and abnormal conditions. The combined use of synthetic peptides as immunogens, the rat lymph node method as making monoclonal antibodies, and the multipin-peptide scanning as epitope mapping is found to be a strong tool for identification of peptides and proteins whose amino acid sequences are known or have been deduced.

    Web of Science

    researchmap

  • Establishment by the rat lymph node method of epitope-defined monoclonal antibodies recognizing the six different alpha chains of human type IV collagen. Reviewed International journal

    Y Sado, M Kagawa, Y Kishiro, K Sugihara, I Naito, J M Seyer, M Sugimoto, T Oohashi, Y Ninomiya

    Histochemistry and cell biology   104 ( 4 )   267 - 75   1995.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A group of rat monoclonal antibodies recognizing the six different alpha chains of human type IV collagen have been established by our novel method. The method is designated the rat lymph node method in which enlarged medial iliac lymph nodes of a rat injected with an antigen emulsion via hind footpads are used as a source of B cells for cell fusion to produce hybridomas. The immunogens used were synthetic peptides having non-consensus amino acid sequences near the carboxyl termini of type IV collagen alpha chains. Hybridomas were screened both by ELISA with synthetic peptides and by indirect immunofluorescence with cryostat sections of human kidneys. Because the epitopes of all antibodies were determined by multipin-peptide scanning, they were confirmed to be isoform-specific. They are useful for identification of alpha chains of type IV collagen at the protein level in normal and abnormal conditions. The combined use of synthetic peptides as immunogens, the rat lymph node method as making monoclonal antibodies, and the multipin-peptide scanning as epitope mapping is found to be a strong tool for identification of peptides and proteins whose amino acid sequences are known or have been deduced.

    PubMed

    researchmap

  • Differential expression of two basement membrane collagen genes, COL4A6 and COL4A5, demonstrated by immunofluorescence staining using peptide-specific monoclonal antibodies. Reviewed International journal

    Y Ninomiya, M Kagawa, K Iyama, I Naito, Y Kishiro, J M Seyer, M Sugimoto, T Oohashi, Y Sado

    The Journal of cell biology   130 ( 5 )   1219 - 29   1995.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Genes for the human alpha 5(IV) and alpha 6(IV) collagen chains have a unique arrangement in that they are colocalized on chromosome Xq22 in a head-to-head fashion and appear to share a common bidirectional promoter. In addition we reported a novel observation that the COL4A6 gene is transcribed from two alternative promoters in a tissue-specific manner (Sugimoto, M., T. Oohashi, and Y. Ninomiya. 1994. Proc. Natl. Acad. Sci. USA. 91:11679-11683). To know whether the translation products of both genes are colocalized in various tissues, we raised alpha 5(IV) and alpha 6(IV) chain-specific rat monoclonal antibodies against synthetic peptides reflecting sequences near the carboxy terminus of each noncollagenous (NC)1 domain. By Western blotting alpha 6(IV) chain-specific antibody recognized 27-kD monomers and associated dimers of the human type IV collagen NC1 domain, which is the first demonstration of the presence in tissues of the alpha 6(IV) polypeptide as predicted from its cDNA sequence. Immunofluorescence studies using anti-alpha 6(IV) antibody demonstrated that in human adult kidney the alpha 6(IV) chain was never detected in the glomerular basement membrane, whereas the basement membranes of the Bowman's capsules and distal tubules were positive. The staining pattern of the glomerular basement membrane was quite different from that obtained with the anti-alpha 5(IV) peptide antibody. The alpha 5(IV) and alpha 6(IV) chains were colocalized in the basement membrane in the skin, smooth muscle cells, and adipocytes; however, little if any reaction was seen in basement membranes of cardiac muscles and hepatic sinusoidal endothelial cells. Thus, both genes are expressed in a tissue-specific manner, perhaps due to the unique function of the bidirectional promoter for both genes, which is presumably different from that for COL4A1 and COL4A2.

    DOI: 10.1083/jcb.130.5.1219

    PubMed

    researchmap

  • The genes COL4A5 and COL4A6, coding for basement membrane collagen chains alpha 5(IV) and alpha 6(IV), are located head-to-head in close proximity on human chromosome Xq22 and COL4A6 is transcribed from two alternative promoters. Reviewed International journal

    M Sugimoto, T Oohashi, Y Ninomiya

    Proceedings of the National Academy of Sciences of the United States of America   91 ( 24 )   11679 - 83   1994.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The genes for the alpha 5(IV) and alpha 6(IV) chains of human basement membrane collagen type IV have been found together on chromosome X at segment q22 and have been reported to be arranged in a head-to-head fashion. Here we report the 5' flanking sequences of COL4A5 and COL4A6 and that COL4A6 is transcribed from two alternative promoters in a tissue-specific fashion. Analysis of the sequence immediately upstream of the transcription start sites revealed some features of housekeeping genes--i.e., the lack of a TATA motif and the presence of CCAAT and CTC boxes. Further analysis revealed that COL4A6 contains two alternative promoters that control the generation of two different transcripts. One transcription start site (from exon 1') is 442 bp away from the transcription start site of COL4A5, while an alternative transcription start site (from exon 1) is located 1050 bp from the first one and drives the expression of a second transcript that encodes an alpha 6(IV) chain with a different signal peptide. Reverse transcription-PCR experiments revealed that the transcript from exon 1' is abundant in placenta, whereas the transcript from exon 1 is more frequently found in kidney and lung. These results provide additional clues to answering the general question of what mechanisms are used to generate unique basement membrane structures in different tissues.

    DOI: 10.1073/pnas.91.24.11679

    PubMed

    researchmap

  • Purification and characterization of a membrane-bound ATPase from Acetabularia cliftonii that corresponds to a Cl(-)-translocating ATPase in Acetabularia acetabulum. Reviewed International journal

    C Moritani, T Ohhashi, S Satoh, D Oesterhelt, M Ikeda

    Bioscience, biotechnology, and biochemistry   58 ( 11 )   2087 - 9   1994.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A Mg(2+)-ATPase was solubilized from membranes of Acetabularia cliftonii using nonanoyl-N-methylgluconamide and purified by ion-exchange and gel permeation chromatography. One active ATPase fraction after Mono Q chromatography had a specific activity of 10 units/mg of protein. Judged from subunit composition [54 (a), 50 (b) with a fainter band around 40 kDa], catalytic properties, and N-terminal amino acid sequence of the b subunit, the isolated enzyme was comparable to the Cl(-)-ATPase of Acetabularia acetabulum. Immunological characterization of both subunits showed significant similarity to the F type of ATPase. Cl(-)-transport activity was observed by reconstitution studies into liposomes.

    PubMed

    researchmap

  • Identification of a new collagen IV chain, alpha 6(IV), by cDNA isolation and assignment of the gene to chromosome Xq22, which is the same locus for COL4A5. Reviewed International journal

    T Oohashi, M Sugimoto, M G Mattei, Y Ninomiya

    The Journal of biological chemistry   269 ( 10 )   7520 - 6   1994.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    To date, five distinct alpha chains have been identified in basement membrane collagen IV. We have cloned a gene encoding a new alpha chain belonging to basement membrane collagen IV by cDNA isolation under low stringency conditions. Isolation of overlapping clones and the technique of 5' rapid amplification of cDNA ends enabled us to derive the primary structure of the entire polypeptide. The deduced collagen polypeptide contained 1678 amino acid residues, including a 21-residue signal peptide, a 24-residue amino-terminal NC domain, a central 1405-residue collagenous (COL1) domain, and a 228-residue carboxyl-terminal NC1 domain. We have designated this newly found alpha chain as the alpha 6(IV) chain. The gene was mapped to chromosome Xq22 by in situ hybridization of metaphase lymphocytes. This is the same region of chromosome X where the gene coding for the alpha 5(IV) collagen chain (COL4A5) resides. Mutations in COL4A5 have been characterized in more than 50 patients with Alport syndrome. However, some of the X-linked cases of Alport syndrome are not apparently caused by COL4A5 mutations. The gene we describe in this paper therefore seems to be a candidate for mutations in this group of Alport syndrome patients.

    PubMed

    researchmap

  • Chloroplast ATPase in Acetabularia acetabulum: purification and characterization of chloroplast F1-ATPase. Reviewed International journal

    S Satoh, C Moritani, T Ohhashi, K Konishi, M Ikeda

    Bioscience, biotechnology, and biochemistry   58 ( 3 )   521 - 5   1994.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    ATPases were isolated from chloroplasts of the unicellular marine alga Acetabularia acetabulum. Two preparations of ATPase, a chloroplast-enriched fraction and an alpha beta gamma-complex were compared. The alpha beta gamma-complex was released into an EDTA solution and purified by anion-exchange chromatography, hydrophobic chromatography, and gel permeation chromatography. The subunit composition of this enzyme appeared to be 52-53 (alpha), 51 (beta), and 40 (gamma) kDa from SDS-PAGE. ATPase activity was enriched about 260-fold to a specific activity of approximate 4.1 U.mg protein-1. The catalytic properties of the alpha beta gamma-complex were as follows: pH optimum at 7.5; substrate specificity, ATP > ITP, GTP > UTP = CTP (Km for ATP 0.2 mM); divalent cation requirement, Mg2+ = Mn2+ = Co2+ > Zn2+ > Ni2+ > Ca2+; ATPase activity was inhibited by monovalent anions (NO3-, SCN-), while monovalent cations had neither inhibitory nor stimulatory effect. Orthovanadate had no inhibitory effect on the enzyme activity of alpha beta gamma-complex. Azide was the most effective inhibitor of the alpha beta gamma-complex. N-Terminal amino acid sequences of the alpha and beta subunits were not obtained and appeared to be blocked. The gamma subunit gave a sequence of AGLKEMKD-XIGSVXNTKKI, which showed 60% similarity to the gamma subunits of spinach and Chlamydomonas reinhardtii CF1-ATPase and EF1-ATPase.

    PubMed

    researchmap

  • Isolation and characterization of human cDNAs and genomic DNAs encoding alpha-4(IV) and alpha-6(IV) chains reveal the presence of a distinct subclass of collagen IV genes. Reviewed International journal

    M Sugimoto, T Oohashi, M G Mattei, A Fukutomi, N Kashihara, N Matsuo, H Yoshioka, Y Ninomiya

    Contributions to nephrology   107   29 - 35   1994

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PubMed

    researchmap

  • cDNA isolation and partial gene structure of the human alpha 4(IV) collagen chain. Reviewed International journal

    M Sugimoto, T Oohashi, H Yoshioka, N Matsuo, Y Ninomiya

    FEBS letters   330 ( 2 )   122 - 8   1993.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A novel collagen IV chain, alpha 4(IV), has recently been identified in basement membranes. We describe part of the primary structure of the human alpha 4(IV) polypeptide for the first time, which has been determined by cloning and sequencing of cDNAs encoding 241 amino acid residues of the COL domain and 231 residues of the NC1 domain. We also characterized a genomic DNA fragment containing 4 exons coding for the entire NC1 domain. Among five known alpha chains of collagen IV, the alpha 4(IV) chain is distinct from the other four chains. However, it is more similar to the alpha 2(IV) chain than to the alpha 1(IV), alpha 3(IV) and alpha 5(IV) chains in terms of amino acid sequence homology, domain structure of polypeptides and exon/intron structure of the genes, suggesting the presence of two phylogenetically distinct subclasses of collagen IV alpha chains; one composed of alpha 2 and alpha 4 chains and the other of alpha 1, alpha 3 and alpha 5 chains.

    PubMed

    researchmap

  • Improvement of reconstitution of the Cl--translocating ATPase isolated from Acetabularia acetabulum into liposomes and several anion pump characteristics Reviewed

    Toshitaka Ohhashi, Takashi Katsu, Mikiko Ikeda

    BBA - Biomembranes   1106 ( 1 )   165 - 170   1992.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The improved reconstitution of the Mono Q-III fraction, a Cl--translocating ATPase, isolated from Acetabularia acetabulum (Ikeda et al. (1990) Biochemistry 29, 2057-2065) into liposomes rendered transport properties of this enzyme clear. The liposomes were prepared by the reversed-phase method using egg lecithin and cholesterol in a molar ration of 2:1 and the purified ATPase was incorporated into the liposomes by a dialysis for 3 h. About 80% of the ATPase was incorporated into the liposomes. The weight ratio of the enzyme to lipid was 1:400-600. A sigmoid curve was obtained when the Cl--transport activity of the enzyme was plotted against Cl- concentration. Hill's plot afforded a half-subsrate concentration [S]0.5 of 45 mM and a Hill's coefficient n of 2.33. Effects of Br- and F- on the Cl--transport were also examined in the reconstituted system, both halide ions decrease the 36Cl- efflux significantly. These kinetic data are in good agreement with the electrophysiological data presented by Tittor et al. (1983) J. Membr. Biol. 75, 129-139). © 1992.

    DOI: 10.1016/0005-2736(92)90235-E

    Scopus

    PubMed

    researchmap

  • Improvement of reconstitution of the Cl(-)-translocating ATPase isolated from Acetabularia acetabulum into liposomes and several anion pump characteristics. Reviewed International journal

    T Ohhashi, T Katsu, M Ikeda

    Biochimica et biophysica acta   1106 ( 1 )   165 - 70   1992.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The improved reconstitution of the Mono Q-III fraction, a Cl(-)-translocating ATPase, isolated from Acetabularia acetabulum (Ikeda et al. (1990) Biochemistry 29, 2057-2065) into liposomes rendered transport properties of this enzyme clear. The liposomes were prepared by the reversed-phase method using egg lecithin and cholesterol in a molar ratio of 2:1 and the purified ATPase was incorporated into the liposomes by a dialysis for 3 h. About 80% of the ATPase was incorporated into the liposomes. The weight ratio of the enzyme to lipid was 1:400-600. A sigmoid curve was obtained when the Cl(-)-transport activity of the enzyme was plotted against Cl- concentration. Hill's plot afforded a half-substrate concentration [S]0.5 of 45 mM and a Hill's coefficient n of 2.33. Effects of Br- and F- on the Cl(-)-transport were also examined in the reconstituted system, both halide ions decreased the 36Cl- efflux significantly. These kinetic data are in good agreement with the electrophysiological data presented by Tittor et al. ((1983) J. Membr. Biol. 75, 129-139).

    PubMed

    researchmap

  • Preparative high-yield electroelution of proteins after separation by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and its application to analysis of amino acid sequences and to raise antibodies. Reviewed International journal

    T Ohhashi, C Moritani, H Andoh, S Satoh, S Ohmori, F Lottspeich, M Ikeda

    Journal of chromatography   585 ( 1 )   153 - 9   1991.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A method for the preparative high-yield electroelution of proteins from sodium dodecyl sulphate (SDS) polyacrylamide gel strips was established. The method consisted of SDS-polyacrylamide gel electrophoresis, detection of proteins with sodium acetate and electrophoretic elution at 200 V for 3 h by utilizing a horizontal flat-bed gel electrophoresis apparatus. Standard proteins with molecular masses of 14-66 kilodalton (cytochrome c, aldolase, ovalbumin and bovine serum albumin) were recovered with an average yield of 73.6 +/- 2.3%. A membrane-bound protein, rat skeletal muscle Ca(2+)-ATPase (100 kilodalton) was also well recovered (over 60%). This method was applicable to the purification of proteins required for N-terminal amino acid sequencing and to raise antibodies.

    DOI: 10.1016/0021-9673(91)85069-R

    PubMed

    researchmap

  • Characterization of fibroblast-derived prolidase. The presence of two forms of prolidase. Reviewed International journal

    T Oono, H Yasutomi, T Ohhashi, H Kodama, J Arata

    Journal of dermatological science   1 ( 5 )   319 - 23   1990.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Crude enzyme solutions of prolidase were extracted from cultured human skin fibroblasts derived from control and prolidase-deficient sisters. Two forms of prolidases (prolidase-I and II) were partially purified by high performance liquid chromatography equipped with an ion exchange column. On gel filtration, the relative molecular weights of prolidase-I and II were estimated to be MW = 105,000 and 151,000, respectively. The substrate specificity of partially purified prolidase-I and II in control fibroblasts was estimated against Gly-Pro, Ala-Pro, Met-Pro. Each form of prolidase differed in its substrate specificity. In prolidase-deficient sisters, the elder with typical clinical manifestations and the younger with only slight clinical manifestations, the activity of prolidase-I was absent. However, the activity of prolidase-II was sufficiently present in both sisters. The substrate specificity of prolidase-II in the patients was similar to that of control. No difference in substrate specificity was found between these two patients.

    PubMed

    researchmap

  • Characterization of prolidase I and II from erythrocytes of a control, a patient with prolidase deficiency and her mother. Reviewed International journal

    T Ohhashi, T Ohno, J Arata, K Sugahara, H Kodama

    Clinica chimica acta; international journal of clinical chemistry   187 ( 1 )   1 - 9   1990.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Prolidase I (EC 3.4.13.9) was purified to homogeneity from the erythrocytes of a normal human (control) and the patient's mother, and prolidase II from erythrocytes of a control and the patient's mother, and prolidase from the patient's erythrocytes was also highly purified. The various properties of the patient's prolidase were compared to those of prolidase from a control and the patient's mother. Prolidase I from a control and the patient's mother had a molecular weight of about 112,000, and was composed of two subunits with an identical molecular weight of 56,000. The Km values for Gly-Pro of the control's and the patient's mother's prolidase I were 2.90 +/- 0.22 and 2.88 +/- 0.27 mM, but the Vmax values for Gly-Pro of the mother's enzyme was reduced about 30% compared to that of control enzymes (mother: 6.02 units/mg protein, control: 22.21 units/mg protein). Isoionic points of these enzymes by chromatofocusing were pH 4.6 approximately 4.7. Prolidase II from the control and the patient's mother, and the patient's prolidase had a molecular weight of about 185,000, and was composed of two subunits with an identical molecular weight of 95,000. The Km and Vmax values for various substrates of prolidase II from a control and the patient's mother, and the patient's prolidase were almost the same.

    PubMed

    researchmap

  • Characteristics and partial purification of prolidase and prolinase from leukocytes of a normal human and a patient with prolidase deficiency. Reviewed International journal

    H Kodama, T Ohhashi, C Ohba, T Ohno, J Arata, I Kubonishi, I Miyoshi

    Clinica chimica acta; international journal of clinical chemistry   180 ( 1 )   65 - 72   1989.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PubMed

    researchmap

  • CHARACTERISTICS OF PARTIALLY PURIFIED PROLIDASE FROM ERYTHROCYTES OF NORMAL INDIVIDUALS, OF 2 PATIENTS WITH PROLIDASE DEFICIENCY, AND OF THE PATIENTS MOTHER Reviewed

    T OHHASHI, T OHNO, J ARATA, H KODAMA

    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION   5 ( 3 )   183 - 192   1988.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION  

    Web of Science

    researchmap

  • Biochemical investigations on prolidase and prolinase in erythrocytes from patients with prolidase deficiency. Reviewed International journal

    H Kodama, H Mikasa, T Ohhashi, T Ohno, J Arata

    Clinica chimica acta; international journal of clinical chemistry   173 ( 3 )   317 - 23   1988.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PubMed

    researchmap

  • Biochemical studies on prolidase in sera from control, patients with prolidase deficiency and their mother. Reviewed International journal

    T Ohhashi, T Ohno, J Arata, H Kodama

    Journal of inherited metabolic disease   11 ( 2 )   166 - 73   1988

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Prolidase activity in serum from normal subjects and the mother of two patients was readily detected without adding Mn2+ to the assay, and the activity was increased by addition of Mn2+ to the assay or preincubation with Mn2+. However, the activity in serum from patients with prolidase deficiency against gly-pro, leu-pro and val-pro could not be detected irrespective of Mn2+ conditions and activity against met-pro, ala-pro and phe-pro also showed a marked reduction compared to controls. Both normal and the patients' mother's prolidase activity against gly-pro was reduced about 20% at 60 degrees C compared to the activity at 37 degrees C, but the addition of Mn2+ at 55 degrees C increased the activity about 1.8-fold, whereas prolidase activity of patients could not be increased by the addition of Mn2+. The addition of Co2+ increased prolidase activity in serum from control and the patients' mother but did not increase the heat stability. These results indicate that prolidase in serum from patients with prolidase deficiency is altered rather than markedly reduced in amount.

    PubMed

    researchmap

▼display all

Books

  • 細胞外マトリックス実験法

    大橋俊孝( Role: Contributor ,  プロテオグリカンの基礎知識)

    丸善出版株式会社  2021.12 

     More details

  • Human pathobiochemistry : from clinical studies to molecular mechanisms

    大橋, 俊孝, Tsukahara, Hirokazu, Ramirez, Francesco, Barber, Chad L., Otsuka, Fumio(Editor in Chief)

    Springer  2019.4  ( ISBN:9789811329760

     More details

    Total pages:xi, 349 p.   Language:English

    CiNii Books

    researchmap

  • Neural Proteoglycan

    Research Signpost,Kerala, India  2007.5 

     More details

  • Proteoglycan Glycoword Reviewed

    Toshitaka Oohashi( Role: Sole author ,  Role of hyaluronan andproteoglycan link protein)

    Glycoforum  2023.4 

     More details

  • 平成18〜平成19年度科学研究費補助金(基盤研究(c))研究成果報告書

    2008 

     More details

  • (財)中冨健康科学振興財団 第17回研究助成業績集

    (財)中冨健康科学振興財団  2006 

     More details

  • 平成14-15年度科学研究費補助金(基盤研究B)成果報告書

    2004 

     More details

  • Advancement of Life Science

    Roan AMVO Publishing Company, Taipei  2003 

     More details

  • 平成13-14年度科学研究費補助金(萌芽的研究)成果報告書

    2003 

     More details

  • 平成14年度科学研究費補助金(特定領域研究(2))成果報告書

    2003 

     More details

  • 平成13-14年度科学研究費補助金(基盤研究B)成果報告書

    2003 

     More details

  • 平成11-13年度科学研究費補助金(基盤研究B)成果報告書

    2002 

     More details

  • 平成12-13年度科学研究費補助金(基盤研究B)成果報告書

    2002 

     More details

  • 細胞外マトリックスと血管内皮細胞

    メディカルレビュー社  2002 

     More details

  • 科学研究費補助金(基盤研究(B)展開)研究報告書

    2001 

     More details

  • 科学研究費補助金(萌芽)研究報告書

    2001 

     More details

  • Hyaluronan : structure, metabolism, biological activities, therapeutic applications

    Balazs, Endre A., Hascall, Vincent C.

    Matrix Biology Institute  ( ISBN:9780977135905

     More details

    Total pages:2 v.   Language:English

    CiNii Books

    researchmap

  • コラーゲン遺伝子の構造機能および発現調節(共著)

    新生化学実験講座 第10巻 血管内皮と平滑筋 

     More details

▼display all

MISC

  • Inverse genetics to trace the differen to trace the differentiation pathway of human chondrocytes retrospectively Reviewed

    Hang Thuy Do, Mitsuaki Ono, Ziyi Wang, Wakana Kitagawa, Anh Tuan Dang, Tomoko Yonezawa, Takuo Kuboki, Toshitaka Oohashi, Satoshi Kubota

    2024.3

     More details

  • 1細胞解析を用いた老化マウス長管骨創傷治癒遅延メカニズムの解明

    北川若奈, 大野充昭, 土佐郁恵, 石橋 啓, 窪木拓男, 大橋俊孝

    岡山歯学会抄録集   2023.12

     More details

    Authorship:Last author  

    researchmap

  • Inverse genetic tracing of the entire differentiation pathway of human chondrocytes by single cell RNA-seq.

    2023.12

     More details

  • 下垂体後葉Neurovascular unitにおけるIV型コラーゲンの解析

    米澤朋子, Tang Shaoying, 大橋俊孝

    第49回日本神経内分泌学会学術集会抄録集   2023.10

     More details

    Authorship:Last author  

    researchmap

  • ハンチントン病モデルマウスにおける神経ペプチド関連遺伝子群の遺伝子発現変化の解析

    宮﨑 晴子, 貫名 信行, 大橋 俊孝

    第49回 日本神経内分泌学会学術集会抄録集   2023.10

     More details

  • The role of link protein HAPLN4, an organizer of perineuronal net, in the synapse formation and the synaptic transmission

    89th Harden Conference, Proteoglycans: Matrix, Master Regulators

    2023.9

     More details

    Authorship:Lead author, Corresponding author  

    researchmap

  • Assessment of perineuronal nets and parvalbumin interneurons in the brain of activity-based anorexia mouse model

    Toshikata Oohashi, Hoang Duy Nguyen, Haruko Miyazaki, Shinji Sakamoto, Manabu Takaki

    2023.8

     More details

    Authorship:Lead author, Corresponding author  

    researchmap

  • 老化がBMP-2の骨誘導能に与える影響の検討

    北川 若奈, 大野 充昭, 土佐 郁恵, Dang Tuan Anh, Do Thuy Hang, 石橋 啓, 窪木 拓男, 大橋 俊孝

    日本結合組織学会学術大会プログラム・抄録集   55回   156 - 156   2023.6

     More details

    Authorship:Last author   Language:Japanese   Publisher:日本結合組織学会  

    researchmap

  • 長鎖型XVIII型コラーゲンは新規膜結合型コラーゲンである可能性が高い

    上野 智規, 米澤 朋子, 百田 龍輔, 佐々木 隆子, 大橋 俊孝, 水野 一乘

    日本結合組織学会学術大会プログラム・抄録集   55回   147 - 147   2023.6

     More details

    Language:Japanese   Publisher:日本結合組織学会  

    researchmap

  • β3インテグリン遺伝子導入ヒト表皮角化細胞を用いた難治性潰瘍に対する新規再生医療の開発

    久保 美代子, 山本 健一, 木下 理恵, 米澤 朋子, 大橋 俊孝, 阪口 政清

    日本結合組織学会学術大会プログラム・抄録集   55回   134 - 134   2023.6

     More details

    Language:Japanese   Publisher:日本結合組織学会  

    researchmap

  • 1細胞解析を応用した加齢変化が骨髄ニッチ関連細胞へ及ぼす影響の解明

    石橋 啓, 大野 充昭, 土佐 郁恵, Dang Tuan Anh, 北川 若奈, Do Thuy Hang, 窪木 拓男, 大橋 俊孝

    日本結合組織学会学術大会プログラム・抄録集   55回   60 - 60   2023.6

     More details

    Authorship:Last author   Language:Japanese   Publisher:日本結合組織学会  

    researchmap

  • 発達期および成熟期におけるHapln4欠損マウスCalyx-MNTBシナプス周囲のグリア細胞の分布に関する研究

    北見 智, 谷 祐一, 野島 弘二郎, 兼城 一媛乃, Nguyen Duy Hoang, 宮崎 晴子, 堀 哲也, 大橋 俊孝

    日本結合組織学会学術大会プログラム・抄録集   55回   150 - 150   2023.6

     More details

    Authorship:Last author, Corresponding author   Language:Japanese   Publisher:日本結合組織学会  

    researchmap

  • Assessment of perineuronal nets and parvalbumin interneurons in the brain of activity-based anorexia mouse model

    Hoang Duy Nguyen, Haruko Miyazaki, Shinji Sakamoto, Manabu Takaki, Toshikata Oohashi

    2023.2

     More details

    Authorship:Last author, Corresponding author  

    researchmap

  • Comparative in silico analysis of keratinized and non-keratinized gingiva by reanalysis of previously published human single-cell RNA-seq data

    DO THUY Hang, DO THUY Hang, 大野光昭, 大野光昭, 小盛大志, 小盛大志, 北川若奈, 北川若奈, 窪木拓男, 窪木拓男, 大橋俊孝

    日本補綴歯科学会誌(Web)   15   2023

  • Mechanism of delayed bone wound healing in mice long bone due to bone marrow aging using scRNA-seq

    北川若奈, 北川若奈, 大野充昭, 大野充昭, 土佐郁恵, 石橋啓, 石橋啓, 窪木拓男, 窪木拓男, 大橋俊孝

    日本補綴歯科学会誌(Web)   15   2023

  • Potential impact of perineuronal net on the pathogenesis of Schizophrenia.

    Toshitaka Oohashi

    In Commemoration of the 30th Anniversary of Mizutani Foundation for Glycoscience   71 - 73   2022.11

     More details

    Authorship:Lead author, Corresponding author  

    researchmap

  • Roles of basement membrane in oral mucosal keratinization Invited

    Toshitaka Oohashi

    2022 Korea-Japan Joint Symposium on Matrix Biology   14 - 14   2022.10

     More details

    Authorship:Lead author, Corresponding author  

    researchmap

  • 加齢が骨髄ニッチ関連細胞および類洞基底膜に与える影響

    石橋啓, 大野 充昭, 土佐 郁恵, 北川若奈, 秋山謙太郎, 窪木 拓男, 大橋 俊孝

    日本補綴歯科学会第131回学術大会抄録集   14 ( 特別号 )   148 - 148   2022.7

     More details

    Authorship:Last author   Language:Japanese   Publisher:(公社)日本補綴歯科学会  

    researchmap

  • Assessment of glial cells on the development of calyx-MNTB synapse in the Hapln4-deficient mice Reviewed

    宮崎晴子, 谷祐一, 野島弘二郎, 兼城一媛乃, NGUYEN Duy Hoang, 堀哲也, 大橋俊孝

    日本結合組織学会学術大会抄録集   65th   2022.7

     More details

    Authorship:Lead author, Corresponding author  

    J-GLOBAL

    researchmap

  • BMP-2は造血機能を有した骨・骨髄組織を誘導する

    北川 若奈, 大野 充昭, 土佐 郁恵, 石橋 啓, 大橋 俊孝, 窪木 拓男

    日本補綴歯科学会誌   14 ( 特別号 )   176 - 176   2022.7

     More details

    Language:Japanese   Publisher:(公社)日本補綴歯科学会  

    researchmap

  • Possible metabolic changes in the liver of Collagen XVIII knock out mice Reviewed

    百田龍輔, 米澤朋子, 柳井広之, 大橋俊孝

    日本結合組織学会学術大会抄録集   54th (Web)   89 - 89   2022.6

     More details

    Authorship:Last author  

    J-GLOBAL

    researchmap

  • XVIII型コラーゲン欠損マウスにおける皮膚創傷治癒の解析 Reviewed

    米澤朋子, 前川明日華, 前場崇宏, 百田龍輔, 渋谷千晶, 岩田宗一郎, 大野充昭, 大橋俊孝

    120 - 120   2022.6

     More details

    Authorship:Last author  

    researchmap

  • Hapln4欠損マウスにおけるCayx-MNTBシナプスの発達に及ぼすグリア細胞 Reviewed

    宮﨑晴子, 谷祐一, 野島弘二郎, 兼城一媛乃, Nguyen Duy Hoang, 堀哲也, 大橋俊孝

    第54回日本結合組織学会学術大会抄録集   115 - 115   2022.6

     More details

    Authorship:Last author, Corresponding author  

    researchmap

  • BMP-2 induces the formation of bone and marrow tissues with real hematopoetic function.

    北川若奈, 北川若奈, 大野充昭, 大野充昭, 土佐郁恵, 石橋啓, 石橋啓, 大橋俊孝, 窪木拓男, 窪木拓男

    日本補綴歯科学会誌(Web)   14   2022

  • Effect of aging on bone marrow niche and sinusoidal basement membrane

    石橋啓, 石橋啓, 大野充昭, 大野充昭, 土佐郁恵, 北川若奈, 北川若奈, 秋山謙太郎, 窪木拓男, 窪木拓男, 大橋俊孝

    日本補綴歯科学会誌(Web)   14   2022

  • rhBMP-2、rhFGF-2の骨形成能は移植部位に存在する骨髄組織の影響を受ける

    納所 秋二, 大野 充昭, 土佐 郁恵, 石橋 啓, 田仲 由希恵, 大野 彩, 大橋 俊孝, 窪木 拓男

    日本口腔インプラント学会誌   34 ( 特別号 )   優秀 - 3   2021.12

     More details

    Language:Japanese   Publisher:(公社)日本口腔インプラント学会  

    researchmap

  • MRONJ様病変誘発モデルマウスの抜歯窩へのE-rhBMP-2含有骨補填材移植が抜歯窩周囲の骨壊死を抑制する

    田仲 由希恵, 三海 晃弘, 大野 充昭, 土佐 郁恵, 納所 秋二, 大野 彩, 窪木 拓男, 大橋 俊孝

    日本口腔インプラント学会誌   34 ( 特別号 )   ポスター - 4   2021.12

     More details

    Language:Japanese   Publisher:(公社)日本口腔インプラント学会  

    researchmap

  • Cysltr1遺伝子変異は破骨細胞分化と炎症性骨破壊に影響しない

    藤田 洋史, 土生田 宗憲, 大野 充昭, 大橋 俊孝, 服部 高子, 久保田 聡, 大内 淑代

    第94回日本生化学会大会, 横浜(Web開催)[P-925]   94th   [P - 925]   2021.11

     More details

    Language:Japanese   Publishing type:Research paper, summary (national, other academic conference)   Publisher:(公社)日本生化学会  

    J-GLOBAL

    researchmap

  • 骨髄細胞がBMP-2、FGF-2の骨形成能に与える影響の検討

    納所 秋二, 大野 充昭, 土佐 郁恵, 石橋 啓, 三海 晃弘, 田仲 由希恵, 大野 彩, 小盛 大志, 前川 賢治, 大橋 俊孝, 窪木 拓男

    日本補綴歯科学会誌   13 ( 特別号 )   200 - 200   2021.6

     More details

    Language:Japanese   Publisher:(公社)日本補綴歯科学会  

    researchmap

  • 薬剤関連顎骨壊死様モデルマウスにおけるE-rhBMP-2の治療効果の検討

    三海 晃弘, 大野 充昭, 土佐 郁恵, 納所 秋二, 大野 彩, 縄稚 久美子, 田仲 由希恵, 大橋 俊孝, 窪木 拓男

    日本補綴歯科学会誌   13 ( 特別号 )   114 - 114   2021.6

     More details

    Language:Japanese   Publisher:(公社)日本補綴歯科学会  

    researchmap

  • 薬剤関連顎骨壊死様モデルマウスにおけるE-rhBMP-2の治療効果の検討

    三海 晃弘, 大野 充昭, 土佐 郁恵, 納所 秋二, 大野 彩, 縄稚 久美子, 田仲 由希恵, 大橋 俊孝, 窪木 拓男

    日本補綴歯科学会誌   13 ( 特別号 )   114 - 114   2021.6

     More details

    Language:Japanese   Publisher:(公社)日本補綴歯科学会  

    researchmap

  • アグリカン欠損は成長板軟骨細胞のアポトーシスを誘導する Reviewed

    大橋俊孝, 塚野萌美, 古谷満寿美, 大野充昭

    第33回日本軟骨代謝学会抄録集   107 - 107   2021.3

     More details

    Authorship:Lead author, Corresponding author  

    researchmap

  • コラーゲン研究の新展開:基礎から創薬まで マウス皮膚創傷モデルにおけるXVIII型コラーゲンの解析

    米澤 朋子, 前場 崇宏, Tang Shaoying, 大野 充昭, 百田 龍輔, 稲川 喜一, 大橋 俊孝

    日本生化学会大会プログラム・講演要旨集   93回   [1S08e - 06]   2020.9

     More details

    Authorship:Last author   Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • 口腔粘膜上皮の角化制御に関わる基底膜分子の同定

    Ha Nguyen, 大野 充昭, 小盛 大志, 大野 彩, 前川 賢治, 窪木 拓男, 大橋 俊孝

    日本口腔インプラント学会誌   33 ( 特別号 )   135 - 135   2020.9

     More details

    Authorship:Last author   Language:English   Publisher:(公社)日本口腔インプラント学会  

    researchmap

  • 骨髄存在・非存在下にてrhBMP-2、rhFGF-2が骨形成に与える影響の検討

    納所 秋二, 大野 充昭, 土佐 郁恵, 三海 晃弘, 石橋 啓, 大野 彩, 窪木 拓男, 大橋 俊孝

    日本補綴歯科学会誌   12 ( 特別号 )   215 - 215   2020.6

     More details

    Language:Japanese   Publisher:(公社)日本補綴歯科学会  

    researchmap

  • 要介護高齢者の腸内細菌叢とボディマス指数の関係 介護老人保健施設における横断研究

    大森 江, 大野 充昭, 大野 彩, 水口 真実, 小山 絵理, 徳本 佳奈, 山本 道代, 大橋 俊孝, 窪木 拓男

    日本補綴歯科学会誌   12 ( 特別号 )   225 - 225   2020.6

     More details

    Language:Japanese   Publisher:(公社)日本補綴歯科学会  

    researchmap

  • XVIII型コラーゲン欠損が骨髄造血幹細胞に与える影響

    石橋 啓, 大野 充昭, 土佐 郁恵, 納所 秋二, 窪木 拓男, 大橋 俊孝

    日本補綴歯科学会誌   12 ( 特別号 )   224 - 224   2020.6

     More details

    Authorship:Last author   Language:Japanese   Publisher:(公社)日本補綴歯科学会  

    researchmap

  • Effects of rhBMP-2 and rhFGF-2 on the bone formation in presence and absence of the bone marrow.

    納所秋二, 納所秋二, 大野充昭, 土佐郁恵, 三海晃弘, 三海晃弘, 石橋啓, 石橋啓, 大野彩, 大野彩, 窪木拓男, 大橋俊孝

    日本補綴歯科学会誌(Web)   12   2020

  • Postnatal Runx2 deletion causes age-related changes in bone.

    Ikue Tosa, Daisuke Yamada, Shunpei Tsukamoto, Kenji Kawabe, Takeshi Takarada, Mitsuaki Ono, Toshitaka Oohashi, Takuo Kuboki

    JOURNAL OF BONE AND MINERAL RESEARCH   34   219 - 219   2019.12

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:WILEY  

    Web of Science

    researchmap

  • DNMTによる軟骨細胞分化制御メカニズムの解明

    野村 優, 吉岡 裕也, Nguyen Ha Thi, 納所 秋二, 小盛 大志, 大橋 俊孝, 大野 充昭, 窪木 拓男

    日本口腔インプラント学会誌   32 ( 2 )   E88 - E88   2019.6

     More details

    Language:Japanese   Publisher:(公社)日本口腔インプラント学会  

    researchmap

  • 骨髄間葉系幹細胞におけるRunx2の発現低下は骨および骨髄の加齢様変化をもたらす

    土佐 郁恵, 山田 大祐, 大野 充昭, 大橋 俊孝, 窪木 拓男, 宝田 剛志

    日本補綴歯科学会誌   11 ( 特別号 )   129 - 129   2019.5

     More details

    Language:Japanese   Publisher:(公社)日本補綴歯科学会  

    researchmap

  • 骨髄環境におけるBMP-2誘導性骨形成・骨芽細胞分化抑制メカニズムの解明

    納所 秋二, 大野 充昭, Nguyen Ha, 笈田 育尚, 小盛 大志, 秋山 謙太郎, 大橋 俊孝, 窪木 拓男

    日本補綴歯科学会誌   11 ( 特別号 )   130 - 130   2019.5

     More details

    Language:Japanese   Publisher:(公社)日本補綴歯科学会  

    researchmap

  • 変形性関節症:from bench to bedside 関節軟骨のバイオイメージング

    大橋 俊孝, 加来田 博貴, 大野 充昭, 西田 圭一郎

    日本整形外科学会雑誌   93 ( 2 )   S331 - S331   2019.3

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • 骨髄間葉系幹細胞におけるRunx2の発現低下は骨および骨髄の加齢様変化をもたらす

    土佐郁恵, 土佐郁恵, 山田大祐, 大野充昭, 大野充昭, 大橋俊孝, 窪木拓男, 宝田剛志

    日本補綴歯科学会誌(Web)   11   2019

  • 骨髄環境におけるBMP-2誘導性骨形成・骨芽細胞分化抑制メカニズムの解明

    納所秋二, 大野充昭, 大野充昭, NGUYEN Ha, NGUYEN Ha, 笈田育尚, 小盛大志, 秋山謙太郎, 大橋俊孝, 窪木拓男

    日本補綴歯科学会誌(Web)   11   2019

  • Novel function of BMP-2 in inhibiting bone formation in marrow environment

    Ha Nguyen Thi, Mitsuaki Ono, Yasutaka Oida, Emilio Satoshi Hara, Taishi Komori, Kentaro Akiyama, Ha Nguyen Thi Thu, Hai Thanh Pham, Kyawthu Aung, Toshitaka Oohashi, Takuo Kuboki

    JOURNAL OF BONE AND MINERAL RESEARCH   33   338 - 338   2018.11

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:WILEY  

    Web of Science

    researchmap

  • Aggrecanは胎生後の長管骨の発生において必須である

    鳥原 秀美, 大野 充昭, 上岡 寛, 大橋 俊孝

    日本矯正歯科学会大会プログラム・抄録集   77回   234 - 234   2018.10

     More details

    Language:Japanese   Publisher:(公社)日本矯正歯科学会  

    researchmap

  • 骨髄細胞は骨髄環境下においてBMP-2誘導性骨形成を抑制する(Marrow cells inhibits BMP-2-induced bone formation in the marrow)

    Nguyen Ha, Nguyen H, 大野 充昭, 笈田 育尚, 小盛 大志, 秋山 謙太郎, 大橋 俊孝, 窪木 拓男

    日本口腔インプラント学会学術大会抄録集   48回   302 - 302   2018.9

     More details

    Language:Japanese   Publisher:(公社)日本口腔インプラント学会  

    researchmap

  • 変形性関節症関連microRNAの検索並びに解析

    大月 孝志, オメル・ファルク・ハティポール, 品岡 玲, メフメット・ゼイネル・チレッキ, 西村 拓人, 浅野 恵一, 稲垣 純子, 大橋 俊孝, 西田 圭一郎, 岡田 保典, 廣畑 聡

    日本結合組織学会学術大会プログラム・抄録集   50回   111 - 111   2018.6

     More details

    Language:Japanese   Publisher:日本結合組織学会  

    researchmap

  • アグリカン欠損マウスの成長板は、軟骨マトリックスの硬化および軟骨細胞の形態異常を呈する

    大橋 俊孝, Alberton Paolo, 野坂 浩一, 栗原 伸之介, 枝松 緑, 大野 充昭, Aszodi Attila

    日本結合組織学会学術大会プログラム・抄録集   50回   96 - 96   2018.6

     More details

    Language:Japanese   Publisher:日本結合組織学会  

    researchmap

  • 生後の骨・軟骨におけるアグリカンの役割の解明

    鳥原 秀美, 大野 充昭, 栗原 伸之介, 枝松 緑, 宝田 剛志, 上岡 寛, 大橋 俊孝

    日本結合組織学会学術大会プログラム・抄録集   50回   155 - 155   2018.6

     More details

    Language:Japanese   Publisher:日本結合組織学会  

    researchmap

  • 遺伝子検査に関する講義・実習の補綴学教育への導入

    大野 充昭, 秋山 謙太郎, 大野 彩, 納所 秋二, 三海 晃弘, 樋口 隆晴, 前川 賢治, 大橋 俊孝, 窪木 拓男

    日本補綴歯科学会誌   10 ( 特別号 )   288 - 288   2018.6

     More details

    Language:Japanese   Publisher:(公社)日本補綴歯科学会  

    researchmap

  • Type IV collagen α6は口腔粘膜上皮の角化を制御する

    小盛 大志, 大野 充昭, 植田 淳二, 前川 賢治, 大橋 俊孝, 窪木 拓男

    日本補綴歯科学会誌   10 ( 特別号 )   126 - 126   2018.6

     More details

    Language:Japanese   Publisher:(公社)日本補綴歯科学会  

    researchmap

  • Col4a3ノックアウトマウスにおける網膜の表現型解析

    米澤 朋子, 松前 洋, 神崎 勇希, Chuyuan Lou, 前場 崇宏, 森實 祐基, 美名口 順, Miner Jeffrey, 大橋 俊孝

    日本結合組織学会学術大会プログラム・抄録集   50回   106 - 106   2018.6

     More details

    Language:Japanese   Publisher:日本結合組織学会  

    researchmap

  • 骨髄内加齢変化のRunx2コンディショナル欠損による模倣

    土佐郁恵, 土佐郁恵, 山田大祐, 塚本俊平, 河邊憲司, 大野充昭, 大橋俊孝, 窪木拓男, 宝田剛志

    日本分子生物学会年会プログラム・要旨集(Web)   41st   2018

  • Development of osteoblast and osteoclast visualization mice and its validation

    三海晃弘, 大野充昭, 秋山謙太郎, 納所秋二, 小盛大志, 大野彩, 窪木拓男, 大橋俊孝

    日本補綴歯科学会中国・四国支部学術大会プログラム・抄録集(Web)   2018   2018

  • Type IV collagenα6は口腔粘膜上皮の角化を制御する

    小盛大志, 大野充昭, 植田淳二, 前川賢治, 大橋俊孝, 窪木拓男

    日本補綴歯科学会誌(Web)   10   2018

  • 骨細胞におけるPerlecan/HSPG2の発現部位は細胞の成熟とともに細胞体から細胞突起へと変化する

    鳥原 秀美, 大野 充昭, 佐々木 隆子, 上岡 寛, 大橋 俊孝

    生命科学系学会合同年次大会   2017年度   [2P - 0326]   2017.12

     More details

    Language:Japanese   Publisher:生命科学系学会合同年次大会運営事務局  

    researchmap

  • 骨細胞の成熟過程におけるPerlecan/HSPG2の発現解析

    鳥原 秀美, 大野 充昭, 大橋 俊孝, 上岡 寛

    日本矯正歯科学会大会プログラム・抄録集   76回   175 - 175   2017.10

     More details

    Language:Japanese   Publisher:(公社)日本矯正歯科学会  

    researchmap

  • 口腔粘膜上皮の角化制御におけるCollagen IV α6の役割

    小盛 大志, 大野 充昭, 植田 淳二, 土佐 郁恵, 前川 賢治, 大橋 俊孝, 窪木 拓男

    日本口腔インプラント学会学術大会抄録集   47回   O - 5   2017.9

     More details

    Language:Japanese   Publisher:(公社)日本口腔インプラント学会  

    researchmap

  • 必須アミノ酸Tryptophanは骨髄由来間葉系幹細胞の幹細胞性を制御し骨形成を促進する

    大野 充昭, Hai Pham, 笈田 育尚, 小盛 大志, 土佐 郁恵, 大橋 俊孝, 秋山 謙太郎, 窪木 拓男

    日本口腔インプラント学会学術大会抄録集   47回   O - 7   2017.9

     More details

    Language:Japanese   Publisher:(公社)日本口腔インプラント学会  

    researchmap

  • The hyaluronan and proteoglycan link proteins: organizers of the brain ecm and key molecules for neuronal function and plasticity

    T. Oohashi, T. Sakaba

    JOURNAL OF NEUROCHEMISTRY   142   53 - 53   2017.8

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:WILEY  

    Web of Science

    researchmap

  • がん微小環境の実体 がん微小環境におけるバーシカン分解酵素ADAMTSの局在と血管新生におけるバーシカンの意義

    浅野 恵一, 廣畑 聡, 大月 孝志, オメル・ファルク・ハティポール, 稲垣 純子, 大橋 俊孝

    日本結合組織学会学術大会プログラム・抄録集   49回   56 - 56   2017.6

     More details

    Language:Japanese   Publisher:日本結合組織学会  

    researchmap

  • ヒト骨髄由来間葉系幹細胞および軟骨細胞の核内の染色体配置の解析の試み

    大野 充昭, 小盛 大志, 土佐 郁恵, 秋山 謙太郎, 大野 彩, 窪木 拓男, 大橋 俊孝

    日本補綴歯科学会誌   9 ( 特別号 )   271 - 271   2017.6

     More details

    Language:Japanese   Publisher:(公社)日本補綴歯科学会  

    researchmap

  • ヒト骨髄由来間葉系幹細胞および軟骨細胞の核内の染色体配置の解析の試み

    大野充昭, 大野充昭, 小盛大志, 土佐郁恵, 秋山謙太郎, 大野彩, 大野彩, 窪木拓男, 大橋俊孝

    日本補綴歯科学会誌(Web)   9   2017

  • 変形性関節症へのヒアルロン酸投与、いつ投与すべきか? 動物モデルからの知見

    大月 孝志, 品岡 玲, 熊岸 加苗, 河野 真優美, 篠原 真歩, 浅野 恵一, 稲垣 純子, 大橋 俊孝, 西田 圭一郎, 廣畑 聡

    日本結合組織学会学術大会プログラム・抄録集   48回   60 - 60   2016.6

     More details

    Language:Japanese   Publisher:日本結合組織学会  

    researchmap

  • 皮膚創傷治癒過程におけるCCN4/WISP-1の役割

    大野 充昭, 正木 明日香, 前田 あずさ, Hara Emilio S., 小盛 大志, 久保田 聡, Young Marian F., 大橋 俊孝, 窪木 拓男

    日本結合組織学会学術大会プログラム・抄録集   48回   88 - 88   2016.6

     More details

    Language:Japanese   Publisher:日本結合組織学会  

    researchmap

  • 伸展刺激の強度による細胞外マトリックスタンパクおよびマトリックス分解酵素発現への影響

    大月 孝志, 金道 幸子, 長谷川 みさ, 稲垣 純子, 浅野 恵一, 障子 友理, 熊岸 加苗, 西田 圭一郎, 大橋 俊孝, 廣畑 聡

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集   88回・38回   [2P0078] - [2P0078]   2015.12

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • メカニカルストレスが軟骨様細胞の細胞外マトリックス及びマトリックス分解酵素のmRNA発現へ示す効果の検討

    大月 孝志, 金道 幸子, 長谷川 みさ, 平田 彩, 川地 輝幸, 浅野 恵一, 稲垣 純子, 障子 友理, 熊岸 加苗, 西田 圭一郎, 大橋 俊孝, 廣畑 聡

    日本結合組織学会学術大会プログラム・抄録集   47回   134 - 134   2015.5

     More details

    Language:Japanese   Publisher:日本結合組織学会  

    researchmap

  • 関節軟骨造影剤を用いた関節軟骨プロテオグリカンの評価

    大橋 俊孝, 加来田 博貴, 芳谷 学, 山田 翔也, 大月 孝志, 廣畑 聡, 二宮 善文, 西田 圭一郎

    日本結合組織学会学術大会プログラム・抄録集   47回   97 - 97   2015.5

     More details

    Language:Japanese   Publisher:日本結合組織学会  

    researchmap

  • ADAMTSによるバーシカン分解と腫瘍内血管新生の関連

    浅野 恵一, 稲垣 純子, 障子 友理, Hofmann Matthias, 大月 孝志, 廣畑 聡, 大橋 俊孝

    日本結合組織学会学術大会プログラム・抄録集   47回   114 - 114   2015.5

     More details

    Language:Japanese   Publisher:日本結合組織学会  

    researchmap

  • 新規X線造影剤による変形性膝関節症ラット関節軟骨の高解像度マイクロCT造影

    大橋 俊孝, 加来田 博貴, 芳谷 学, 大月 孝志, 大野 充昭, 山田 翔也, 前原 亜美, 廣畑 聡, 西田 圭一郎, 窪木 拓男, 二宮 善文

    日本結合組織学会学術大会・マトリックス研究会大会合同学術集会プログラム・抄録集   46回・61回   106 - 106   2014.6

     More details

    Language:Japanese   Publisher:日本結合組織学会・マトリックス研究会  

    J-GLOBAL

    researchmap

  • リジンオリゴマーからなる関節軟骨特異的X線プローブの創出

    大橋俊孝, 芳谷学, 大野充昭, 山田翔也, 大月孝志, 前原亜美, 廣畑聡, 西田圭一郎, 窪木拓男, 加来田博貴, 二宮善文

    日本軟骨代謝学会プログラム・抄録集   27th   2014

  • Structurally simple cartilage probes constructed with epsilon-lysine oligomers targeting chondroitin sulfates

    Hiroki Kakuta, Manabu Hagaya, Shoya Yamada, Fuminori Ohsawa, Ami Maehara, Aki Yoshida, Mitsuaki Ono, Ryuichi Nakahara, Keiichiro Nishida, Toshitaka Oohashi

    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY   246   2013.9

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:AMER CHEMICAL SOC  

    Web of Science

    researchmap

  • 肝細胞癌におけるXV型コラーゲン発現とその臨床応用

    木村 紘爾, 大橋 俊孝, 中山 勝, 小見山 高明, 市村 浩一, 内藤 一郎, 浅野 博昭, 佃 和憲, 大塚 愛二, 二宮 善文

    日本結合組織学会学術大会・マトリックス研究会大会合同学術集会プログラム・抄録集   45回・60回   106 - 106   2013.6

     More details

    Language:Japanese   Publisher:日本結合組織学会・マトリックス研究会  

    researchmap

  • まれなEGFR変異を有する肺腺癌の1例

    木村 紘爾, 山根 正修, 豊岡 伸一, 古川 公之, 大橋 俊孝, 山本 寛斉, 宗 淳一, 大藤 剛宏, 三好 新一郎

    日本呼吸器外科学会雑誌   27 ( 3 )   P04 - 06   2013.4

     More details

    Language:Japanese   Publisher:(NPO)日本呼吸器外科学会  

    researchmap

  • レチノイドX受容体パーシャルアゴニストNEt-4IBの創出と薬効・副作用評価

    加来田 博貴, 川田 浩平, 中山 真理子, 山田 翔也, 小林 俊貴, 古沢 優貴, 大橋 俊孝, 田井 章博, 矢間 太

    ビタミン   87 ( 4 )   254 - 254   2013.4

     More details

    Language:Japanese   Publisher:(公社)日本ビタミン学会  

    researchmap

  • PS-082-4 肝細胞癌切除標本におけるXV型コラーゲン発現の検討とその臨床応用へ対する考察(PS ポスターセッション,第113回日本外科学会定期学術集会)

    木村 紘爾, 大橋 俊孝, 中山 勝, 小宮山 高明, 市村 浩一, 内藤 一郎, 浅野 博昭, 佃 和憲, 内藤 稔, 三好 新一郎, 大塚 愛二, 二宮 善文

    日本外科学会雑誌   114 ( 2 )   634 - 634   2013.3

     More details

    Language:Japanese   Publisher:一般社団法人日本外科学会  

    CiNii Article

    CiNii Books

    researchmap

  • 肝細胞癌切除標本におけるXV型コラーゲン発現の検討とその臨床応用へ対する考察

    木村 紘爾, 大橋 俊孝, 中山 勝, 小宮山 高明, 市村 浩一, 内藤 一郎, 浅野 博昭, 佃 和憲, 内藤 稔, 三好 新一郎, 大塚 愛二, 二宮 善文

    日本外科学会雑誌   114 ( 臨増2 )   634 - 634   2013.3

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 肝細胞癌におけるXV型コラーゲンの発現解析

    中山 勝, 大橋 俊孝, 小見山 高明, 木村 紘爾, 内藤 一郎, 三好 新一郎, 大塚 愛二, 二宮 善文

    日本生化学会大会プログラム・講演要旨集   85回   2P - 823   2012.12

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • Discovery of a novel benzotriazole-type retinoid X receptor partial-agonist decreasing plasma glucose level in type-2 diabetes mellitus with decreased side effects

    Hiroki Kakuta, Nobumasa Yakushiji, Fuminori Ohsawa, Shoya Yamada, Mariko Nakayama, Kohei Kawata, Yui Ohta, Chisa Fujiwara, Toshitaka Oohashi, Makoto Makishima, Akihiro Tai, Hiroyuki Yasui, Yutaka Yoshikawa

    CANCER RESEARCH   72   2012.4

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:AMER ASSOC CANCER RESEARCH  

    DOI: 10.1158/1538-7445.AM2012-946

    Web of Science

    researchmap

  • 関節軟骨に特異的に結合するX線造影化イメージングプローブの創出研究

    芳谷 学, 大澤 史宜, 加来田 博貴, 大橋 俊孝

    日本薬学会年会要旨集   132年会 ( 2 )   271 - 271   2012.3

     More details

    Language:Japanese   Publisher:(公社)日本薬学会  

    researchmap

  • アルポート症候群

    大橋俊孝, 喜多村真治

    別冊 日本臨床 先天代謝異常症候群(下)   20   704 - 707   2012

     More details

  • ADAMTS1のin vitroでのリンパ管新生阻害効果

    稲垣 純子, 高橋 克之, 小川 弘子, Hatipoglu Omer F, Cilek Mehmet Zeynel, 小比賀 真就, 米澤 朋子, 大橋 俊孝, 廣畑 聡, 二宮 善文

    日本生化学会大会プログラム・講演要旨集   84回   2P - 0343   2011.9

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    J-GLOBAL

    researchmap

  • ADAMTS1は腫瘍壊死因子刺激下の内皮細胞におけるアポトーシスに関連する

    オメル・ファルク・ハティポール, 小比賀 真就, 廣畑 聡, 小川 弘子, メフメット・ゼェイネル・チレッキ, 稲垣 純子, 大月 孝志, 石井 裕子, 幡中 邦彦, 草地 省蔵, 米澤 朋子, 大橋 俊孝, 二宮 善文

    日本結合組織学会学術大会・マトリックス研究会大会合同学術集会プログラム・抄録集   43回・58回   104 - 104   2011.5

     More details

    Language:Japanese   Publisher:日本結合組織学会・マトリックス研究会  

    J-GLOBAL

    researchmap

  • ADAMTS1は血管新生を阻害しアポトーシスを抑制する

    廣畑 聡, 小比賀 真就, オメル・ファルク・ハティポール, 小川 弘子, メフメット・ゼェイネル・チレッキ, 稲垣 純子, 大月 孝志, 石井 裕子, 幡中 邦彦, 草地 省蔵, 米澤 朋子, 大橋 俊孝, 二宮 善文

    日本結合組織学会学術大会・マトリックス研究会大会合同学術集会プログラム・抄録集   43回・58回   103 - 103   2011.5

     More details

    Language:Japanese   Publisher:日本結合組織学会・マトリックス研究会  

    J-GLOBAL

    researchmap

  • 炎症標的化金コロイド内包リポソームのリウマチ関節炎症部位への集積

    古谷 満寿美, 松本 衣未, 美名口 順, 小川 弘子, 古松 毅之, 廣畑 聡, 二宮 善文, 西田 圭一郎, 大塚 愛二, 大橋 俊孝

    日本結合組織学会学術大会・マトリックス研究会大会合同学術集会プログラム・抄録集   43回・58回   118 - 118   2011.5

     More details

    Language:Japanese   Publisher:日本結合組織学会・マトリックス研究会  

    researchmap

  • 関節軟骨のバイオイメージング

    大橋俊孝, 西田圭一郎

    Clin Calcium   21 ( 6 )   100 - 106   2011

     More details

  • 軟骨組織のバイオイメージング

    大橋俊孝

    臨床整形外科   45 ( 5 )   454 - 457   2010

  • ADAMTS1遺伝子治療はプロテアーゼ非依存的に血管新生阻害効果を発揮し,腫瘍増大を阻害する

    廣畑聡, 小比賀真就, HATIPOGLU Omer Faruk, 小川弘子, CILEK Mehmet Zeynel, 高橋克之, 稲垣純子, 三好亨, 大月孝志, 石井裕子, 草地省蔵, 米澤朋子, 大橋俊孝, 二宮善文

    日本結合組織学会学術大会抄録集   42nd   2010

  • ADAMTS1の内皮細胞に対するアポトーシス効果の検討

    HATIPOGLU Omer Faruk, 廣畑聡, 小比賀真就, CILEK Mehmet Zeynel, 小川弘子, 三好亨, 稲垣純子, 大月孝志, 草地省蔵, 米澤朋子, 大橋俊孝, 二宮善文

    日本結合組織学会学術大会抄録集   42nd   2010

  • ADAMTS1プロモーターは急性低酸素状態の内皮細胞選択的に遺伝子発現を誘導する

    CILEK Mehmet Zeynel, 廣畑聡, HATIPOGLU Omer Faruk, 小川弘子, 三好亨, 稲垣純子, 大月孝志, 大橋俊孝, 米澤朋子, 原田浩, 上川滋, 草地省蔵, 二宮善文

    日本結合組織学会学術大会抄録集   42nd   2010

  • ADAMTS1のin vitroでのリンパ管新生阻害効果

    稲垣純子, 高橋克之, 小川弘子, HATIPOGLU Omer F., CILEK Mehmet Zeynel, 小比賀真就, 米澤朋子, 大橋俊孝, 廣畑聡, 二宮善文

    日本結合組織学会学術大会抄録集   42nd   2010

  • 炎症部位を標的としたドラッグデリバリシステムの組織学的検討

    美名口 順, 峯松 秀希, 大橋 俊孝, 大谷 敬亨, 稲川 喜一, 竹花 一成, 大塚 愛二, 二宮 善文

    日本獣医学会学術集会講演要旨集   148回   153 - 153   2009.9

     More details

    Language:Japanese   Publisher:(公社)日本獣医学会  

    researchmap

  • 軟骨基質集積ペプチドを用いた軟骨組織のバイオイメージング

    大橋 俊孝, 稲川 喜一, 西田 圭一郎, 松本 衣未, 大丸 奈月, 大塚 愛二, 二宮 善文

    バイオイメージング   18 ( 2 )   182 - 183   2009.7

     More details

  • UTILIZATION OF ADAMTSI AS A NEW TOOL FOR DETECTING HYPOXIA

    Mehmet Zeynel Cilek, Satoshi Hirohata, Omer Faruk Hatipoglu, Kadir Demircan, Junko Inagaki, Tomoko Yonezawa, Toshikata Oohashi, Yoshifumi Ninomiya

    IUBMB LIFE   61 ( 3 )   357 - 358   2009.3

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:JOHN WILEY & SONS INC  

    Web of Science

    researchmap

  • Brevican organizes hyaluronan-binding extracellular assemblies distinctively at the large diameter nodes of Ranvier in the CNS

    Yoko Bekku, Yoshifumi Ninomiya, Toshitaka Oohashi

    NEUROSCIENCE RESEARCH   65   S73 - S73   2009

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.neures.2009.09.254

    Web of Science

    researchmap

  • 軟骨のバイオイメージング

    大橋俊孝

    関節外科   2009

     More details

  • 高密度金コロイド内包標的指向性リポソームの開発

    大谷 敬亨, 峯松 秀希, 平井 政彦, 大橋 俊孝, 大塚 愛二, 大家 一典, 五十嵐 貢一

    Drug Delivery System   23 ( 3 )   427 - 427   2008.5

     More details

    Language:Japanese   Publisher:日本DDS学会  

    researchmap

  • がん細胞株におけるADAMTS1の発現レベルの検討

    メフメット・ゼネユル・チレッキ, 廣畑 聡, カディール・デミルジャン, オメル・ファルク・ハティポール, 小川 弘子, 米澤 朋子, 草地 省蔵, 大橋 俊孝, 二宮 善文

    日本結合組織学会学術大会・マトリックス研究会大会合同学術集会プログラム・抄録集   39回・54回   144 - 144   2007.5

     More details

    Language:Japanese   Publisher:日本結合組織学会・マトリックス研究会  

    researchmap

  • Bral1, brain-specific link protein, is essential for stabilizing extracellular matrix at the node of Ranvier in the CNS

    Yoko Bekku, Yoshifumi Ninomiya, Toshitaka Oohashi

    NEUROSCIENCE RESEARCH   58   S40 - S40   2007

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

  • Alport症候群に合併した食道びまん性平滑筋腫症の1例

    西江学, 猶本良夫, 白川靖博, 山辻知樹, 浅海信也, 田中紀章, 大原信哉, 内藤一郎, 大橋俊孝, 二宮善文

    消化器外科   2005

     More details

  • GM-CSF刺激によりヒト末梢血単核球におけるバーシカンの発現は増加する

    山脇均, 広畑聡, 小比賀真就, 小川弘子, 大橋俊孝, 草地省蔵, 二宮善文

    日本結合組織学会学術大会抄録集   37th   2005

  • 5) Identification and Characterization of a novel rat link protein gene : Lp3/Hapln3

    小川 弘子, 廣畑 聡, 三好 亨, 村上 充, 白鳥 康史, 大橋 俊孝, 二宮 善文, 草地 省蔵, 佐田 政隆

    Circulation journal : official journal of the Japanese Circulation Society   68 ( 0 )   938 - 938   2004.10

     More details

    Language:Japanese   Publisher:Japanese Circulation Society  

    CiNii Article

    CiNii Books

    researchmap

  • 新規マトリックスリンクプロテインLp3/Hapln3 クローニングおよびその発現解析

    小川 弘子, 廣畑 聡, 大橋 俊孝, 佐田 政隆, 村上 充, 二宮 善文, 草地 省蔵, 白鳥 康史, 大江 透

    日本動脈硬化学会総会プログラム・抄録集   36回   197 - 197   2004.7

     More details

    Language:English   Publisher:(一社)日本動脈硬化学会  

    researchmap

  • ヒト大腸癌細胞におけるIV型コラーゲンα鎖の動態とその遺伝子発現の解析

    池田 公英, 本田 由美, 猪山 賢一, 江上 寛, 大橋 俊孝, 二宮 善文, 佐渡 義一

    マトリックス研究会大会   ( 51 )   30 - 30   2004.4

     More details

    Language:Japanese   Publisher:マトリックス研究会  

    researchmap

  • 新規の脳特異的ヒアルロン酸-プロテオグリカン結合蛋白質: Bral1, Bral2

    大橋俊孝, 別宮洋子, 二宮善文

    蛋白質核酸酵素   49,15,2354-2361   2004

     More details

  • 新規ラットリンク蛋白質遺伝子,Lp3/Hapln3の道程と特色(原標題は英語)

    小川弘子, 広畑聡, 三好亨, 村上充, 白鳥康史, 大橋俊孝, 二宮善文, 草地省蔵, 佐田政隆

    Circulation Journal   68 ( Supplement 3 )   2004

  • Brain Link Proteins : New Insights for Hyaluronan-Binding Proteoglycans in Brain

    OOHASHI Toshitaka, NINOMIYA Yoshifumi

    Connective tissue   35 ( 1 )   25 - 30   2003.3

     More details

    Language:English   Publisher:The Japanese Society for Connective Tissue  

    Link protein is originally characterized as an abundant extracellular matrix protein in cartilage and named Crtl1. It can stabilize aggregates of aggrecan and hyaluronan, giving cartilage its tensile strength. Similarly to the cartilage matrix, a high content of hyaluronan matrix has also been recognized in the brain matrix. Subsequently, several hyaluronan binding chondroitin sulphate proteoglycans, called lecticans, have been identified as the abundant extracellular matrix molecules in the developing and/or adult brain. Other than Crtl1, brain-specific link protein gene, Brail, was cloned recently. The two link proteins (LPs), old and new, are differentially expressed and seemed to be coordinately expressed with lecticans in the brain. In this review, we will focus on these brain link proteins that may play crucial roles in hyaluronan matrix.

    CiNii Article

    CiNii Books

    researchmap

  • 新規脳リンクプロテインBral2のクローニングと発現

    大橋 俊孝, 蘇 衛東, 別宮 洋子, 大塚 愛二, 二宮 善文

    生化学   74 ( 8 )   734 - 734   2002.8

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • バーシカンV2・脳リンクプロテイン会合体の中枢神経ランビエ絞輪での発現とその機能

    大橋俊孝, 別宮洋子, 平川聡史, 李勝天, 松井秀樹, 二宮善文

    Connective tissue   34 ( 1 )   50 - 50   2002.4

     More details

    Language:Japanese   Publisher:日本結合組織学会  

    ヒアルロン酸(HA)結合型の細胞外マトリックス及び細胞膜蛋白質は、HA結合ドメインとして機能するリンクモジュールを持つ。そのうちHA結合型コンドロイチン硫酸プロテオグリカン(CSPG)はレクティカンプロテオグリカンと呼ばれる。レクティカンファミリーは、Aggrecan,Versican,Neurocan,Brevicanの4遺伝子からなり、通常HA/Lectican/Link Proteinの会合体として機能すると考えられる。我々は最近中枢神経特異的リンクプロテイン遺伝子Bral1をクローニングし、Bral1は中枢神経特異的プロテオグリカンversican V2とランビエ絞輪にcolocalizeすることを報告した。ランビエ絞輪は神経の活動電位の発生と跳躍伝導に重要であることが知られている。我々はBral1が絞輪の細胞外部において、ヒアルロン酸にversicanコアプロテインを固定し、その結果versicanコアプロテインに結合している多数のグリコサミノグリカン鎖をランビエ絞輪に蓄積させ陰性に荷電させているのではないかと予想している。即ち、電位依存性NaイオンチャンネルによりNaイオンが細胞内外に出入りし活動電位を生ずるための細胞外環境を整えている役割をしていると考えている。我々は絞輪における「細胞外Naイオンプール」という仮説をたて、Bral1がその中心的な分子であるのでは...

    CiNii Article

    CiNii Books

    researchmap

  • 脳特異的リンクプロテイン(Bral1)の発現パターンの解析

    別宮 洋子, 大橋 俊孝, 平川 聡史, 蘇 衛東, 大塚 愛二, 二宮 善文

    神経化学   40 ( 2-3 )   292 - 292   2001.9

     More details

    Language:Japanese   Publisher:(一社)日本神経化学会  

    researchmap

  • 脳リンクプロテイン(Bral1)はランビエ絞輪で「細胞外Naイオンプール」の中心的役割を果たしているか?

    大橋 俊孝, 別宮 洋子, 平川 聡史, 蘇 衛東, 大塚 愛二, 二宮 善文

    生化学   73 ( 8 )   1064 - 1064   2001.8

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • 脳神経系におけるリンクモジュール遺伝子の発現

    大橋 俊孝, 平川 聡史, 蘇 衛東, 別宮 洋子, 大塚 愛二, 二宮 善文

    マトリックス研究会大会   ( 48 )   68 - 68   2001.4

     More details

    Language:Japanese   Publisher:マトリックス研究会  

    researchmap

  • 成熟した脳・脊髄のプロテオグリカン

    村上宅郎, 大塚愛二, 大橋俊孝, 二宮善文

    細胞   33,8,44-47 ( 8 )   320 - 323   2001

     More details

    Language:Japanese   Publisher:ニュー・サイエンス社  

    CiNii Article

    CiNii Books

    researchmap

    Other Link: http://search.jamas.or.jp/link/ui/2001236515

  • 脳神経系におけるリンクモジュール蛋白の機能発現

    大橋 俊孝, 平川 聡史, 蘇 衛東, 大塚 愛二, 村上 宅郎, 二宮 善文

    岡山医学会雑誌   112 ( 9~12 )   218 - 218   2000.12

     More details

    Language:Japanese   Publisher:岡山医学会  

    researchmap

  • Collagen Type IV alpha Chains in the Basement Membrane beneath the Serous Membrane

    Naito I, Saito K, Oohashi T, Miner JH, Matsubara T, Okigaki T, Ninomiya Y

    Connective tissue   32 ( 2 )   202 - 202   2000.5

     More details

    Language:Japanese   Publisher:The Japanese Society for Connective Tissue  

    CiNii Article

    CiNii Books

    researchmap

  • Molecular cloning of a novel link protein gene.

    HIRAKAWA Satoshi, SU Wei-Dong, OOHASHI Toshitaka, MURAKAMI Takuro, ARATA Jiro, NINOMIYA Yoshifumi

    Connective tissue   32 ( 2 )   211 - 211   2000.5

     More details

    Language:Japanese   Publisher:The Japanese Society for Connective Tissue  

    CiNii Article

    CiNii Books

    researchmap

  • Molecular cloning and characterization of human ten-m/odz genes.

    OOHASHI Toshitaka, SU Wei-Dong, HIRAKAWA Satoshi, UEKI Yasuyoshi, NAGAOKA Yoshiharu, NINOMIYA Yoshifumi

    Connective tissue   32 ( 2 )   126 - 126   2000.5

     More details

    Language:Japanese   Publisher:The Japanese Society for Connective Tissue  

    CiNii Article

    CiNii Books

    researchmap

  • Expression of col4a5 and col4a6 genes in basement membranes in mouse testis.

    SAITO Kenji, SEKI Tsugio, OOHASHI Toshitaka, MOMOTA Ryusuke, NINOMIYA Yoshifumi

    21   430 - 430   1998.12

     More details

  • In vitro analysis of mouse ten-m/odz protein structure and it's expression

    OOHASHI Toshitaka, FASSLER Reinhard, SU Wei-Dong, NINOMIYA Yoshifumi

    21   614 - 614   1998.12

     More details

  • Hypoxia Increases Transforming Growth Factor-β1 Concomitantly with Types I and III Collagen without Further Enhancement by Reoxygenation in Cultured Rat Cardiac Fibroblasts

    NUNOYAMA Hiroshi, KUSACHI Shozo, NINOMIYA Yoshifumi, OOHASHI Toshitaka, KONDO Jun, MURAKAMI Masahiro, MURAKAMI Takashi, OHNISHI Hiromichi, DOI Masayuki, TSUJI Takao

    Connect Tissue   30 ( 3 )   207 - 211   1998.9

     More details

    Language:English   Publisher:The Japanese Society for Connective Tissue  

    The effects of oxygen concentration and reoxygenation following hypoxic culture on transforming growth factor-β1(TGF-β1)expression and types I and III collagen[α2(I)and α1(III)]mRNA expression were examined in neonatal rat cardiac fibroblasts cultured with medium containing 10% or 1% fetal calf serum at confluency. The oxygen tension was varied using a N_2-CO_2-O_2 controllable incubator. Cells were exposed to continuous hypoxia(2% O_2)or were reoxygenated(21% O_2)after hypoxic culture. The TGF-β1 protein expression level was determined by an enzyme-linked immunosorbent assay, and the expression levels of TGF-β1, α2(I)and α1(III)mRNA were measured by a Northern blot analysis. Both the TGF-β1 mRNA and protein levels were higher in the continuous hypoxic cultures than in the continuous normoxic cultures. Their levels in reoxygenation cultures were not substantially different from those in the continuous normoxic cultures. Similarly, the expressions of both α2(I)and α1(III)mRNA were enhanced in continuous hypoxic culture, and no differences were obtained between normoxic and reoxygenation cultures. The present results indicate that hypoxia induces high expression levels of TGF-β1 and types I and III collagen in rat cardiac fibroblasts and reoxygenation does not further enhance this hypoxia-induced upregulation.

    CiNii Article

    CiNii Books

    researchmap

  • COL4A3 and COL4A4 are arranged head-to-head and COL4A4 has two alternative promoters.

    Momota Ryusuke, Oohashi Toshitaka, Ninomiya Yoshifumi

    Connective tissue   30 ( 2 )   135 - 135   1998.6

     More details

    Language:Japanese   Publisher:The Japanese Society for Connective Tissue  

    CiNii Article

    CiNii Books

    researchmap

  • Alport症候群(共著)

    百田龍輔, 大橋俊孝

    日本臨床 別冊 先天代謝異常症候群(下巻)   522 - 525   1998

     More details

  • Alternative transcripts are also found in the human COL4A4 gene expression.

    R Momota, T Oohashi, M Sugimito, Naito, I, Y Sado, Y Ninomiya

    MATRIX BIOLOGY   15 ( 3 )   171 - 172   1996.9

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:GUSTAV FISCHER VERLAG  

    Web of Science

    researchmap

  • マウスIV型コラーゲンα6鎖の遺伝子発現

    斎藤 健司, 大橋 俊孝, 関 次男, 佐渡 義一, 内藤 一郎, 小田 琢三, 二宮 善文

    日本分子生物学会年会プログラム・講演要旨集   19   435 - 435   1996.8

     More details

  • PARTIAL GENE STRUCTURE OF THE HUMAN ALPHA-4(IV) COLLAGEN CHAIN

    M SUGIMOTO, T OOHASHI, H YOSHIOKA, N MATSUO, Y NINOMIYA

    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE   34 ( 4 )   1203 - 1203   1993.3

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:LIPPINCOTT-RAVEN PUBL  

    Web of Science

    researchmap

▼display all

Presentations

  • The role of link protein HAPLN4, an organizer of perineuronal net, in the synapse formation and the synaptic transmission

    89th Harden Conference, Proteoglycans: Matrix, Master Regulators

    2023.9 

     More details

    Event date: 2023.9

    researchmap

  • The role of link protein HAPLN4, an organizer of perineuronal net, in the synapse formation and the synaptic function. Invited

    Toshitaka Oohashi

    KSBMB International Conference  2023.5 

     More details

    Event date: 2023.5

    researchmap

  • Cysltr1遺伝子変異は破骨細胞分化と炎症性骨破壊に影響しない

    藤田 洋史, 土生田 宗憲, 大野 充昭, 大橋 俊孝, 服部 高子, 久保田 聡, 大内 淑代

    日本生化学会大会プログラム・講演要旨集  2021.11  (公社)日本生化学会

     More details

    Event date: 2021.11

    Language:Japanese  

    researchmap

  • 肝細胞癌におけるXV型コラーゲン発現とその臨床応用

    木村 紘爾, 大橋 俊孝, 中山 勝, 小宮山 高明, 市村 浩一, 内藤 一郎, 浅野 博昭, 佃 和憲, 大塚 愛二, 二宮 善文

    日本結合組織学会学術大会・マトリックス研究会大会合同学術集会プログラム・抄録集  2013.6  日本結合組織学会・マトリックス研究会

     More details

    Event date: 2013.6

    Language:Japanese  

    researchmap

  • 肝細胞癌切除標本におけるXV型コラーゲン発現の検討とその臨床応用へ対する考察

    木村 紘爾, 大橋 俊孝, 中山 勝, 小宮山 高明, 市村 浩一, 内藤 一郎, 浅野 博昭, 佃 和憲, 内藤 稔, 三好 新一郎, 大塚 愛二, 二宮 善文

    日本外科学会雑誌  2013.3  (一社)日本外科学会

     More details

    Event date: 2013.3

    Language:Japanese  

    researchmap

  • 肝細胞癌におけるXV型コラーゲンの発現解析

    中山 勝, 大橋 俊孝, 小見山 高明, 木村 紘爾, 内藤 一郎, 三好 新一郎, 大塚 愛二, 二宮 善文

    日本生化学会大会プログラム・講演要旨集  2012.12  (公社)日本生化学会

     More details

    Event date: 2012.12

    Language:Japanese  

    researchmap

  • Analysis of the perineuronal net formation in the mouse medial nucleus of the trapezoid body (MNTB)

    International Symposium on Glyco-Neuroscience  2014 

     More details

  • リジンオリゴマーからなる関節軟骨特異的X線プローブの創出

    第27回日本軟骨代謝学会  2014 

     More details

  • 成熟脳のペリニューロナルECMの形成と機能について

    第21回 プロテオグリカンフォーラム  2014 

     More details

  • Role of nodal protroglycan-enriched ECM on formation and maintenance of CNS node of Ranvier

    8th International Conference on Proteoglycans  2013 

     More details

  • 幹細胞癌におけるXV型コラーゲン発現とその臨床応用

    第45回日本結合組織学会学術大会  2013 

     More details

  • 中枢神経ランビエ絞輪の形成・維持への細胞外マトリックス分子の関与

    第45回日本結合組織学会学術大会  2013 

     More details

  • 炎症標的化金コロイド内包リポソームのリウマチ関節炎症部位への集積の光学・電子顕微鏡観察

    第26回日本軟骨代謝学会  2013 

     More details

  • 神経細胞局所のヒアルロン酸結合性細胞外マトリックスの機能-ミッシングリンク-

    第3回 新潟プロテオグリカン研究会  2013 

     More details

  • マウス聴覚系内側台形体核(MNTB)におけるペリニューロナルネット形成

    第36回日本分子生物学会年会  2013 

     More details

  • Analysis of the perineuronal net formation in the mouse medial nucleus of the trapezoid body (MNTB)

    9th Pan Pasific Connective Tissue Society Symposium  2013 

     More details

  • バイオイメージングを用いた関節軟骨の評価

    第40回日本臨床バイオメカニクス学会  2013 

     More details

  • Changes of the extracellular matrix and extracellular space diffusion parameters in the thalamus of aged Bral2 deficient mice

    SfN 2013  2013 

     More details

  • Structurally simple cartilage probes constructed with epsilon-lysine oligomers targeting chondroitin sulfates

    8th International Conference on Proteoglycans  2013 

     More details

  • Bral2はbrevicanのペリニューロナルネットの構造形成に重要である

    第43回日本結合組織学会  2011 

     More details

  • 関節軟骨のバイオイメージング

    第33回生体膜と薬物シンポジウム  2011 

     More details

  • THE ION-DIFFUSION BARRIER MODEL AT THE NODE OF RANVIER: FROM THE EXTRACELLULAR ION DIFFUSION ANALYSIS IN BRAL1-DEFICIENT MICE

    7th International Conference on Proteoglycans  2011 

     More details

  • Bral2はbrevicanのペリニューロナルネットの構造形成に重要である

    第84回日本生化学会大会  2011 

     More details

  • Neurocan-GFP, a novel probe for hyaluronan in atherosclerotic plaques

    大43回日本動脈硬化学会総会・学術集会  2011 

     More details

  • 半月板細胞におけるII型コラーゲンの発現制御-メカニカルストレスによるエピジェネティックな転写制御

    第43回日本結合組織学会  2011 

     More details

  • 炎症標的化金コロイド内包リポソームのリウマチ関節炎症部位への集積

    第43回日本結合組織学会  2011 

     More details

  • The nodal ECM barrier model in the CNS: From an extracellular ion diffusion anaslsis in Bral1-deficient mice

    Ninth Biennial Satellite Meeting of the International Society for Neurochemistry on Myeline Biology: Myeline Development, Function and Related Diseases  2009 

     More details

  • OUMS-27軟骨肉腫細胞または軟骨細胞におけるNFATc1を解したIL-1bによるADAMTS9遺伝子の活性化

    第22回日本軟骨代謝学会  2009 

     More details

  • 生体構成成分を可視化する

    生体機能制御学講座研究構想シンポジウム  2009 

     More details

  • THE ION-DIFFUSION BARRIER MODEL AT THE NODE OF RANVIER: FROM THE EXTRACELLULAR ION DIFFUSION ANALYSIS IN BRAL1-DEFICIENT MICE

    IUPS 2009(国際生理学会議)  2009 

     More details

  • 軟骨組織のバイオイメージング

    第27回日本骨代謝学会学術集会  2009 

     More details

  • 軟骨基質集積ナノプローブを用いた軟骨組織のバイオイメージング

    第5回北海道結合組織勉強会  2009 

     More details

  • Optical imaging of mouse articular cartilage using the glycosaminoglycans binding property of fluorescent-labeled octaarginine

    第8回環太平洋結合組織学会  2009 

     More details

  • Brevican determines specialization of the hyaluronan-binding nodal matrix assemblies at the large diameter nodes of Ranvier in the CNS

    第8回環太平洋結合組織学会  2009 

     More details

  • 関節軟骨変性疾患の分子標的治療システムの開発

    ナノバイオ標的医療等の新たな医療の創造とその基盤技術研究事業成果報告会  2009 

     More details

  • 軟骨基質集積ペプチドを用いた軟骨組織のバイオイメージング

    第18回日本バイオイメージング学会  2009 

     More details

  • The active targeting liposome encapusulated high-density colloidal gold

    11th Liposome Research days conference  2008 

     More details

  • 新しい軟骨基質結合ペプチドを用いた関節軟骨in vivo蛍光イメージング法の開発

    第40回日本結合組織学会学術集会・第55回日本マトリックス研究会大会合同学術集会  2008 

     More details

  • 新しい軟骨基質結合ペプチドを用いた関節軟骨in vivo蛍光イメージング法の開発

    第21回日本軟骨代謝学会  2008 

     More details

  • The inhibition of the ADAMTS9 induced by Interleukin 1b using 11R-VIVIT peptide in OUMS27 Chondrosarcoma cells and in Human Chondrocytes.

    American Society of Matrix Biology  2008 

     More details

  • Bral1欠損マウスでは脳梁での細胞外イオン拡散が促進される

    北米神経科学会議 2008  2008 

     More details

  • A 3D Imaging of Mouse Knee Joint Articular Surface by Optical Projection Tomography

    WMIC(World Molecular Imaging Congress) 2008  2008 

     More details

  • The inhibition of the ADAMTS9 induced by Interleukin 1b using 11R-VIVIT peptide in OUMS27 Chondrosarcoma cells and in Human Chondrocytes.

    第11回 国際リポソーム会議  2008 

     More details

  • 高密度金コロイド内包標的指向性リポソームの開発

    第40回日本結合組織学会学術集会・第55回日本マトリックス研究会大会合同学術集会  2008 

     More details

  • シアリルルイスX糖鎖結合リポソームの炎症組織特異的集積性

    第4回北海道結合組織勉強会  2008 

     More details

  • 軟骨特異的集積ペプチド(CSBP)を用いたin vivo 蛍光イメージングおよびDDS の試み

    第4回北海道結合組織勉強会  2008 

     More details

  • シアリルルイスX糖鎖結合リポソームのリウマチ関節炎症部位への集積についての組織学的検討

    第40回日本結合組織学会学術集会・第55回日本マトリックス研究会大会合同学術集会  2008 

     More details

  • 関節炎モデルマウスにおけるシアリルルイスX糖鎖結合リポソームの特異的集積に関する検討

    BMB2008(第31回日本分子生物学会年会・第81回日本生化学会大会合同大会)  2008 

     More details

  • The inhibition of the ADAMTS9 induced by Interleukin 1b using 11R-VIVIT peptide in OUMS27 Chondrosarcoma cells and in Human Chondrocytes.

    アメリカマトリックス生物学会 年会  2008 

     More details

  • Deletion of the brain-specific link protein Bral-1 facilitates extracellular diffusion in the mouse corpus callosum.

    SfN 2008  2008 

     More details

  • ペプチドや核酸などの遺伝子性薬剤を放出するステントの開発

    平成18年度 特別電源所在権科学技術振興事業研究成果発表会  2007 

     More details

  • Cellular mechanism for cytokine induction in hyaluronan-stimulated human mononuclear cells.

    Hyaluronan 2007  2007 

     More details

  • Developmental and transgenic expression of crtl1/hapln1 in zebrafish

    第20回日本軟骨代謝学会  2007 

     More details

  • 光投射型断層撮影イメージング技術(OPT)によるマウス関節標本の3D画像解析

    BMB2007  2007 

     More details

  • The effect of the length of arginine chain on the internalization into the Rat AoSMC.

    アメリカ糖質生物学会(Glycobiology 2007)  2007 

     More details

  • Nodal extracellular molecule Bral1 plays a key role in assembling stable extracellular matrices in the CNS

    SfN(Society for Neuroscience)2007  2007 

     More details

  • Bral1, brain-specific link protein, is essential for stabilizing extracellular matrix at the node of Ranvier in the CNS

    日本神経科学学会Neuro2007  2007 

     More details

  • Differential expression of ADAMTS1 gene in cancer cell lines.

    第39回日本結合組織学会  2007 

     More details

  • 光投射型断層撮影イメージング技術(OPT)によるマウス関節標本の3D画像解析

    日本結合組織学会・マトリックス研究会合同大会  2007 

     More details

  • PTD法を利用した遺伝子性薬剤放出型ステントの開発

    平成17年度 特別電源所在権科学技術振興事業研究成果発表会  2006 

     More details

  • 脳リンクプロテイン-CSPG複合体の機能制御に関する研究

    特定領域研究第4回公開シンポジウム  2006 

     More details

  • Alport-leiomyomatosis症候群1例のIV型コラーゲン遺伝子変異解析および免疫組織化学的解析

    第53回日本マトリックス研究会  2006 

     More details

  • ADAMTSプロテアーゼのうちADAMTS-4が心筋梗塞早期に誘導され、梗塞辺縁部でバーシカンを分解する

    日本分子生物学会 2006 フォーラム  2006 

     More details

  • Developmental and transgenic expression of crtl1/hapln1 in zebrafish

    American Society of Matrix Biology  2006 

     More details

  • 脳リンクプロテインによる脳実質ヒアルロン酸‐CSPG複合体の機能制御に関する研究 (Brain link proteins: The role in the formation and function of the chondroitin sulfate proteoglycan complexes in the brain.)

    文部科学省科学研究費特定領域研究「糖鎖によるタンパク質と分子複合体の調節機能」第4回夏期シンポジウム  2006 

     More details

  • Adenoviral gene therapy using NC1 domain of collagen IV suppresses vessel formation and tumor growth

    欧州結合組織連合学術集会(FECTS)  2006 

     More details

  • Aggrecanase member of ADAMTS proteases are differently regulated in ventricular remodeling

    20th IUBMB International Congress of Biochemistry and Molecular Biology  2006 

     More details

  • Bral1, brain-specific link protein, is essential for stabilizing extracellular matrix at the node of Ranvier in the CNS.

    20th IUBMB International Congress of Biochemistry and Molecular Biology  2006 

     More details

  • Hyaluronan induced cytokine expression in peripheral blood mononuclear cells

    Glycomatrix, Extracellular Glycomatrix in Health and Disease  2006 

     More details

  • Tumor-specific expression of the noncollagenous domain-1 of collagen IV suppresses endothelial tube formation and tumor growth in mice.

    第38回日本結合組織学会学術大会  2006 

     More details

  • PTD法を利用した遺伝子性薬剤放出ステントの開発

    岡山県産業振興財団 医療・福祉・健康ミクロものづくり共同研究事業成果発表会  2006 

     More details

  • Alport-leiomyomatosis症候群1例のIV型コラーゲン遺伝子解析および免疫組織化学的解析

    第52回日本マトリックス研究会  2005 

     More details

  • 脳リンクプロテイン-CSPG複合体の機能制御に関する研究

    特定領域(グライコ)研究第3回夏期シンポジウム  2005 

     More details

  • GM-CSF刺激によりヒト末梢血単核球におけるバーシカンの発現は増加する

    日本結合組織学会  2005 

     More details

  • Analysis of neurocan/link protein interactions and distribution of hyaluronan with alkaline phosphatase and GFP fusion proteins.

    The 19th FECTS meeting  2004 

     More details

  • Idenstification and Characterization of a novel rat link protein: Lp3/Hapln3

    第84回日本循環器学会中国地方会  2004 

     More details

  • ヒト大腸がん細胞におけるIV型コラーゲンα鎖の動態とその遺伝子発現の解析

    第48回マトリックス研究会  2004 

     More details

  • Characterization of dermacan, a novel zebrafish lectican gene, expressed in dermal bones.

    第48回マトリックス研究会  2004 

     More details

  • Lp3/Hapln3, A novel Rat Link Protein is Upregulated in Pressure Overload Heart.

    第68回日本循環器学会  2004 

     More details

  • Dynamic induction od ADAMTS1 gene in the early phase of acute myocardial infarction.

    2nd national meeting of the American Society for matrix Biology  2004 

     More details

  • Lp3/Hapln3, a novel llink protein which colocalize with versican and is coordinately upregulated by PDGF.

    2nd national meeting of the American Society for matrix Biology  2004 

     More details

  • 軟骨細胞におけるIL-1βとTNF-αによるアグリカナーゼ遺伝子発現誘導の多様性

    第77回日本生化学会  2004 

     More details

  • 血管障害モデルにおけるヒアルロン酸結合リンクプロテインLp3/Hapln3の発現解析

    第77回日本生化学会  2004 

     More details

  • 中枢神経系軸索ランビエ絞輪における脳特異的リンクプロテイン1, Bral1/Hapln2の機能解析

    Neuro2004  2004 

     More details

  • 新規マトリックスプロテインLp3/Hapln3:クローニングおよびその発現解析

    第84回日本動脈硬化学会  2004 

     More details

  • Expression of Versican and its Degrading Enzymes in Acute Myocardial Infarction

    5th Pan-Pacific Connective Tissue Societies Symposium  2003 

     More details

  • Brain link proteins: New insights for hyaluronan-binding proteoglycan in the brain

    5th Pan-Pacific Connective Tissue Societies Symposium  2003 

     More details

  • Dermacan: a novel zebrafish lectican gene expressed in dermal bones and required for dermal bone formation

    第26回日本分子生物学会年会  2003 

     More details

  • Identification of the new rat Vascular link protein, Vasl1

    日本生化学会  2003 

     More details

  • Brain link proteins: new insights for hyaluronan-binding proteoglycans in the brain

    Hyaluronan 2003  2003 

     More details

  • Zebrafish dermacan, A new member of the hyaluronan-binding proteoglycan family, lectican

    3rd International conferenca on proteoglycans: Pathobiology of proteoglycans  2003 

     More details

  • 脳リンクプロテインによる脳実質コンドロイチン硫酸プロテオグリカン複合体機能制御に関する研究

    科学研究費特定領域研究、糖鎖によるタンパク質と分子複合体の機能調節、 第一回夏期シンポジウム  2003 

     More details

  • Perineuronal nets: 分子生物学的手法による新展開

    日本顕微鏡学会、第59回学術講演会  2003 

     More details

  • 新規脳リンクプロテインBral1の中枢神経ランビエ絞輪における発現と機能

    プロテオグリカンフォーラム、神経組織プロテオグリカン研究会合同会  2002 

     More details

  • 新規脳リンクプロテインBral2のクローニングと発現

    第75回日本生化学会  2002 

     More details

  • Expression and possible function of versican/Bral1 complex at the nodes of Ranvier in the CNS.

    第45回日本神経化学会  2002 

     More details

  • バーシカンV2・脳リンクプロテイン会合体の中枢神経ランビエ絞輪での発現とその機能

    第34回日本結合組織学会・第49回マトリックス研究会合同会議  2002 

     More details

  • 新規脳リンクプロテインBral1の中枢神経ランビエ絞輪における発現と機能

    第8回プロテオグリカンフォーラム、第2回神経組織プロテオグリカン研究会合同会  2002 

     More details

  • 脳神経系におけるリンクモジュール遺伝子の発現

    日本マトリックス研究会  2001 

     More details

  • 脳リンクプロテイン(Bral1)はランビエ絞輪で「細胞外Naイオンプール」の中心的役割をはたしているか?

    日本生化学会  2001 

     More details

  • 脳特異的リンクプロテイン(Bral1)の発現パターンの解析

    日本神経科学会 Neuro2001  2001 

     More details

▼display all

Works

  • BioJapan2013

    2013

     More details

  • JST 六大学合同新技術説明会

    2013

     More details

  • 米国ライセンシング協会展示発表

    2013

     More details

  • Licencing Executives Society 2013

    2013

     More details

Awards

  • Best Oral Presentation Award

    2018.11   PPCTSS (Pan-Pasific Connective Tissue Society Symposium)  

     More details

  • 日本結合組織学会優秀演題賞

    2011  

     More details

    Country:Japan

    researchmap

  • 日本バイオイメージング学会 ベストイメージング賞

    2009  

     More details

    Country:Japan

    researchmap

  • 結城賞(岡山医学会)

    1995  

     More details

    Country:Japan

    researchmap

Research Projects

  • ペリニューロナルネットをディメンジョナルマーカーとした摂食障害モデルマウスの解析

    Grant number:24K10733  2024.04 - 2027.03

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    大橋 俊孝, 酒本 真次, 高木 学, 宮崎 晴子

      More details

    Grant amount:\4550000 ( Direct expense: \3500000 、 Indirect expense:\1050000 )

    researchmap

  • 難治性潰瘍での変性コラーゲンの局在証明、再上皮化遅延の病態解明とその治療法開発

    Grant number:23K09079  2023.04 - 2026.03

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    久保 美代子, 山本 健一, 米澤 朋子, 大橋 俊孝

      More details

    Grant amount:\4680000 ( Direct expense: \3600000 、 Indirect expense:\1080000 )

    researchmap

  • Molecular mechanisms of synaptic pruning in the mouse auditory system regulated by perineuronal nets.

    Grant number:23H04235  2023.04 - 2025.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Transformative Research Areas (A)

    大橋 俊孝

      More details

    Grant amount:\7280000 ( Direct expense: \5600000 、 Indirect expense:\1680000 )

    researchmap

  • Elucidating the Mechanisms of Palatal Development by Combining Molecular Biology and Information Biology

    Grant number:22KF0265  2023.03 - 2024.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for JSPS Fellows

    Wang Ziyi

      More details

    Authorship:Principal investigator 

    Grant amount:\2300000 ( Direct expense: \2300000 )

    researchmap

  • 分子生物学と情報生物学の融合による口蓋発生メカニズムの解明

    Grant number:22F22114  2022.04 - 2024.03

    日本学術振興会  科学研究費助成事業  特別研究員奨励費

    大橋 俊孝, WANG ZIYI

      More details

    Grant amount:\2300000 ( Direct expense: \2300000 )

    researchmap

  • Functional deteriorations of liver/pancreas caused by age-related changes of type XVIII collagen

    Grant number:20K11556  2020.04 - 2023.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    百田 龍輔, 米澤 朋子, 大塚 愛二, 大橋 俊孝, 内藤 一郎

      More details

    Grant amount:\4290000 ( Direct expense: \3300000 、 Indirect expense:\990000 )

    脂肪肝の症状がはっきりとみられるXVIII型コラーゲン欠損老齢マウスだけでなく、若い欠損マウスで”予兆”のような現象を改善することで脂肪肝、NAFLDへの進行を予防できるのではないかと考え、加齢マウスだけでなく2ヶ月齢の若いマウスを用いて改めて、網羅的に遺伝子発現と組織学的な検討を行った。若い欠損マウスは細胞内脂肪滴の蓄積では組織学的に大きな差は認められなかったが、血管周囲の構造について野生型と比較して若干違いが見られたのでその再現性について確認を行っている。
    さらに、野生型、欠損の若いマウスについても、双方の肝臓からRNAを抽出し、RNA-seqにより全転写産物の解析を進めている。前年度の加齢マウスで行ったネットワーク解析、コンピューターによる代謝シミュレーションを行い、代謝経路・産物について経時的にどう変化するかについて検討する予定である。
    また、新たにリピドミクスの系を立ち上げたので、マウスの血液中や肝臓に蓄積する脂質組成について比較検討を行っている。すなわち、上記のコンピューターシミュレーションの結果を生体で実際に起きているかどうか確認を進めている。
    一方、上記のシミュレーション結果をもとに、ネットワーク解析などから中心的な役割を果たす複数の代謝経路、遺伝子産物、代謝産物を同定した。これらの候補遺伝子産物で薬理学的な調節が可能な候補を抽出した。また、その機能を調節できるような化合物検索をバーチャルに行う高性能GPU搭載コンピューターの解析環境を立ち上げた。現在これらの結果をもとに論文作成に取り掛かっている。

    researchmap

  • 基底膜構成分子の誘導制御による低侵襲角化歯肉獲得療法の確立

    Grant number:19H03841  2019.04 - 2023.03

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    前川 賢治, 窪木 拓男, 冨田 秀太, ハラ エミリオ・サトシ, 大橋 俊孝, 大野 充昭

      More details

    Grant amount:\17030000 ( Direct expense: \13100000 、 Indirect expense:\3930000 )

    天然歯や口腔インプラント義歯が長期的に良好な予後を維持するためには,歯頚部や口腔インプラント周囲に十分な幅の「角化した付着歯肉」が必要であると考えられている。我々は,角化歯肉に特異的に高発現している基底膜分子(Ⅳ型コラーゲン556, ⅩⅧ型コラーゲン,ラミニン332)を世界で初めて同定した.また,これらは上皮細胞から分泌され,上皮細胞の角化をオートクライン的に促進していること,さらには,付着・角化歯肉より採取した間葉細胞と口腔粘膜上皮細胞を共培養した場合にのみ,口腔粘膜上皮細胞の角化が促進されることを明らかとした.これらの研究成果から,基底膜直下に存在する角化歯肉由来間葉細胞と非角化歯肉由来間葉細胞の遺伝子発現の相違を明らかにすることで,上皮細胞の角化に関わっている間葉細胞からのシグナル分子を抽出することが可能であると考えた.そこで,レーザーマイクロダイセクション (LMD)法とRNA-Seq を組み合わせて,候補因子の抽出を実施してきた.具体的には,マウスの口蓋粘膜(角化粘膜) と頬粘膜(非角化粘膜)の凍結組織切片を作製, LMDにより上皮組織直下の間葉組織を採取したうえでRNAを抽出し,cDNAライブラリーを作製,シークエンス解析を行った.そして,非角化粘膜と比較し,角化粘膜の間葉組織に高発現する遺伝子を抽出を行ってきた.2021年度は,発現量に有意差があった遺伝子を用いて,Ingenuity Pathway Analysis (IPA)にて上流解析を行い,粘膜の角化に関わる遺伝子を抽出した.そして,すでに確立している口腔粘膜を模倣した3次元培養モデルを用いて抽出された遺伝子の機能解析を実施した.その結果,候補遺伝子のリコンビナントタンパク質を培養液に添加することで上皮の角化が誘導されることが明らかとなった.次年度,in vivoにて候補遺伝子の機能解析を実施する予定である.

    researchmap

  • Role of Aggrecan in the postnatal development of bone and cartilage.

    Grant number:19K09649  2019.04 - 2023.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    大橋 俊孝, 大野 充昭, 西田 圭一郎

      More details

    Grant amount:\4290000 ( Direct expense: \3300000 、 Indirect expense:\990000 )

    生後発達および生体恒常性維持におけるAcanの役割を明らかにするため,Acanfl/flマウスを作製し,タモキシフェン(TAM)誘導性時期特異的Acan全身ノックアウトマウスを樹立した.アグリカンの欠損がECMネットワークの乱れがECMの硬さとTGFβスーパーファミリーの発現に影響し軟骨細胞の増殖分化に影響するという仮説を立て,これを同モデルで検証することを行っている.これまでの主な成果として,透過電子顕微鏡観察から上記ノックアウトマウス脛骨成長板の軟骨細胞の形態異常・カラム配列の乱れ・肥大軟骨層のアポトーシス亢進を認め,アグリカンが生後の骨成長に重要であることを明らかにした.成長板の軟骨細胞が増殖すべきところ、周囲のアグリカンが欠損することにより、異常な細胞接着を生じ,細胞分裂からの細胞形態の平坦化と層状化を阻害していると仮説を立て、そのメカニズムを検討中である.原子間力顕微鏡によるECMの硬さの解析を共同研究者Aszodi博士と引き続き共同研究中で在る.コロナ禍やウクライナ問題で渡航や国際学会発表が行いにくいがオンラインによる研究交流を進める.研究成果の一部は日本結合組織学会や日本軟骨代謝学会等で発表を行い、あるいは論文発表予定である.

    researchmap

  • スクラップ&ビルドによるペリニューロナルネット機能の作動原理の解明

    Grant number:19H04754  2019.04 - 2021.03

    日本学術振興会  科学研究費助成事業  新学術領域研究(研究領域提案型)

    大橋 俊孝

      More details

    Grant amount:\9620000 ( Direct expense: \7400000 、 Indirect expense:\2220000 )

    ペリニューロナルネット(PNN)はパルブアルブミン陽性のGABA作動性介在ニューロン(PVI)などに最も顕著に存在する特殊な細胞外マトリックス(ECM)構造である。
    我々は、ペリニューロナルなECM構造の安定化に重要な複数のリンクプロテイン分子(HAPLN)に注目し、それらの遺伝子ノックアウトマウス等を駆使して、HAPLNがPNNの高密度な会合体形成を通じて、神経可塑性の制御やその他の神経活動に重要なことを示すことを目的としている。本研究は、小脳や脳幹部(聴覚系神経核)に焦点を絞り、PNNの会合体形成を傷害する(PNNスクラップ)手法によりPNN機能(動作原理)を追求するものである。
    初年度に、台形体核神経細胞のcalyx of Heldシナプスが複数入力することを電気生理学手法により明らかにした。複数入力が認められるシナプスにおいて自発的EPSCやシナプス短期可塑性の測定、発生に伴うシナプス後細胞のグルタミン酸受容体のサブタイプ変化を調べたが今のところコントロールマウスと統計的な有意差は認められていない。KOマウスで、シナプスのプレとポストのpair recordingで高頻度刺激に対する活動電位発生能力の追随性が低下することが発見された。二年度目には、複数入力を形態学的に確かめることやグリア細胞のシナプス刈込への関与を調べることに注力した。これまでのところ、シナプス刈込みに関与するとされるグリア細胞の挙動が野生型と異なることを見出している。
    成果は日本神経科学会や日本結合組織学会で発表する予定である。

    researchmap

  • Functional analysis of type XVIII collagen and its application in skin wound healing

    Grant number:17K11540  2017.04 - 2021.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Yonezawa Tomoko

      More details

    Grant amount:\4680000 ( Direct expense: \3600000 、 Indirect expense:\1080000 )

    The function of the extracellular matrix is thought to be essential for skin wound healing, but the biological role remains unexplored. In mouse skin wound healing, collagen XVIII was found to appear early in the basement membrane zone beneath the newly forming epidermis. The type of isoform of collagen XVIII was found to change as re-epithelialization progressed, suggesting that collagen XVIII is involved in the formation and stabilization of the basement membrane and regulation of the re-epithelialization.

    researchmap

  • The functions of collagen XVIII in skin aging

    Grant number:17K01848  2017.04 - 2020.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Momota Ryusuke

      More details

    Grant amount:\4420000 ( Direct expense: \3400000 、 Indirect expense:\1020000 )

    We analyzed transcriptomic data of human skin to find transcripts whose expression levels showed significant changes in age-dependent manner. These transcripts involve in biological functions such as RNA transcription, splicing, transmembrane, lipoproteins, mitochondrial components, epithelial keratinization, and microtubules. We found that fresh unripe peach extract significantly improved mRNA levels and partially localizations of basement membrane components.
    We had established a very simple less invasive method to detect collagen types XVIII and IV. In addition, we had established a method to detect immature epidermal cells which appear during barrier formation after skin damage and wrote a computational script for quantification.

    researchmap

  • The development of bone regeneration therapy based on the clarification of mechanism of BMP-2 induced bone formation and resorption

    Grant number:16H05524  2016.04 - 2019.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    Ono Mitsuaki

      More details

    Grant amount:\17160000 ( Direct expense: \13200000 、 Indirect expense:\3960000 )

    Bone morphogenetic protein 2 (BMP-2) is widely known as a potent growth factor that promotes bone formation. However, in this experiment, we revealed that the effect of BMP-2 in inducing bone formation is remarkably repressed by marrow cells via direct cell-cell contact with osteoblasts; this opens new perspectives on the clarification of the side-effects associated with BMP-2 application.

    researchmap

  • Search of master regulator of odontoblastogenesis using iPS interference

    Grant number:16K15802  2016.04 - 2018.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Challenging Exploratory Research

    Ono Mitsuaki

      More details

    Grant amount:\3380000 ( Direct expense: \2600000 、 Indirect expense:\780000 )

    It is still unknown not only the mechanism but also the master regulator of odontoblastogenesis. Therefore, the final goal of our study is to identify the mater regulator of odontoblastogenesis. We performed the comprehensive analysis from the histological and developmental point of view using RNA-Seq, and could narrow down the several candidate odontoblastogenesis related genes. In the future, we are planing to perform the functional analysis of these candidate genes.

    researchmap

  • Establishment of in vivo imaging and quantification of articular cartilage by using a cartilage-specific probe.

    Grant number:15K15551  2015.04 - 2017.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Challenging Exploratory Research

    Oohashi Toshitaka, HIROHATA Satoshi, OHTSUKI Takakashi, ASZDI Attila

      More details

    Grant amount:\3640000 ( Direct expense: \2800000 、 Indirect expense:\840000 )

    A new X-ray imaging probe 2Ke2-TIB has been created in addition to Ke4-TIB. These probes were examined for in vivo imaging of articular cartilage by CT using rat osteoarthritic model. A new patent regarding Ke4-TIB has been established on March 24th, 2017. Since we speculate the increasing use of mouse genetic model for drug discovery research, we created a new mouse genetic model by crossing floxed "A" gene mice, encoding a proteoglycan gene abundant in the articular cartilage, with Rosa26-creERT mice. The mice exhibited a dwarfism and articular cartilage degeneration after starting injection of tamoxifen at one week of age. These developments of new imaging probes and a mouse model will contribute to the future research on osteoarthritis drug discovery. A collaboration with a group in the University of Munich has started for nano Xray CT.

    researchmap

  • Epigenetic regulation of miRNA induced by mechanical stress in human chondrocytes

    Grant number:26462299  2014.04 - 2017.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Nishida Keiichiro

      More details

    Grant amount:\3380000 ( Direct expense: \2600000 、 Indirect expense:\780000 )

    Human chondro-osteophytes were obtained at the time of total joint arthroplasty from knee joints and hip joints of patients with osteoarthritis (OA). ADAM12, one of the target gene of miRNA29-b was observed in chondrocytes of the proliferative and hypertrophic zones in human chondro-osteophytes by immunohistochemistry. ADAM12 mRNA was up-regulated during chondrogenic differentiation in ATDC5 cells, before up-regulation of type X collagen mRNA. In patients with OA, mechanical forces acting on the sites of soft tissue attachments at the joint margins play a primary role in chondro-osteophyte formation and may cause joint pain leading to impaired activity of daily living. In addition, it has been reported that the haplotypes in the ADAM12 gene are strongly related to the risk of clinical knee OA. Modulation of signaling pathway of miRNA29b-ADAM12 axis may contribute the future development of a novel therapy against OA.

    researchmap

  • Analysis of trans-plasma membrane molecular machinery between collagen types XV/XVIII and mitochondria

    Grant number:26350892  2014.04 - 2017.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Momota Ryusuke, OOHASHI Toshitaka, YONEZAWA Tomoko, KOMIYAMA Takaaki, NARASAKI Masahiro

      More details

    Grant amount:\4810000 ( Direct expense: \3700000 、 Indirect expense:\1110000 )

    To identify the molecules which would compose "the tran-plasma membrane molecular machinery" of collagen types XV/XVIII and mitochondria, we have screened thousands of genes expressed in muscular tissues and identified possible candidate G-protein coupled receptors. In addition, our histological analyses on collagen types XV/XVIII mutant animals revealed abnormal structures of cytoskeletons, which would potentially compromise the mitochondrial and cellular functions. Moreover, we had successfully optimized the immunohistochemical conditions for the anti-collagen XV/XVIII monoclonal antibodies, which enabled us to use variously processed tissue samples to diagnose human diseases caused by defective collagen XV/XVIII.

    researchmap

  • プロテオグリカンによるシナプス伝達調節の分子メカニズム:Bral2欠損マウス解析

    Grant number:26110713  2014.04 - 2016.03

    日本学術振興会  科学研究費助成事業  新学術領域研究(研究領域提案型)

    大橋 俊孝

      More details

    Grant amount:\8320000 ( Direct expense: \6400000 、 Indirect expense:\1920000 )

    脳幹部神経核・小脳に特異的なペリニューロナルネット(PNN)が部位特異的に障害されたBral2/Hapln4 KOマウスを用いて、PNNによる神経活動制御機構を電気生理学的手法(パッチクランプ記録法)を用いて解析した。プルキンエ細胞の軸索を電気刺激して、小脳核細胞体より抑制性シナプス後電流を記録したところ、Bral2欠損マウスではその振幅が野生型に比べて減少した。興奮性シナプス後電流に変化はなかったことから、Bral2を含むPNNが抑制性シナプス伝達に特異的に関与していることが示唆された。また、反復刺激の間に観察される短期シナプス抑圧の減少が観察されたことから、短期可塑性の変化を示された。これらの結果はプルキンエ細胞と小脳核細胞体間のシナプスにおいて、Bral2が安定したシナプス結合のために不可欠であること、短期シナプス可塑性に関与していることを示す。
    PNN関連プロテオグリカン遺伝子のfloxマウスが完成し、f/+のオスメスの交配により、f/fマウスが出産され、生育上の大きな問題は観察されていない。今後同遺伝子の中枢神経系条件的KOマウス作製に供される予定である。

    researchmap

  • Creation of articular cartilage-specific bio-molecular imaging probe with potentials of dual modalities.

    Grant number:25670648  2013.04 - 2015.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Challenging Exploratory Research

    OOHASHI Toshitaka, NISHIDA Keiichiro, KAKUTA Hiroki

      More details

    Grant amount:\3770000 ( Direct expense: \2900000 、 Indirect expense:\870000 )

    In the process of cartilage degeneration seen in osteoarthritis, loss of proteoglycan from articular cartilage has been widely accepted as a critical early event. We investigated bio-molecular imaging of articular cartilage using our molecular probes targeting articular GAGs.
    Chondroitin sulfate, a major component of articular cartilage, has negative charge caused by sulfates. We designed lysine oligomers (monomer - pentamer) which were connected with the a-carboxyl and e-amino group. These lysine oligomers possess e-amino groups as cationic moieties. Then, we created a novel articular cartilage imaging X-ray probe Ke4-triiodobenzene (Ke4-TIB) and demonstrated an ex vivo imaging of articular cartilage in rat osteoarthritic models. The imaging could quantitate loss of proteoglycan from osteoarthritic cartilage. Ke4-TIB may have a potential of in vivo X-ray imaging in animal arthritic models in future, which contribute to drug discovery research for osteoarthritis.

    researchmap

  • Anti tumor effect of micro RNA transferred by active targeting liposomes

    Grant number:24659590  2012.04 - 2014.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Challenging Exploratory Research

    NINOMIYA Yoshifumi, TOYOOKA Shinichi, OOHASHI Toshitaka

      More details

    Grant amount:\3770000 ( Direct expense: \2900000 、 Indirect expense:\870000 )

    Lung cancer and malignant pleural mesothelioma are refractory disease. Particularly, establishment of new effective therapies are urgent business to improve prognosis of inoperable tumor with the metastasis.
    We have discovered microRNA (miRNA) which works inhibitory to these diseases and aimed at the establishment of active targeting liposome (lip) to accumulate to tumor cells selectively. In this study, we planned to evaluate the accumulation of the lip for the cultured tumor cells and the mouse subcutaneous tumor models for the first and the antitumor effect of the miRNA-lip the second.
    At first, expected enough accumulation of the lip were not observed with cells and mouse models either, but we were successful for improvement of the accumulation efficiency by improving the lip, administration condition, and model construction methods in detail. However we spent most of the period by these processes, evaluation of the lip taking into cells and developing miRNA-lip are future problems.

    researchmap

  • 糖鎖拡散型ペリニューロナルネット障害マウスモデルによる神経機能解析

    Grant number:24110509  2012.04 - 2014.03

    日本学術振興会  科学研究費助成事業  新学術領域研究(研究領域提案型)

    大橋 俊孝

      More details

    Grant amount:\9490000 ( Direct expense: \7300000 、 Indirect expense:\2190000 )

    我々は脳幹部神経核・小脳に特異的なPNNを部位特異的に形成障害するモデルとして、Bral2欠損マウスを用いて、PNN形成メカニズムの解析を行った。本モデルは、糖鎖合成や糖鎖ドメインの合成不全を起こすものではないが、本来ヒアルロン酸に依存してPG等が高密度に・秩序よく会合すべきPNNがdiffuseになる特徴をもつ(Bekku et al., J Comp Neurol 2012)。
    Bral2が制御するPNNは聴覚神経系神経核に顕著な発現を示すこと、そのなかでも巨大神経終末を持つ内側台形体核(MNTB)に焦点を絞り研究を行った。
    野生型マウスの内側台形体核(MNTB)においてaggrecanとbrevicanは分離独立(住み分け)した発現をしており、Bral2欠損マウスではbrevicanはaggrecanと共局在した。シナプス周囲・間隙近傍に存在するaggrecanとbrevicanの局所における「住み分け」を規定するのはLPであるBral2とCrtl1とのaffinityの差によると考え、ヒアルロン酸結合ドメイン(G1)のリコンビナントタンパク発現を行った。また、MNTBは聴覚系神経回路の代表的神経核であるので、上記PNN変化が聴覚機能にどの程度影響を与えているかについて、チェコ共和国Syka教授との国際共同研究を行い、聴力の低下を認めている。今後、このECMの変化が聴力低下をもたらすメカニズム解明を行う。

    researchmap

  • Role of basement membranes in small-vessel disease of brain

    Grant number:23390348  2011.04 - 2014.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    NINOMIYA YOSHIFUMI, YONEZAWA Tomoko, OOHASHI Toshitaka, HIROHATA Satoshi, OHTSUKA Aiji, HATANAKA Kunihiko, SAITO Kenji, MOMOTA Ryusuke, OGAWA Hiroko, INAGAKI Jyunko

      More details

    Grant amount:\19240000 ( Direct expense: \14800000 、 Indirect expense:\4440000 )

    Abnormalities of the basement membranes in brain small vessels are considered to cause the break-down of blood-brain barrier (BBB) and intracerebral hemorrhage. We established the mouse encephalopathy model by the administration of TNF-alpha intravenously, in which BBB permeability increase transiently. To know the change of type IV collagen, as major component of the basement membranes, in the encephalopathy model, we performed Western blot and immunohistochemistry. The results suggested that the degradation of type IV collagen was associated with the break-down of BBB.

    researchmap

  • Inhibition of experimental arthritis in mice by small interfering RNA targeting histone deacetylase 1 (siHDAC1) using in vivo electroporation method

    Grant number:23592215  2011 - 2013

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    NISHIDA Keiichiro, OOHASHI Toshitaka, KAWABATA Tomoko

      More details

    Grant amount:\3510000 ( Direct expense: \2700000 、 Indirect expense:\810000 )

    We examined the therapeutic effects of siRNA targeting histone deacetylase 1 (siHDAC1) using in vivo electroporation method. Intraarticular injection of siHDAC did not affected redness or paw swelling of anti-collagen antibody-induced arthritiis in mice. However, synovial proliferation, bone erosion, and degeneration of articular cartilage were milder in the knee joints treated with siHDAC1 than in the control group and the non-specific siRNA group. TUNEL stain revealed increased number of positive cells in the synovial tissue of siHADC group. Decreased HDAC1 expression was noted in the synovial fibroblasts isolated from arthritic knee joints treated by siHDAC, but no significant difference was shown by RT-PCR in IL-6, TNF, and MMP-3 mRNA expression with those from control and non-specific siRNA group. Our results suggested therapeutic effects of intraarticular siHDAC1 with electroporation was derived by its anti-proliferative property by induction of synovial cell apoptosis.

    researchmap

  • 聴覚におけるペリニューロナルネットの役割ー聴覚伝導路特異的Bral2の機能解析ー

    Grant number:22591879  2010 - 2012

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    別宮 洋子, 大橋 俊孝, 大塚 愛二, 百田 龍輔

      More details

    Grant amount:\3640000 ( Direct expense: \2800000 、 Indirect expense:\840000 )

    Bral2は、リンクプロテイン(LP)の一種で、ヒアルロン酸(HA)結合型コンドロイチン硫酸プロテオグリカン(CSPG)およびHAとともに複合体を形成する。LPは、その複合体形成及び安定化に必須の分子であると考えられている。Bral2は、CSPGの中でもブレビカンと共局在する事がわかっている。これらは、成体脳ではペリニューロナルネット(PNN)と呼ばれる、神経細胞周囲の網目状構造に存在する。
    本研究では、聴覚伝導路において、Bral2複合体のシナプス伝達への関わりを1)シナプスの固定、2)イオンプールとしての可能性、3)イオンチャネルとの分子間相互作用という観点から解析し、聴覚伝導のメカニズムの一端を解明する事を目的とした。
    (I)Bral2欠損マウスにおける神経細胞体への影響(大塚・別宮)
    Bral2欠損マウスにおいて、PNNを構成するCSPG複合体構成分子が小脳核では局在できないことがわかっている。この神経核においてシナプスの接着等に何らかの形態的変化がないかを、電子顕微鏡での観察によって詳細に調べた。その結果、Bral2の小脳核において、単位面積当たりにおけるシナプス数が有意に減少していることが確認された。
    (II)Bral2タンパクの発現機構(百田・大橋)
    Bral2は、in situ hybridization等の結果から、mRNA発現神経細胞が投射した先の神経周囲にタンパクを産出していることが示唆されている。この発現機構を調べるために、Bral2のリコンビナントタンパクを神経細胞に発現させ、軸索輸送により投射先にタンパクが発現されるのかを解析したところ、確かに軸策輸送が観察された。軸索輸送に関与していると予測された配列を欠くリコンビナントタンパクも発現させたが、その配列によるものではないという結果が得られた。
    (III)Bral2欠損マウスにおけるCSPG複合体構成分子への影響(別宮)
    Bral2欠損マウスにおいて、聴覚伝導路におけるCSPG複合体構成分子が、各神経核または神経のサブタイプで異なる変化を示すという結果を得た。ブレビカンは、Bral2欠損マウスにおいてPNNパターンを維持できないことから、その局在はBral2に依存していることがわかった。これらCSPGの構成に関して、解析が単純であるランビエ絞輪においてその不均一性を更に解析し、その結果を論文にまとめた。現在印刷中である。

    researchmap

  • Development of cartilage directed multifunctional nano-probes for diagnosis and treatment of osteoarthritis.

    Grant number:22591686  2010 - 2012

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    OOHASHI Toshitaka, NISHIDA Keiichiro, KOMATSU Naoki

      More details

    Grant amount:\4680000 ( Direct expense: \3600000 、 Indirect expense:\1080000 )

    Current research aimed to develop a new multifunctional nano-probes for diagnosis and treatment of osteoarthritis, which will increase according to the acceleration of demographic aging. We could demonstrate the effect of cartilage-specific contrast agent, octaarginine peptide conjugated with DOTA-Gd, in ex vivo and in vivo experiments of rabbit knee joints. While R8-N-TIMP3, designed as a cartilage protective agent, did not show sufficient protective effect in a mouse model of rheumatoid arthritis although it showed in ex vivo tissue culture experiments. Further study is necessary after a prolonged expression of R8-NTIMP-3 in the arthritic knee joints.

    researchmap

  • Development of Imaging Diagnosis for Lymphedema

    Grant number:22659323  2010 - 2011

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Challenging Exploratory Research

    NINOMIYA Yoshifumi, OOHASHI Toshitaka

      More details

    Grant amount:\3230000 ( Direct expense: \2900000 、 Indirect expense:\330000 )

    Current research aimed to establish a new active targeting liposome system for diagnosis of lymphedema, by targeting it to the lymphatic endothelial cell markers. Specific binding of the molecular targeting liposome to cultured lymphatic endothelial cells in vitro and visualization of lymphatic vessels in normal mice were demonstrated. However, we could not establish the measuring system in rat lymphedema model. As for its related technique, we could develop a new liposome encapsulated with colloidal gold which enables both light-and electron-microscopic analysis.

    researchmap

  • Aggrecanase regulation system in osteoarthritis and strategy for early diagnosis and therapy for osteoarthritis

    Grant number:20390399  2008 - 2010

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    HIROHATA Satoshi, NINOMIYA Yoshifumi, NARUSE Keiji, OOHASHI Toshitaka, NISHIDA Keiichiro

      More details

    Grant amount:\19630000 ( Direct expense: \15100000 、 Indirect expense:\4530000 )

    We analyzed ADAMTS9 single nucleotide polymorphism in arthritis patients. We identified the NF-κB binding to the ADAMTS9 promoter. When mechanical stress was loaded to the cells, the expression of ADAMTS1, 4, 5, 9 were differently induced. In addition, COL1A1 was increased and this induction was mediated by integrin. Mechanical stress induced MMP-13 and ADAMTS5 mRNA and two molecules (RUNX-2 and p38MAPK) play important roles.

    researchmap

  • 軟骨基質イメージング用マルチモードプローブ開発による変形性関節症治療の新戦略

    Grant number:20659232  2008 - 2009

    日本学術振興会  科学研究費助成事業  挑戦的萌芽研究

    大橋 俊孝, 西田 圭一郎, 二宮 善文

      More details

    Grant amount:\3200000 ( Direct expense: \3200000 )

    デュアルモードプローブの作製(二宮・大橋)
    20年度の成果に基づき、CSBP(R8)ペプチドに付加するシグナル発生部分の大きさの検討を行なった。蛍光タンパクであるEGFPを付加したR8-EGFPが軟骨基質に浸透可能であったことから、タンパク質量にして30kDa以下のものが、軟骨基質浸透性が良いと判断した。
    さらに、X線吸収性を持つ微小タンパクとして、メタロチオネインを候補とした。pETベクターにMT cDNAを組み込んだコンストラクトを構築し、BE21株に形質転換し、R8-MTタンパクを精製した。タンパク質の安定発現のため、GSTタンパク質との融合タンパクとして発現し、プレシジョンプロテアーゼにより切断後回収するほうが良い結果を得た。しかし、金含有タンパクの精製までには至らなかった。
    MRI検出プローブ作製を同時に進行させた。CSBP(R8)ペプチドに金属器レート剤のDOTAを結合させ、そこにGdを配位させる方法をとった。精製し、マスによる分子量同定を行なった。R8-DOTA(Gd)溶液はTI短縮効果を認めた。
    健常マウスと関節炎モデルマウス関節軟骨のイメージング(大橋・西田)
    イヌ大腿骨頭を摘出し、0.4mM R8-DOTA(Gd)に浸漬させ、1.5T MRIによる造影を行なった。同造影剤を含まない溶液での対照では関節軟骨が造影されなかったが、同し撮影条件で軟骨部の造影ができた。

    researchmap

  • Development of siRNA-eluting stent using PTD-peptide vector

    Grant number:18500364  2006 - 2007

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    OOHASHI Toshitaka, HIROHATA Satoshi, MATSUI Hideki, NIIDOME Takoro, MORI Kohji

      More details

    Grant amount:\4020000 ( Direct expense: \3600000 、 Indirect expense:\420000 )

    1. Coating method for siRNA on stent was examined. As one of the model cases, Glycosminoglycans were bound on the titanium oxide surface. A basic PTD peptide binding to GAGs was determined by QCM method. Further, the uptake of the peptide into the smooth muscle cells from the titanium surface was quantified. However; the uptake amount was not significantly different from the control. We suppose that the peptide could not stably bound on titanium after the cells were seeded.
    2. Various genes are induced by cytokines when the vascular smooth muscle cells proliferate in stent-restenosis. We predicted the ADAM-TS gene, a subfamily of matrix metaroproteinase, expression in this situation. These might be involved in the remodeling in the processes of restenosis. As a result, one of the ADAM-TS gene is upregurated 3-6 hrs after the IL-1 induction. Promoter of the gene contained putative NFAT-binding sites. NFAT inhibitors could suppress the ADAM-TS gene expression, indicating the induction through NFAT. These results might implicate the possible target of siRNA treatment.
    3. Small stent designed in this project was examined in rat Stent implantation was performed in aorta or femoral artery The implantation in aorta is rather successful compared to that in femoral artery. Narrowing the size and increasing the flexibility is required for stenting in the femoral artery

    researchmap

  • びまん性平滑筋腫瘍を来す疾患の原因遺伝子の探索

    Grant number:17659412  2005 - 2006

    日本学術振興会  科学研究費助成事業  萌芽研究

    二宮 善文, 大橋 俊孝, 猶本 良夫, 内藤 一郎

      More details

    Grant amount:\3300000 ( Direct expense: \3300000 )

    Alport-leiomyomataosis(AS-DL)症候群はAlport症候群にみられる諸病変と主に食道に発生する平滑筋病変を合併するX染色体性優性遺伝の疾患であり、その原因として、我々の報告を含めてCOL4A5,COL4A6上流の部分欠損との関連が論じられてきた。岡山大学医学部倫理委員会審査とAS-DL症候群の女性患者本人承諾のもと、患者および長男より末梢血DNAの提供を得、COL4A5,COL4A6遺伝子部分の変異および免疫組織学的解析を行った。昨年度194kbの欠失範囲を大まかに同定した。
    本年度は
    1.新しい症例での194kb deletionからbreak pointを同定した。Break point sequenceからnon-homologous recombinationであると判明したが、反復配列の一種であるLINE elementの関与が示唆された。
    2.消化管基底膜でのCOL4A5,COL4A6発現:悪性腫瘍手術時に摘出される組織の正常部を用い食道、胃、小腸、大腸皮膚基底膜の免疫染色を行った。AS-DLの平滑筋肉腫の多発する食道、胃の平滑筋周囲基底膜には発現しているが、ほかでは陰性と判断した。COL4A5,COL4A6の発現と何らかの有意な関係が推測される。
    3.発現メカニズムについて:本疾患はCOL4A5&6の発現している平滑筋において、その上流部が欠失すると、優性遺伝的に良性平滑筋腫瘍が発生。増殖する。また、多くのアルポート症候群にあるCOL4A5の変異により、α5鎖ペプチドの欠失とα5/a5/a6分子が欠失するにもかかわらず、平滑筋腫瘍は発生しない。これらから、本疾患はコラーゲン分子のLoss of Functionでなく何らかの遺伝子のGain of Function によると考える。本疾患を含めたCOL4A5&6共通欠失部分にインスレータ一結合部位を想定した。インスレーターであるCTCFの結合が推定される配列をその部分に認めた。

    researchmap

  • 脳リンクプロテインによる脳実質ヒアルロン酸-CSPG複合体の機能制御

    Grant number:17046012  2005 - 2006

    日本学術振興会  科学研究費助成事業  特定領域研究

    大橋 俊孝, 別宮 洋子

      More details

    Grant amount:\4400000 ( Direct expense: \4400000 )

    1.Bral2/Haln4ノックアウトマウスの神経周囲網マトリックス分子発現への影響:まず、Northern blottingと免疫組織学的方法でBral2/Hapln4遺伝子発現がないことを確認した。我々は先に発表した論文(Bekku et al.,Mol.Cell.Neurosci.,2003)で、Bral2/Hapln4の神経周囲網(PNN)へのタンパク質局在を報告し、ヒアルロン酸結合型コンドロイチン硫酸プロテオグリカンであるbrevicanとの共局在を示した。Bral2/Hapln4ノックアウトマウスでは抗brevican抗体の神経核でのPNN様の染色性が大きく低下し、diffuseになっていることが確認できた。しかしながら、reticulotegmental nucleus of the pons (RtTg)ではBral2欠損マウスでbrevicanのPNN様の発現パターンが一部のみdiffuseになっていたことから、RtTgにおいてはBral2以外のLPが補償している可能性も考えられる。
    2.PNN形成におけるBral2/Haln4の役割:我々はBral2/Hapln4ノックアウトマウスのBral2/Hapln4遺伝子のエキソンにtauLacZ遺伝子をノックインしている。すなわち、+/-マウスではBral2/Hapln4遺伝子の転写活性に従い、Bral2発現神経軸索をX-gal染色でき、同時にBral2タンパク質は免疫染色できる。脳の神経回路の中でも単純な回路を持つ小脳に焦点を当て発現細胞とタンパク質局在の関係についての情報収集を行った。X-galの染色はtauの発現に依存しており、本来軸索に染まるはずであるが、プルキンエ細胞においては樹状突起もX-galで染色されてしまい、関係を可視化することはできなかった。これは、もともとプルキンエ細胞では樹状突起でもtauが発現しているためであると考えられる。しかしながら、小脳核においてBral2タンパクのみの発現が見られる細胞と、Bral2mRNAとBral2タンパクの両方の発現が見られる神経細胞が存在していた。これはBral2発現神経細胞とBral2タンパクの局在が必ずしも一致していないことを示す。このことから、Bral2mRNAの発現部位とタンパク発現部位が異なっていることがわかり、Bral2mRNA発現細胞の終末でタンパクが発現することが更に強く示唆された。
    またBral2/Hapln4欠損マウスにおいてはbrevicanのPNN様の発現パターンがdiffuseになるという結果を得ている。Bral2/Hapln4は一部の神経回路の神経核に特異的に発現している。Bral2の欠損により、brevican以外のプロテオグリカンのPNNの局在に影響する結果も観察できたが、その度合いは神経核ごとにより異なる。
    Bral2の欠損により各々の会合体破壊がおこることから、ランビエ絞輪周囲あるいは神経周囲膜の細胞外微小環境において特異的会合体形成に必須であることがわかった。

    researchmap

  • Function of newly identified basal lamina structure fractone and regulation of neural stem cell differentiation at subventricular zone

    Grant number:16390048  2004 - 2005

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    NINOMIYA Yoshifumi, YONEZAWA Tomoko, OOHASHI Toshitaka, HIROHATA Satoshi, OHTSUKA Aiji, NAITO Ichiro

      More details

    Grant amount:\14400000 ( Direct expense: \14400000 )

    We analyzed molecular components of the new basement membrane-like structure of capillaries in the brain, fractone. We also tried identification and separation of adult neural stem cells existing subventricular zone, and investigated mechanisms of stem cell differentiation.
    [1]Molecular and cellular analysis of the new basement membrane like structure fractone.
    We detected the basement mambrane molecules such as laminin and type IV collagen in the mouse fractone by immunohistochemistry. Especially, several laminin chains and type IV collagen chains were present in the fractone, but fibronectin was not expressed there. Moreover, the fractone was distributed around almost all of subventricular zone in the brain and spinal code but it was not present in some areas of the third and forth ventricle. Developmental studies showed that the fractone started its expression around subventricular zone at postnatal day seven, and then expression pattern was limited to lateral part of ventricle at postnatal day 14. Furthermore, we recognized the fractone structure more precisely using immunoelectron-microscopic analysis.
    [2]Identification and separation of neural stem cells from subventricular zone
    We tried to separate neural stem cells from adult mouse subventricular zones and allowed them to further differentiate into neurons and astrocytes in various conditions. To set-up differentiation conditions, we prepared substrates rich in matrix macromolecules.
    [3]Control of stem cell differentiation by extracellular matrix
    We successfully culture neurospheres prepared from subventricular zone of the lateral ventricles and set-up conditions to further differentiate into neurons and astrocytes.

    researchmap

  • Toe role of novel aggrecanase in rheumatoid arthritis and its diagnostic potential

    Grant number:15390459  2003 - 2004

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    HIROHATA Satoshi, NINOMIYA Yoshifumi, OOHASHI Toshitaka, YONEZAWA Tomoko, NISHIDA Keiichiro

      More details

    Grant amount:\15000000 ( Direct expense: \15000000 )

    1 Expression analysis of novel aggrecanase
    RNA was extracted from IL-1 b stimulated chondrosarcoma cells and chondrocytes and the aggrecanase expressions were analyzed by quantitative RT-PCR. When compared with fibroblasts, chondrosarcoma cells and chondrocytes showed higher induction of novel aggrecanase, thus indicating this novel aggrecanase is IL-1 induced specifically in cartilage cells. When chondrosarcoma cells were stimulated with IL-1b and TNFa, novel aggrecanase induced synergistically.
    2 Antibody against novel aggrecanase
    We raised a polyclonal antibody against novel aggrecanase, and checked its specificity by Western blotting. A novel aggrecanase was induced by IL-1b stimulation by Western blot analysis.
    3 KO mouse
    We got hetero mice
    4 Signal mechanism for novel aggrecanase induction
    MAP kinase inhibitor(PD98059,SB203580) were added to IL- 1b stimulated chondrosarcoma cells and the signaling pathway was determined.

    researchmap

  • Molecular biological and electrophyrsiological studies of extranodal matrices on the saltatory conduction of the optic nerve

    Grant number:15591857  2003 - 2004

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    OOHASHI Toshitaka, NINOMIYA Yoshifumi

      More details

    Grant amount:\3500000 ( Direct expense: \3500000 )

    The Bral1/Hapln2 proteins are expressed specifically at the nodes of Ranvier in the central nervous system and supposed to be important for the maintenance of matrix molecules by stable binding on the hyaluronan. To explore the role of the extranodal matrices on the saltatory conduction, we analyzed the Bral1/Hapln2 knockout mice.
    1.Immunohistochemical and electronmicroscopic analysis
    There was no obvious alteration on the formation of paranodes, which is consisted of glial cell (oligodendrocyte) and neuron (axon) interactions. There was also no obvious effect on the clustering of Na+ channels, which is essential for the production of action potentials and propagation of the signals.
    2.Electrophiological analysis
    However, when we compared the speed of propagation of action potentials on the optic nerves via electrophysiological measurement, there was a significant difference between wild type and Bral1/Hapln2 deficient mice. To figure out those differences, we investigated further the differences of the extranodal matrices as well as the attachment of the endofoot of astrocyte at the node. We could find the mislocalization of several ECM molecules including versican (a chondroitin sulfate proteoglycan), tenascin-R and others in the Bral1/Hapln2 deficient mice. During those analyses, we could find one ECM molecule, which has not reported so far to localize at the nodes of Ranvier, is colocalizing and stabilized with Bral1/Hapln2. Nevertheless, there was no obvious difference of the attachment of the endofoot of the astrocyte.
    3.Possible physiological roles of the extranodal matrix
    Collectively, there was no obvious difference in formation of paranodes and astrocyte foot process via glial and neuronal cell interactions. We could only observe the difference in the formation of the structure of extranodal matrices. Therefore, we assume that the complex of matrix molecules consisting of chondroitin sulfate proteoglycans and other glycoprotein is contributing to the maintenance of the microenvironment around the nodes. Possibly, it can serve as a Na+ ion-pool, which is important for generating the action potentials via influx through the voltage dependent Na+ channels at the nodes.

    researchmap

  • 脳リンクプロテインによる脳実質コンドロイチン硫酸プロテオグリカン複合体の機能制御

    Grant number:15040215  2003 - 2004

    日本学術振興会  科学研究費助成事業  特定領域研究

    大橋 俊孝, 二宮 善文

      More details

    Grant amount:\3500000 ( Direct expense: \3500000 )

    1.Bral1/Hapln2ノックアウトマウス解析:ランビエ絞輪外マトリックス分子は傍絞輪形成やNaチャンネルのクラスター化には影響を与えないが、絞輪外のマトリックス環境には大きな変化をもたらす。これらの形成分子はランビエ絞輪外に局在するヒアルロン酸に依存するものであり、それをさらに安定化するものとしてBral1/Hapln2が重要な役割をはたす。
    2.Hapln3/Lp3の脳実質での発現解析:Haplnの中で発現解析の最も遅れていたHapln3について、特異的抗体作製を行い、その抗体を用いてマウス成体脳での発現解析を行った。脳実質での発現は認められないが、ある程度の大きさの動静脈の平滑筋周囲にversicanと共発現しているものである。脳実質瘢痕形成時などの病態での発現は不明であるが、この結果、正常マウス成体脳実質での主なHapln遺伝子はHapln2,Hapln4となる。
    3.Bral2/Hapln4ノックアウトマウス作製:前年度までに行った我々の実験からBral2/Hapln4は神経特異的で、神経細胞周膜とよばれるマトリックスを構成する分子の1つであることが明らかとなった。本年度の研究計画としてBral2/Hapln4ノックアウトES細胞の樹立とノックアウトマウス個体の作製を目標とした。ES細胞の樹立、キメラマウス個体の作製は順調に行われたが、野生型マウスとの交配による、生殖系列マウスの作製に時間をとり、なかなか生殖系列の完成が成功しなかった。現在、交配による複数の♀からF1世代マウスが出産したところである。+/-マウスの存在がこの中に期待される。
    4.マウス以外のHapln遺伝子解析モデル動物解析について:前年度我々は、発生期におけるHapln遺伝子および関連コンドロイチン硫酸プロテオグリカン遺伝子の機能解析モデルとして、ゼブラフィッシュを用い遺伝子クローニングと発現解析、遺伝子停止(ノックダウン)実験をversican, dermacan, aggrecanを題材に行った。さらに、今年度はHapln1/Crtl1遺伝子クローニングと発現解析をおこない、Hapln1/Crtl1遺伝子はマウス等と同様に胎生期脳に発現していることを確認した。ゼブラフィッシュの特色を生かしたモデル動物になりうることを試行した。具体的には、モルフォリノによるノックダウンのほかに、トランスジェニックフィッシュ作製が有効手段となることを確認した。
    以上のように、いくつかの遺伝子学的手法により、脳に発現するHapln遺伝子の機能解析が進んだ。

    researchmap

  • Function of subendothelial basement membranes in Blood-Brain Barrier

    Grant number:14370434  2002 - 2003

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    NINOMIYA Yoshifumi, HIROHATA Satoshi, OOHASHI Toshitaka, YONEZAWA Tomoko, OHTSUKA Aiji

      More details

    Grant amount:\14100000 ( Direct expense: \14100000 )

    We report the molecular cloning of a new member of the transmembrane-type immunoglobulin superfamily and designate the encoded protein as limitrin since it selectively localized to glia limitans in mouse brain. Limitrin cDNA was obtained using a subtractive hybridization procedure designed to identify molecules responsible for blood-brain barrier function. Western blots using a limitrin-specific antibody demonstrated that the gene product is expressed significantly in mouse brain and primary murine astrocytes, and is distributed in the plasma membrane. Immunohistochemical studies using confocal and electron microscopy clearly demonstrated highly polarized localization in astroglial endfeet in the perivascular region and under the pia mater in vivo. Limitrin is expressed in spinal cord and many areas of the brain but not in the median eminence or subfornical organ (the circumventricular organs) where the blood-brain barrier is lacking. Disruption of the blood-brain barrier by cold injury resulted in a drastic reduction in limitrin expression. Furthermore, during retrieval from cold injury the increased expression of limitrin in perivascular endfeet correlated with the recovery of angiogenesis in capillaries within the lesion margins. Our results suggest that limitrin is physically and functionally associated with the blood-brain barrier, implying that this protein may be useful as a diagnostic determinant of barrier integrity.

    researchmap

  • がん特異的遺伝子導入法を用いた血管新生阻害治療の試み

    Grant number:14030056  2002

    日本学術振興会  科学研究費助成事業  特定領域研究

    廣畑 聡, 大橋 俊孝

      More details

    Grant amount:\6400000 ( Direct expense: \6400000 )

    本研究の目的は、がん休眠療法の遺伝子治療の開発である。IV型コラーゲンα3鎖のNC1ドメインは、tumstatinとも呼ばれ、血管新生阻害作用を持つことが報告されている。しかしながらIV型コラーゲンα3鎖のNC1ドメインを治療に利用するにあたっては、同部位がGoodpasture症候群の自己抗原認識部位であることから、がん特異的な遺伝子発現が重要と考えられた。
    そこでhTERT(ヒトテロメラーゼ遺伝子)のプロモーター領域を組み込んだベクターにIV型コラーゲンα3鎖のNC1ドメインを下流に位置することにより、がん細胞特異的遺伝子導入法を試みた。コントロールとして、LacZをいれたベクターによる検討では、hTERTの発現がない細胞である正常内皮細胞には、観察しえた限りではX-gal染色は見られなかった。内皮細胞の他に心臓由来線維芽細胞を用いた実験でも同様の結果が得られた。がん細胞(PC-3,DU145)においてのみ、LacZの発現が見られた。この結果は、CMVベクター下にLacZを挿入した(細胞特異性がない)ものを用いたものと比較して著しい差は認められなかった。
    NC1ドメインの遺伝子発現効率は、LacZ細胞とほぼ同等であると考えられたが、タンパクレベルの発現は充分なものではなかった。血管新生阻害効果を治療応用するには、発現効率を高めることが必須であり、アデノウイルスを用いた新しい発現カセットを作成が重要と考えられた。

    researchmap

  • Identifying new aggrecanase and producing antibody and gene-targeting mouse

    Grant number:13470312  2001 - 2002

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    HIROHATA Satoshi, YONEZAWA Tomoko, OOHASHI Toshitaka, NINOMIYA Yoshufumi, MOMOTA Ryusuke

      More details

    Grant amount:\14000000 ( Direct expense: \14000000 )

    To investigate new aggrecanase, we have done the following experiments and got some data.
    1) Various ADAMTS-specific primers were designed and RT-PCR was performed. We cultured human chondrosarcoma cell lines OUMS-27 (Okayama University Medical School-27) and stimulated with interleukine-1 beta (IL-1β). To determine gene expression quantitatively, we employed real-time RT-PCR method. Briefly, total RNA was extracted and then DNAse treatmeat was done to eliminate contaminating genomic DNA. After reverse transcribed with random primers and enzymes, cDNA was served as a template for RT-PCR. GAPDH was used for the internal control.
    2) The expression and gene regulation by IL-1β was different amonf the ADAMTS-1,4, and -5, which were reported to have aggrecan cleaving property in vitro. We also investigated other ADAMTS gene expressions.
    3) We identified another up-regulating ADAMTS gene by IL-1β in OUMS-27 cells. We raised polyclonal antibody against this new ADAMTS gene using peptide sequence of this ADAMTS.
    4) We also started to making knock-out mouse for this gene. We screened mouse genomic library and identified several clones including this new ADAMTS gene. Under the collaboration with Dr. Apte's lab in the USA, we started to put our clones to ES cells.

    researchmap

  • ADAMTSによるアミロイド前駆体蛋白のプロセッシングと細胞外基質への影響

    Grant number:13877097  2001 - 2002

    日本学術振興会  科学研究費助成事業  萌芽研究

    廣畑 聡, 米澤 朋子, 大橋 俊孝, 二宮 善文, 百田 龍輔

      More details

    Grant amount:\2000000 ( Direct expense: \2000000 )

    ADAMファミリーのうち、ADM-10とADAM-17はαセクレターゼ機能を持つことが知られているが、ADAMTSが同様な機能を持つか検討した。
    まず、基礎的実験としてADAMTS-1はその遺伝子発現がリポポリサッカライド刺激により、各臓器において発現が上昇することから炎症において何らかの役割を持つことが示唆されている。そこで、ラット実験的心筋梗塞モデルを用いてADAMTS-1の発現形式をノーザンブロット法にて検討した。ADAMTS-1は非梗塞心臓では弱い発現しか認めなかったが、梗塞心においては、梗塞後6時間でその発現が大きく上昇していた。
    マウス脳におけるADAMTSの発現をADAMTS-1〜7において検討したが、いずれもそれほど強くなかった。海外共同研究として、アミロイド前駆体蛋白を強制発現し、恒常的に発現する細胞株を樹立している、アラバマ大学Fukuchi教授らと共同実験を開始した。同細胞株は、通常の神経系細胞よりも過剰にアミロイド前駆体蛋白を発現している。これまでの検討によって過剰なアミロイド蛋白前駆体が細胞表面及び培養上清中に存在することが確認された。この実験系において過剰なアミロイド前駆体の切断がαセクレターゼによって制御されているかどうかを検討する目的でこの細胞系におけるαセクレターゼ発現の検討を開始した。実験の条件検討が複雑であり、切断の確認は困難であった。今後は、In vivoの系における実験系の確立およびアルツハイマー脳におけるADAMTSの発現解析が重要と考えられた。

    researchmap

  • 精神分裂病原因候補遺伝子としての脳特異的新規リンクモジュール遺伝子解析

    Grant number:13877151  2001 - 2002

    日本学術振興会  科学研究費助成事業  萌芽研究

    大橋 俊孝, 氏家 寛, 二宮 善文

      More details

    Grant amount:\2000000 ( Direct expense: \2000000 )

    1.第1染色体に連鎖する精神分裂病患者家系の検索
    本邦では遺伝子連鎖解析のための精神分裂病家系のDNAサンプル集めは実質的に困難であり、多くの家系を持つ海外の研究室との共同研究を試みた。Peltonenらの持つフィンランド人精神分裂病家系において第1染色体に連鎖する家系があるかどうか共同研究として検索を行ってもらった。その結果1番染色体長腕上に2つの遺伝子マーカーに連鎖する2家系を同定した。それらは染色体1q32-q42の範囲内に位置するため、本プロジェクトのBRAL1,BCAN両遺伝子は除外されたが、第1染色体上にも精神分裂病家系の連鎖する座位が複数存在することを示し、引き続き他の精神分裂病家系の連鎖解析を行うことの重要性を示唆している。
    2.BRAL遺伝子の発現解析
    マウスで相同遺伝子Bral1をクローニングし、さらにBral1特異的抗体を作成することによりその発現を詳細に調べた。その成果は論文化(Mol.Cell.Neurosci.)することが出来た。Bral1 mRNAは神経細胞が発現しており、そのタンパク質の発現は中枢神経ランビエ絞輪に局在していた。さらにその局在はヒアルロン酸(HA)結合型コンドロイチン硫酸プロテオグリカンのversican V2とcolocalizeすることを示した。ランビエ絞輪は神経の活動電位の発生と跳躍伝導に重要であることが知られている。我々はBral1が絞輪の細胞外部において、陰性に荷電したヒアルロン酸にversicanコアプロテインを固定し、電位依存性NaチャンネルによりNaイオンが細胞内外に出入りし活動電位を生ずるための細胞外環境を整えている役割をしていると考えている。以上の内容は学会・シンポジウムにも取り上げられ議論された。
    リンクモジュール遺伝子に共通したモチーフを指標として、新規リンクモジュール遺伝子である脳リンクプロテインBral2遺伝子をクローニングした。マウスBral2のmRNA, proteinレベルの詳細な発現解析と免疫組織化学的解析より、Bral2は神経核においてbrevicanと共存し、その機能維持に重要であることを見い出した。これは本年度日本生化学会において報告された。

    researchmap

  • Molecular biological studies of Ten-m2 gene function for the olfactory sensory neuron projections

    Grant number:12470356  2000 - 2001

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    OOHASHI Toshitaka, YONEZAWA Tomoko, NINOMIYA Yoshifumi

      More details

    Grant amount:\14700000 ( Direct expense: \14700000 )

    To investigate the function of ten-m2/Neurestin gene for the olfactory sensory neuron projection, we have done the following experiments and got some data.
    Ten-m2 specific antibodies were raised using the C-terminal unique amino acid sequence among the ten-m family. The specific staining was confirmed in the mouse section and confirmed its embryonic expression in combination with in situ hybridization.
    Detection of Ten-m2 ligand: The extracellular domain of Ten-m2 protein was expressed in HEK293 cell culture system. We could detect specific protein band in the SDS-PAGE which bound to the ecto-domain. We are now identifying the protein.
    Chromosomal mapping of human ten-m2 gene. The ten-m2, 3, and 4 genes were mapped to the chromosome 5, 4and 11, respectively. There was no genetic disorder reported to the locus.
    Phenotypic analysis of the ten-m2 knockout mouse: By introducing a neomycin expression cassette in to the transmembrane exon of type II transmembrane protein, ten-m2, ten-m2 null mice were generated. There was no obvious phenotype so far. Ten-m2 null mice were viable and fertile, had a normal life span. There could be some compensation by another ten-m family members. The olfactory neuronal axon is now stained with MBP, marker of myelin and observed carefully.
    Another approach to look for the ligand for ten-m2: The ten-m protein seems to be quite unique for its protein structure. Structural analysis will become a very important information to search the ligands. Ultrastructural analysis of recombinants revealed the dimerfomation through the disufide-bond. The dimer could be formed between the different members of ten-m family in our reconstitution experiments. Since CSPGs are known to act for the axon guidance, and the versican is expressed in the olfactory bulb, we tried to clone some related genes. The Brain link protein is cloned and the expression pattern was analyzed. The data for the novel link protein is published (see references).

    researchmap

  • Functional Analysis of Basement Membrane Collagen Genes

    Grant number:11694280  1999 - 2001

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    NINOMIYA Yoshifumi, YONEZAWA Tomoko, MOMOTA Ryusuke, OOHASHI Toshitaka

      More details

    Grant amount:\8200000 ( Direct expense: \8200000 )

    By analyzing Col4a knockout mice, it is now possible to predict the biological function of α(IV) chains in vivo. We have now knockout mice of two strains: col4a3 and col4a6. Since we have evidence that there are major three molecular forms in basement membranes: (α1)2α2, α3α4α5, and (α5)2α6, it is now possible to set-up experiments to presume in vivo function of several α chains. We also set-up international collaboration to create another new project of gene targeting for col4α1 or col4α2, which makes it possible to make mice without type IV collagen.
    We have solved problems of which of the 6 α(IV) chains can make molecules. We raised monoclonal antibodies specific for α(IV) chains. By using these 6 antibodies, we came to the conclusion that there are at least three molecular forms as mentioned above: (α1)2α2, α3α4α5, and (α5)2α6. New biochemical analysis using antibodies that recognize native chains made possible to immunoprecipitate specific molecules when they are digested by pure bacterial collagenase. The products run on SDS-PAGE were analyzed by other monoclonal antibodies that recognize now denatured α-chains by Western blots. This now method concluded that our prediction from immunocytochemistry was indeed true. In other words, there were three (α1)2α2, α3α4α5, and (α5)2α6 molecules. By this method, we analyzed basement membranes from renal glomeruli and bladder and aortic smooth muscle cells.
    Specialized basement membrane from glomeruli was analyzed to contain supramolecular aggregates of (α1)2α2 and α3α4α5 molecules. The function of it is to filter blood to create urine. The similar phenomenon is found in choroid plexus in the brain. We analyzed it and found that it contains also the same compositions as glomerulus.

    researchmap

  • Inhibitory mechanism of vascular endothelial cell proliferation by endostatin

    Grant number:11470274  1999 - 2001

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    NINOMIYA Yoshifumi, YONEZAWA Tomoko, MOMOTA Ryusuke, OOHASHI Toshitaka

      More details

    Grant amount:\13900000 ( Direct expense: \13900000 )

    Under low oxygen condition, expression of collagen XVIII gene by cultured vascular endothelial cells reduced significantly. When it was analyzed by specific monoclonal antibodies, the collagen XVIII protein level was also reduced.
    Endostatin induced regression of chondrosarcoma growth and tumor angiogenesis in vivo. However, endostatin showed no effects on the proliferation and migration of chondrosarcoma cells in vitro. Next, we investigated the interactions between endostatin and endothelial cells in detail. Endostatin inhibited the migration and attachment on collagen I but did not affect proliferation of endothelial cells. Although the migration of endothelial cells was stimulated with angiogenic factors such as basic fibroblast growth factor and vascular endothelial growth factor, endostatin showed similar inhibitory effects on it in the presence or absence of stimulants.
    We came to the conclusion that non-vascular BMs contain predominantly one of the two types; I.e., subepithelial basement membranes contained type XVIII in general, whereas skeletal and cardiac muscles harbored prominently type XV. But basement membranes surrounding smooth muscle cells in vascular tissues contained one or both of them, depending on their locations. Interestingly, continuous or somatic capillaries contained both type XV and type XVIII collagens in their basement membranes; however, fenestrated or specialized capillaries such as glomeruli, liver sinusoids, lung alveoli, and splenic sinusoids expressed only type XVIII chains in their basement membranes, lacking type XV chain. This observation could imply different functions of basement membranes in various tissues and organs that use different mechanisms for the endogenous control of angiogenesis.

    researchmap

  • 新生血管の構築と基底膜コラーゲンの新しい機能

    Grant number:11877121  1999 - 2000

    日本学術振興会  科学研究費助成事業  萌芽的研究

    二宮 善文, 米澤 朋子, 百田 龍輔, 大橋 俊孝, 植木 靖好

      More details

    Grant amount:\2000000 ( Direct expense: \2000000 )

    1 血管系特に毛細血管全体におけるXVIIIコラーゲンおよびXVコラーゲン遺伝子の発現
    両コラーゲンは内皮細胞直下基底膜と血管壁に存在する平滑筋細胞周囲の基底膜であることがわかった。毛細血管内皮細胞下基底膜ではXVIII型とXV型を共通に発現するものが認められる.即ち腎や小腸粘膜、皮膚の毛細血管の内皮細胞下基底膜はXVIII型/XV型両者が共存する.しかしこれは組織臓器により異なり、肺胞壁、肝類洞、糸球体基底膜はXVIII型が主であり、他方胎盤、心臓、骨格筋、小腸筋層ではXV型が主であった.しかし、XVIII型/XV型両者の発現のない毛細血管は認められなかった.このように、毛細血管内皮細胞下基底膜のXVIII型とXV型の発現には多様性がある、XVIII型とXV型ともに発現するものが基本だが、類洞や糸球体基底膜のように特殊化した毛細血管ではXVIII型が優位に発現された.
    2 基底膜IV型コラーゲンの新しい機能
    IV型コラーゲンのα鎖は6種類あり、中央にコラーゲン部分、N末(NC2ドメイン)とC末(NC1ドメイン)に非コラーゲンドメインを有する。私達は、これらの6種類のα鎖のNC1ドメインをリコンビナントで作製し、これらを用いて血管内皮細胞の接着性と走化性をみたところ、α2、α3、α6鎖NC1ドメインにそれを抑制する活性が認められた。さらに、血管内皮細胞の接着と走化性はインテグリンαvβ1依存性であることが分かった。鶏胚の系(CAMアッセイ)でbFGFによって誘導された血管新生が、明らかにコントロールとくらべて優位に、リコンビナントα2、α3、α6鎖NC1ドメインによって抑制されるという結果を得た。このことは初めての報告であり、IV型コラーゲンの断片に新しい機能があることが明らかになったという意味で意義のある発見である。

    researchmap

  • Reconstruction of basement membranes aiming at artificial organs

    Grant number:10557113  1998 - 2000

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B).

    NINOMIYA Yoshifumi, YONEZAWA Tomoko, MOMOTA Ryusuke, OOHASHI Toshitaka

      More details

    Grant amount:\12900000 ( Direct expense: \12900000 )

    Ultimate goal of the research project is to make artificial organs to insert basement membrane materials between epithelial layers and extracellular matrix. In order to make type IV collagen molecules in vitro, we we did the following investigations :
    * Molecular composition of basement membranes underneath smooth muscle cells varies in different organs, which could be related to specific function of the individual organs.
    * We first isolated and characterized genomic DNA fragments that cover the 5'flanking sequences of COL4A3 and COL4A4 genes, which provided information to delineate the promoter activity for the tissue-specific expression of the six type IV collagen genes.
    * Molecular forms of collagen IV in follicle basement membranes are different in development.
    * We identified interactions between the α2(IV) and ProMMP-9 by immunoprecipitations and blotting.
    * Basement membrane collagen IV molecules diminish in parallel with malignancy and invasiveness when analyzed in tumor progression.
    * Although mRNA expression level of α5 decreased in kidney of a canine Alport case, that of α6 resulted in unchanged. But the protein level of both chains cannot be found any. These results suggest a possibility of a molecular form of α5/α6.
    * Differential expression of collagen IV genes in epithelial basement membranes was analyzed in detail.
    * Here we define a novel function for soluble non-collagenous (NC1) domains of the α2(IV), α3(IV), and α6(IV) chains of human collagen type IV in the regulation of angiogenesis and tumor growth. These NCI domains were shown to regulate endothelial cell adhesion and migration by distinct αv and β1 integrin-dependent mechanisms.
    * In Lmx1b(-/-) mice, expression of both α3 and α4 is strongly diminished in GBM, whereas that of α1, α2 and α5 is unchanged. Moreover, LMX1B binds specifically to a putative enhancer in intron 1 of mouse/human COL4A4 and upregulates reporter constructs containing the enhancer-like sequence.

    researchmap

  • 軟骨細胞分化を誘導する因子のクローニングに関する研究

    Grant number:10877227  1998

    日本学術振興会  科学研究費助成事業  萌芽的研究

    二宮 善文, 植木 靖好, 百田 龍輔, 大橋 俊孝

      More details

    Grant amount:\2000000 ( Direct expense: \2000000 )

    本研究は、肢芽発生過程において、軟骨新生を誘導する分化機構を分子の変化として捉えるために、軟骨分化誘導因子をクローニングすることを目的として、現在までに鶏胚の肢芽Stagc20(間葉系細胞)とStage24(軟骨細胞系)からmRNAを抽出し、前者からcDNAライブラリーを作製、後者から引き算し、残りのcDNAをPCRで増幅することにより前者に陽性であって後者に陰性であるクローンを選び出し、これらのクローンについて、そのポリペゾチド構造、遺伝子構造と発現様式を検索し、性質を調べ、軟骨を誘導する機能を有するか否かを調べてきた。取得クローンについて:1)間葉系細胞mRNAと軟骨細胞系mRNAを用いたノザンプロット、2)データーベースによる既報の情報の入手、3)重複久ローン単離により翻訳部位のアミノ酸配列、4)鶏胚全身in situハイブリダイゼーションによる発現パターンの検索、を行ってきた。間葉系細胞と軟骨細胞RNAを抽出し、引算ハイブリダイゼーションPCR法によって、前者に陽性であって後者に陰性であるcDNAクローンを選び出した結果、このなかで興味ある発現パターンを示すいくつかのクローンについて重点的に、ポリペプチド構造と発現部位の同定、他の軟骨特異的遺伝子群との発現時期の比較、等の性質を詳細に検討してきた。得られた複数のクローンが間葉系細胞RNAに強くハイブリダイズし、これらのなかに間葉系細胞を軟骨へと分化を誘導する因子が含まれていることを示唆した。

    researchmap

  • Molecular Mechanism of Esophageal Diffused Leiomyomatosis

    Grant number:09671309  1997 - 1998

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    OOHASHI Toshitaka, UEKI Yasuyoshi, MOMOTA Ryusuke, NINOMIYA Yoshifumi

      More details

    Grant amount:\3000000 ( Direct expense: \3000000 )

    We have investigated the molecular mechanism of diffused leiomyomatosis and the relationship of type IV collagen and smooth muscle cells differentiation and proliferation.
    We identified a DL/AS deletion and first characterization of the break point sequences. The results showed that the breakpoints share the same sequence, which is in turn closly homologous to the consensuses of topoisomerase I and II.The results implicate the genomic rearrangement responsible for the DL/AS phenotype and raise the possibility that there might be a third gene in interveaning sequence III that is involved in the regulation of smooth-muscle-cell proliferation.
    We have generated col4a6 null mice by introducing Neo^r gene into exon2 of col4a6 gene. The mice are fertile and did not show any obvious phenotype. Neither diffused leiomyomatosis in esophagus nor other tumors in smooth muscle organ were found in the mice which lived more than one year. This result exclude the possibility that deletion of col4a6 gene is a cause of DL.
    We are now investigating other possibilities by mating the col4a6 null mice and a transgemic mice which contains the partial genomic fragment delived5 from DL/AS patient. Also exon trapping was performed using a BAC contig which covers huge intron 2 of COL4A6 gene. These study were particularly relevant to the understunding of DL pathogenesis and its etiology.

    researchmap

  • Analysis of specific gene expression of V/XI collagen genes in chondrocyte and non-chondrocyte

    Grant number:09671497  1997 - 1998

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    YOSHIOKA Hidekazu, MATSUO Noritaka, SHIRABE Koumei, MOMOTA Ryusuke, OOHASHI Toshitaka, NINOMIYA Yoshifumi

      More details

    Grant amount:\3200000 ( Direct expense: \3200000 )

    We isolated the 5' flanking region of mouse alphal(XI) collagen gene. As seen in human gene, this promoter has several transcription start sites. Comparison of the sequence of the promoter with consensus regulatory elements showed that there was no TATA or CCAAT box, and that there were several potential Sp1 binding sites.
    Two promoter fragments , 617 bp (short promoter) and 5 kb (long promoter) in size, sharing the same 3 end were subcloned in the upstream of luciferase. And three Sma fragments, 3.5 kb, 3.0 kb and 7.0 kb in the first intron were subeloned in the downstream of the these constructs. We transfected the DNAs into bovine aorta smooth muscle cells ad human chondrosarcoma cells. The luciferase activity of short promoter fragment was higher than that of long promoter in both cells. Three fragments of first intron seemed to depress the activity of promoter.
    To analyze alternative splicing in the acidic region, we made mini genes for the deletion of exon 6A, 6B, 7, 8 and 6A-8, respectively. We transfected these genes in 204 (rhabdomyosarcoma cell), RCS (rat chondrosarcoma) and 293 (kidney cell). In 293 cell, the exon 6A-7-8 is main splice form, and exon 6B is not expressed. In 204 cell, exon 6A-7-8 is the abundant splice form while 7-8 is also present. In the RCS cell, five splice forms are present. In order to analyze the function of the acidic domain in vivo, we have also begun engineering the gene targeting constructs for the deletion of exon 6A and 6B.

    researchmap

  • Functional Analysis of Collagen IV by Gene Targeting

    Grant number:09044308  1997 - 1998

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for international Scientific Research

    NINOMIYA Yoshifumi, MOMOTA Ryusuke, OOHASHI Toshitaka, REINHARD Faessler, CORD Brakebusch, ATTILA Aszodi

      More details

    Grant amount:\5100000 ( Direct expense: \5100000 )

    Col4a6 null mice were created by introducing NeoィイD1RィエD1 gene into exon II of col4a6 gene. We analyzed if the gene is transcribed and translated into α6(IV) polypeptide by in site hybridization, Northern-blot hybridization, and immunohistochemical staining using α chain-specific monoclonal antibodies. The results demonstrated that the α6(IV) polypeptide was not stained at all in any tissues or organs in col4a6 null mice. We also analyzed if the mice have some phenotypes, but we have not detected ant differences between wild type and col4a6 null mice so far.
    We predicted the presence of the three molecular forms of type IV collagen ; [α1(IV)]2α2(IV), α3(IV)α4(IV)α5(IV), and [α5(IV)]2α6α(IV) by use of double staining of the monoclonal antibodies specific for α(IV) chains. The [α1(IV)]2α2(IV) form is present in all basement membranes, whereas the α3(IV)α4(IV)α5(IV) form is localized in glomeruler and alveolar basement membranes and the [α5(IV)]2α6(IV) form is in the Bowman's capsules of the kidney and dermal basement membrane regions. Heterogeneous distribution of the three molecular forms indicated that they may have specific roles in different basement membranes. To describe the biological roles of the molecules, we should think of how the three molecules are incorporated into the supramolecular aggregates of each basement membrane.
    We identified and characterized the breakpoint sequences of the deletion of DNA from a patient of diffuse leiomyomatosis associated with Alport syndrome. The results demonstrated that a deletion eliminates the first coding exon of COL4A5 and the first two of COL4A6. They also showed that the breakpoints share the same sequence, which is in turn closely homologous to the consensuses of topoisomerases I and II. Additional DNA evidence suggested that the male patient is a somatic for the mutation. This study is greatly relevant to the understanding of DL pathogenesis and its etiology.

    researchmap

  • Supramolecular Assembly and Function of New Basement Membrane Collagen Molecules

    Grant number:08457154  1996 - 1997

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    NINOMIYA Yoshifumi, MOMOTA Ryusuke, OOHASHI Toshitaka, YOSHIOKA Hidekatsu

      More details

    Grant amount:\8800000 ( Direct expense: \8800000 )

    To characterize the structure of mouse col4a6 gene, we screened mouse 129 genomic library and isolated a fragment of TSg6, approximately 18.3kb in size. Fine analysis of the genomic fragment and comparison of the structure to that of the cDNA revealed that alternative transcripts that are observed in the human gene do not exist when the mouse is transcribed. In order to create null mouse for col4a6 gene, we manipulated genomic fragment and inserted NcoR gene into the exon 2 of col4a6 gene. The vector was transfected into the R1-Es cells derived from 129v mouse and positive ES cells screened by G418. The positive ES cells were inserted into blastocysts, then the blastocysts were moved uterus of pseudopregnant mice. Chimera mice, heterozygotes and homozygotes are now being checked if any phenotypes are noticed. When homozygote mice were stained by a6 specific monoclonal antibodies, no positive signals was obtained from any tissues, indicating that a6 polypeptide is not expressed in the mice.
    While collagen IV molecules composed of alpha1 and alpha2 chains are broadly distributed, molecules comprising combinations of the other four chains, alpha3-alpha6, are important components of specialized basement membranes. The precise chain composition of triple-helical molecules assembled from the alpha3-alpha6 chains is not entirely clear, but it is hypothesized that alpha3-alpha5 chains and alpha5 and alpha6 chains form heterotrimeric molecules. Several pieces of evidence indicate that alpha3/alpha4/alpha5 molecules and alpha5/alpha6 molecules are components of the basement membrane network.
    We identified an DL/AS deletion and determined the breakpoint wequences of the Japanese case. The results demonstrated that a deletion clininates the first coding exon of COL4A5 and the first two of COL4A6. They also showed that the breakpoints share the same sequence, which is in turn closely homologous to the consensuses of topoisomerases I and II.Additional DNA evidence suggestetd that the male patient is a somatic mosaic for the mutation. Immunohistochemical analysis using alpha chain-specific monoclonal antibodies supportedthis conclusion in that they revealed the absence of the alpha5 (IV) and alpha6 (IV) collagen chains in most but not all of basement membranes of the smooth muscle cell tumor. This study is greatly relevant to the understanding of DL pathogenesis and its etiology.

    researchmap

  • 血液脳関門をマトリックスの分子構築として理解する試み

    Grant number:08877223  1996

    日本学術振興会  科学研究費助成事業  萌芽的研究

    二宮 善文, 百田 龍輔, 大橋 俊孝

      More details

    本研究は、選択的透過性を有する脳血液関門がアストロサイトから分泌されるシグナルによって、基底膜を産生する内皮細胞に影響を及ぼし、脳以外の毛細血管周囲基底膜と異なる分子構成による超分子会合体が作り上げられているという考えに基づいて、血液脳関門の本能が細胞外マトリックス分子と細胞間の相互作用で説明することにある。具体的に以下の結果を得た。
    1)脳毛細血管と脳以外の毛細血管(腸間膜)よりRNAを抽出した。これを無細胞系のタンパク翻訳を行うと、多くのポリペプチドが共通のバンドとして認識されるが、一方で、確かにいくつかのペプチドが異なっていることがわかった。これらのバンドが異なる超分子会合体を構成している可能性がある。
    2)ヒト脳毛細血管と脳以外の毛細血管について、α1(IV)-α6(IV)コラーゲン鎖に対する特異的モノクローン抗体を用いて蛍光染色すると、α1(IV)鎖とα2(IV)鎖の存在が明らかになった。脳毛細血管と脳以外の毛細血管について、α(IV)鎖の分布の差は特に認められなかったが、現在さらに詳細の解析を行っている。
    3)脳毛細血管と脳以外の毛細血管より抽出したRNAを鋳型にして、種々のプライマーを用いてDifferential display法を行い、いくつかの異なるバンド認められたので、現在これらをクローニングしている。

    researchmap

  • 肺胞基底膜のIV型コラーゲンの分子種と遺伝子発現

    Grant number:08877098  1996

    日本学術振興会  科学研究費助成事業  萌芽的研究

    百田 龍輔, 吉岡 秀克, 大橋 俊孝

      More details

    Grant amount:\1900000 ( Direct expense: \1900000 )

    今年度、我々の研究は以下のような進展が見られた
    1)IV型コラーゲンα4遺伝子転写産物の発現について
    IV型コラーゲンα4の遺伝子転写産物に関して、我々のこれまでの結果から第1エキソンの異なる2つの転写産物(1と1')が存在することがわかっているが、Northern blot法と定量的RT-PCR法によって、これらの転写産物をそれぞれ独立に検出する系を確立することに成功した。
    これによりIV型コラーゲンα4遺伝子転写産物の発現について、以下のような知見を得た。
    i)2つの転写産物は、基底膜に富む様々な組織において発現している。
    上皮細胞由来の細胞株、基底膜を多く含む組織中で発現が見られた。中でも特に発現が顕著なのは、肺胞の上皮細胞由来の細胞株であった。
    ii)競争的PCR法により転写産物1と1'の転写産物の発現の差について比較を行ったところ、ある種の細胞についてこれらの発現量に100倍もの差が見られた。
    こうした発現の差が、組織特異的プロモーターによるものと考え、更に検討を重ねている。
    2)レポーター遺伝子による、IV型コラーゲンα4遺伝子のプロモーター領域の解析
    α4の転写産物1と1'のそれぞれのプロモーターの活性を見るためのレポーター遺伝子の設計と作製を行った。当初の計画であるルシフェラーゼ遺伝子を用いた測定に先立ち、CAT遺伝子による解析も進行中である。エキソン1'、エキソン1それぞれの上流の2kbをカバーするゲノム断片をCAT遺伝子につないだコンストラクトを作製した。このコンストラクトに基づき、さらに他のコラーゲン遺伝子の例でも見られるようなイントロン1内の転写調節配列の存在の可能性も含めて、数種類のコンストラクトを現在作成中である。

    researchmap

  • Biological function of basement membrane

    Grant number:07044268  1995 - 1996

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for international Scientific Research

    NINOMIYA Yoshifumi, MOMOTA Ryusuke, OOHASHI Toshitaka, APTA Suneel, OLSEN Bjorn, OH Suk Paul, WARMAN Matt

      More details

    Grant amount:\4000000 ( Direct expense: \4000000 )

    1) We have cloned many overlapping cDNAs coding for the mouse alpha6 (IV) collagen chain and determined primary structure of the alpha6 (IV) chain polypeptide.
    2) We raised monoclonal antibodies against amino acid sequences from various parts of the mouse alpha6 (IV) collagen polypeptide chain and used them for the tissue distribution. The results indicated that the tissue distribution for the chain was similar to that of the human alpha6 (IV) collagen chain. Interestingly, the distribution of the paired genes ; col4a1/col4a2, col4a3/col4a4, and col4a5/col4a6 is quite synchronous except for the glomerular basement membranes.
    3) We have some indication that shows alternative splicing in exon 31. Currently, we are characterizing this atypical splicing event in terms of tissue specific expression.
    4) In order to create a knockout mice for col4a6, we made several constructs including the one where the exon 2 was taken out and the foreign gene, Neo^R gene was inserted instead. The construct was transfected into Stem cells by homologous recombination. Currently, we are characterizing knockout mice to detect any phenotypic changes in heterozygotes and homozygotes.

    researchmap

  • 腎糸球体基底膜におけるマトリックス分子構築と遺伝子発現

    Grant number:07671251  1995

    日本学術振興会  科学研究費助成事業  一般研究(C)

    大橋 俊孝, 吉岡 秀克, 二宮 善文

      More details

    Grant amount:\2200000 ( Direct expense: \2200000 )

    1.マウスα6(IV)鎖遺伝子(col4a6)及びα5(IV)鎖遺伝子(col4a5)上流プロモーター領域遺伝子断片のクローニング
    マウスα6(IV)鎖及びα5(IV)鎖cDNAをプローブとして129SVJマウスのゲノムDNAライブラリーをスクリーニングし、両遺伝子上流プロモーター領域を含むクローンTSg6を分離した。
    2.col4a6及びcol4a5遺伝子発現調節機構の解析
    上記クローンTSg6を解析したところ、col4a5のエキソン1とcol4a6のエキソン1,2が含まれてした。しかしながら、ヒトでみられた第一エキソンの択一的スプライシングはマウスα6(IV)鎖遺伝子ではみられなかった。現在、col4a6上流DNA断片をCAT遺伝子及びLacZ遺伝子に連結したconstructを作製し遺伝子発現調節機構解析を行なっているところである。
    3.col4a6遺伝子のノックアウトマウスの作製
    第1項で得られたcol4a6断片を利用して、col4a6のエキソン2部分にNeo^r遺伝子を挿入し、null mutationの改変を導入するターゲティングconstructを作成した。ES細胞ヘターゲティングconstruct DNAの注入後、サザンブロティングにより相補的遺伝子組換えの起こっているES細胞クローンを選別し、胚盤胞へ注入した。現在、キメラマウスの誕生を待っている段階である。
    4.Alport症候群,(平滑筋腫との合併症),Goodpasture症候群の病因と各α(IV)鎖との関連を調べる。
    ヒトα6(IV)鎖遺伝子の構造解析プロジェクトから決定されたエクソン・イントロン構造を基に、平滑筋腫との合併を伴ったAlport症候群患者の白血球DNAを用いて、α6(IV)鎖遺伝子及びα5(IV)鎖遺伝子の欠失領域の解析を行なっている。両遺伝子のイントロン1にまたがって欠失した症例が発見できた。さらに、細かい欠失部分解析を行なっている。これらの遺伝子解析によりこの症例の病因解析が進展すると期待される。

    researchmap

  • XI型コラーゲン分子の軟骨及び非軟骨細胞における特異的発現機構の解析

    Grant number:07671593  1995

    日本学術振興会  科学研究費助成事業  一般研究(C)

    吉岡 秀克, 大橋 俊孝, 二宮 善文

      More details

    Grant amount:\2200000 ( Direct expense: \2200000 )

    私たちはヒトコラーゲンα1(XI)鎖のcDNAプローブを用いて、クロスハイブリダイゼーション法にて重視するマウスα1(XI)鎖をコードするcDNAを得て、その全一次構造を決定した。その結果、予想されるマウスproα1(XI)鎖のアミノ酸は1769個であり、そのN末に35個のシグナルペプチドが存在した。ヒトとのアミノ酸レベルのホモロジーは93%であり、N末、中央螺旋部及びC末の領域構造、N-及びC-プロペプチドのシステイン、及び架橋に関与するリジン等の重要な構造はすべて保持されていた。わずかにマウスのN-プロペプチドにおいてアミノ酸が一個少ないのみであった。
    一方、このcDNAプローブを使用し、マウス胎児期における発現をノーザンブロット法、RT-PCR法及びin situ hybridization法で調べた。その結果、RT-PCR法を用いると11日目胎児にはすでにこの遺伝子の発現がみられた。ノーザンブロット法ではヒトと同様に7.3kb及び6.3kbの転写産物がみられ、18日目胎児では軟骨組織ばかりでなく、脳、皮膚、頭蓋骨の非軟骨組織でも発現していた。さらに、in situ hybridizationを行うと、これらの組織に発現が認められたばかりでなく、心臓弁部、舌骨格筋、大動脈平滑筋、腸管平滑筋、歯芽、耳小胞等にも発現がみられ、この遺伝子が軟骨組織ばかりでなく、広く非軟骨組織にも発現していることが証明された。
    さらに、N-プロペプチド部分はヒト同様、塩基性、酸性及び短い螺旋領域よりなっていたが、酸性領域をコードするエクソンは胎児の軟骨や頭蓋骨においては複雑な選択的スプライシングを受けており、この現象が内軟骨性骨化或は膜性骨化過程に関与している可能性が示唆された。

    researchmap

  • 基底膜に会合するIV型コラーゲン分子とそれをコードする遺伝子発現の特性

    Grant number:06454250  1994

    日本学術振興会  科学研究費助成事業  一般研究(B)

    二宮 善文, 大橋 俊孝, 吉岡 秀克

      More details

    Grant amount:\7600000 ( Direct expense: \7600000 )

    本年度施行した研究によって、当初掲げた研究目的の大半を達成することができた.
    1)ヒトα4(IV)鎖のアミノ酸一次構造を決定することができた.
    α4(IV)鎖をコードするcDNAの重複クローンを単離し、ヒトα4(IV)鎖のアミノ酸一次構造を決定することができた.
    2)α6(IV)鎖をコードする遺伝子の上流域の構造決定とα5(IV)遺伝子との関係を明かにした.
    ヒトα6(IV)鎖のアミノ酸一次構造を決定し報告した.さらにこれらのcDNAをもとに遺伝子DNAの構造を決定しつつある.私どもはα6(IV)鎖をコードする遺伝子の上流域にα5(IV)鎖をコードする遺伝子が存在しており、しかもこれらの遺伝子が反対向きに並んでいることをつきとめた.さらに興味あることは、α6(IV)鎖をコードする遺伝子の発現は通常の遺伝子発現と異なって、二つのRNA転写産物が存在することがわかった.このことはおそらくは二つのプロモーターが存在しこれらが組織特異的な発現に関係しているであろうことが想像される.
    3)α(IV)鎖特異的抗体の作製を行いIV型コラーゲン6遺伝子の発現様式を明かにした.
    上述のα4(IV)鎖およびα6(IV)鎖の一次構造より推定される特異抗体を作製に適する部位を同定し合成ペプチドを作製、このペプチドに対するモノクローン抗体を作製した.抗体は各々特異的であり、ウェスタンブロット、各組織の免疫染色法でこれらの特異的なα(IV)鎖の存在部位を特定することができた.その結果α1(IV)およびα2(IV)鎖はすべての基底膜に存在すること、α3(IV)およびα4(IV)鎖は限定された部位にしか発現されないが常にこの二つの遺伝子は同時に発現することがわかった.さらにα5(IV)およびα6(IV)鎖は限定された部位に必ずしも同時には発現しないことがわかった.この部位特異的発現が上述の二プロモーターの存在と関連があることが想像される.

    researchmap

  • 遺伝性腎基底膜疾患に関するIV型コラーゲンの分子生物学的研究

    Grant number:06770869  1994

    日本学術振興会  科学研究費助成事業  奨励研究(A)

    大橋 俊孝

      More details

    Grant amount:\1100000 ( Direct expense: \1100000 )

    申請者は本研究の申請時の目的として、1)α6(IV)鎖,α4(IV)鎖遺伝子構造の決定2)遺伝性腎糸球体基底膜疾患の遺伝子変異の検索を掲げた。その結果、
    1)α6(IV)鎖全遺伝子を含む重複クローンを単離し、全遺伝子構造を決定した(文献2,3参照)。さらに、その中の最上流の遺伝子断片の解析により、α6(IV)鎖遺伝子(COL4A6)とα5(IV)鎖遺伝子(COL4A5)はbidirectional promoterにより転写制御され、COL4A6はAlternativeなpromoterによって発現制御されることを初めて報告した(文献1参照)。この結果は、従来知られていたα1(IV)鎖遺伝子(COL4A1)とα2(IV)鎖遺伝子(COL4A2)と同様にその他α(IV)鎖遺伝子でもbidirectional promoterにより転写制御されていることを初めて示したものである。また、Alternativeなpromoterの存在はCOL4A6の組織特異的発現に関与すると推測される。
    2) 1)の結果をもとに、まずα6(IV)鎖遺伝子およびα5(IV)鎖遺伝子の関与する遺伝性疾患の家系解析に有用なマーカーとして(CA)nマーカーを検索した。1)で単離したCOL4A6断片から(CA)n配列を発見し、3つがマーカーとして有効であると判断された(投稿準備中)。また、疾患検索の準備としてPCR-SSCP実験を行なうため、全エキソンをはさむようにプライマーを設計した。これらは遺伝性腎糸球体基底膜疾患のみならず、最近関連性が示唆されたびまん性平滑筋腫の責任遺伝子としてのα6(IV)鎖遺伝子の変異の検索に有効であると思われる。

    researchmap

  • Biological Function of Type VIII Collagen

    Grant number:06044154  1994

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for international Scientific Research

    NINOMIYA Yoshifumi, OOHASHI Toshitaka, MURAGAKI Yasuteru, APTE Suneel, OLSEN Bjorn, WARMAN Matt, JACENKO Olena

      More details

    Grant amount:\2500000 ( Direct expense: \2500000 )

    In order to know which cells or organs produce type VIII collagen, we extracted RNA from various cells and tissues and performed Northern blot analysis using specific cDNAs. Cultured human aortic endothelial cells were found to keep synthesizing alpha1 (VIII) and alpha2 (VIII) chains until tenth passage. These cells synthesize collagen type I,III,and V at the same time. In separate experiment rat aortic smooth muscle cells were tested whether they produce collagens. What we detected was that the cells synthesized 75 kDa bacterial collagenase sensitive materials. Of interest was that production of this materials was enhanced 20 to 30 times by addition of heparin into the culture medium. Currently we are testing whether this bacterial collagenase sensitive material is the alpha-chain of type VIII by Northern blotting analysis. We also demonstrated that mouse keratinocytes produce collagen VIII at the mRNA level using Northern-blotting and in situ hybridization.
    Several lines of transgenic mice did show strange expression pattern of type VIII collagen gene during development. It seemed that its pattern was strict and developmentally regulated. However, we did not know whether the pattern was artifact or real, since we did not predict the expression pattern ; transient in certain tissues. Direct in situ hybridization was performed using the specific probes for mouse collagen type VIII at the developmental stage and proved that the expression pattern was real.

    researchmap

  • Tissue Specific Function of Basement Membrane and Heterogeneity in Matrix Molecules

    Grant number:04454564  1992 - 1993

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for General Scientific Research (B)

    NINOMIYA Yoshifumi, OOHASHI Toshitaka, YOSHIOKA Hidekatsu

      More details

    Grant amount:\6900000 ( Direct expense: \6900000 )

    We isolated overlapping cDNAs encoding the human and rabbit alpha4(IV) collagen chains. Charcterization and sequencing of the clones demonstrated the primary structure of the human and rabbit alpha4(IV) collagen chains. The amino acid sequence of the chain is homologous to that of the alpha2(IV) collagen chain. Chromosomal location of the gene was assigned to chromosome 2q35-37.1 by in situ hybridization. Interestingly, the size of the mRNA coding for the alpha4(IV) collagen chain is significantly larger than the other four mRNAs for type IV collagen chains. Comparison of the sequences for these five alpha(IV) chains revealed that there are two subclasses of the gene ; the genes for alpha1, alpha3, and alpha5 chains and genes for alpha2 and alpha4 chains. By these analyzes we predicted that there was one more alpha(IV) chain that belonged to the genes for the alpha2(IV) and alpha4(IV) chains. Using low stringency conditions we successfully isolated a novel cDNA encoding yet another alpha(IV) collagen chain. We designated his new chain as alpha6(IV) chain. Of interest was that the chromosomal location of the gene was assigned to chromosome Xq22, which is the same location as the gene for alpha5(IV) collagen chain. We furtheer isolated several fragments of the gene coding for the alpha6(IV) chain and also the alpha5(IV) chain at the same time. Precise analysis of the fragment of the genes revealed that the genes were located on the same fragement but aligned onto the opposite directions sharing bidirectional promoter in the center of the genes. Further, there was an alternativepromoter approximately 1000 bases downstream of the authentic promoter for the alpha6(IV) gene.

    researchmap

▼display all

 

Class subject in charge

  • From molecules to organisms (2024academic year) Third semester  - 金5~6

  • Molecular Biology (2024academic year) special  - その他

  • Pracice in Molecular Biology (2024academic year) special  - その他

  • Practicals: Molecular Biology and Biochemistry (2024academic year) special  - その他

  • Research Projects: Molecular Biology and Biochemistry (2024academic year) special  - その他

  • Research Projects and Practicals: Molecular Biology and Biochemistry I (2024academic year) special  - その他

  • Lecture and Research Projects: Molecular Biology and Biochemistry I (2024academic year) special  - その他

  • Research Projects and Practicals: Molecular Biology and Biochemistry II (2024academic year) special  - その他

  • Lecture and Research Projects: Molecular Biology and Biochemistry II (2024academic year) special  - その他

  • Research Presentation in Molecular Medicine (2024academic year) special  - その他

  • Medical Tutorial (2024academic year) 1st semester  - 火2~3

  • Medical Research Internship (2024academic year) special  - その他

  • Introduction to Medical and Dental Sciences (2024academic year) Concentration  - その他

  • Research in Medical Sciences I (2024academic year) special  - その他

  • Research in Medical Sciences II (2024academic year) special  - その他

  • Project-based Learning in Molecular Pathogenesis (2024academic year) special  - その他

  • Research in Dental Sciences I (2024academic year) special  - その他

  • Research in Dental Sciences II (2024academic year) special  - その他

  • Biochemistry (2024academic year) Concentration  - その他

  • Molecular Biology (2023academic year) special  - その他

  • Pracice in Molecular Biology (2023academic year) special  - その他

  • Practicals: Molecular Biology and Biochemistry (2023academic year) special  - その他

  • Research Projects: Molecular Biology and Biochemistry (2023academic year) special  - その他

  • Research Projects and Practicals: Molecular Biology and Biochemistry I (2023academic year) special  - その他

  • Lecture and Research Projects: Molecular Biology and Biochemistry I (2023academic year) special  - その他

  • Research Projects and Practicals: Molecular Biology and Biochemistry II (2023academic year) special  - その他

  • Lecture and Research Projects: Molecular Biology and Biochemistry II (2023academic year) special  - その他

  • Research Presentation in Molecular Medicine (2023academic year) special  - その他

  • Medical Tutorial (2023academic year) 1st semester  - 火2~3

  • Medical Tutorial (2023academic year) 1st semester  - 火2~3

  • 0 (2023academic year) special  - その他

  • Introduction to Medical and Dental Sciences (2023academic year) Concentration  - その他

  • Research in Medical Sciences I (2023academic year) special  - その他

  • Research in Medical Sciences II (2023academic year) special  - その他

  • Project-based Learning in Molecular Pathogenesis (2023academic year) special  - その他

  • Research in Dental Sciences I (2023academic year) special  - その他

  • Research in Dental Sciences II (2023academic year) special  - その他

  • Biochemistry (2023academic year) Concentration  - その他

  • Molecular Biology (2022academic year) special  - その他

  • Pracice in Molecular Biology (2022academic year) special  - その他

  • Research Projects and Practicals: Molecular Biology and Biochemistry I (2022academic year) special  - その他

  • Lecture and Research Projects: Molecular Biology and Biochemistry I (2022academic year) special  - その他

  • Research Projects and Practicals: Molecular Biology and Biochemistry II (2022academic year) special  - その他

  • Lecture and Research Projects: Molecular Biology and Biochemistry II (2022academic year) special  - その他

  • Research Presentation in Molecular Medicine (2022academic year) special  - その他

  • Medical Tutorial (2022academic year) 1st semester  - 火2~3

  • Medical Tutorial (2022academic year) 1st semester  - 火2~3

  • Medical Research Internship (2022academic year) special  - その他

  • Medical Research Internship (2022academic year) special  - その他

  • Introduction to Medical and Dental Sciences (2022academic year) Concentration  - その他

  • Research in Medical Sciences I (2022academic year) special  - その他

  • Research in Medical Sciences II (2022academic year) special  - その他

  • Project-based Learning in Molecular Pathogenesis (2022academic year) special  - その他

  • Research in Dental Sciences I (2022academic year) special  - その他

  • Research in Dental Sciences II (2022academic year) special  - その他

  • Biochemistry (2022academic year) Concentration  - その他

  • Practice in Biochemistry and Molecular Biology (2022academic year) special  - その他

  • Research Projects and Practicals: Human Morphology I (2021academic year) special  - その他

  • Lecture and Research Projects: Human Morphology I (2021academic year) special  - その他

  • Research Projects and Practicals: Human Morphology II (2021academic year) special  - その他

  • Lecture and Research Projects: Human Morphology II (2021academic year) special  - その他

  • Molecular Biology (2021academic year) special  - その他

  • Pracice in Molecular Biology (2021academic year) special  - その他

  • Research Projects and Practicals: Molecular Biology and Biochemistry I (2021academic year) special  - その他

  • Lecture and Research Projects: Molecular Biology and Biochemistry I (2021academic year) special  - その他

  • Research Projects and Practicals: Molecular Biology and Biochemistry II (2021academic year) special  - その他

  • Lecture and Research Projects: Molecular Biology and Biochemistry II (2021academic year) special  - その他

  • Research Presentation in Molecular Medicine (2021academic year) special  - その他

  • Medical Tutorial (2021academic year) 1st semester  - 火2~3

  • Medical Tutorial (2021academic year) 1st semester  - 火2~3

  • Medical Research Internship (2021academic year) special  - その他

  • Introduction to Medical and Dental Sciences (2021academic year) Concentration  - その他

  • Research in Medical Sciences I (2021academic year) special  - その他

  • Research in Medical Sciences II (2021academic year) special  - その他

  • Project-based Learning in Molecular Pathogenesis (2021academic year) special  - その他

  • Research in Dental Sciences I (2021academic year) special  - その他

  • Research in Dental Sciences II (2021academic year) special  - その他

  • Biochemistry (2021academic year) Concentration  - その他

  • Practice in Biochemistry and Molecular Biology (2021academic year) special  - その他

  • Molecular Biology (2020academic year) special  - その他

  • Research Projects and Practicals: Molecular Biology and Biochemistry I (2020academic year) special  - その他

  • Lecture and Research Projects: Molecular Biology and Biochemistry I (2020academic year) special  - その他

  • Research Projects and Practicals: Molecular Biology and Biochemistry II (2020academic year) special  - その他

  • Lecture and Research Projects: Molecular Biology and Biochemistry II (2020academic year) special  - その他

  • Research Presentation in Molecular Medicine (2020academic year) Year-round  - その他

  • Molecular Medicine (2020academic year) Year-round  - その他

  • Medical Tutorial (2020academic year) 1st semester  - 火2,火3

  • Medical Tutorial (2020academic year) 1st semester  - 火2,火3

  • Exercise in Medical Education (2020academic year) special  - その他

  • Medical Research Internship (2020academic year) special  - その他

  • Practicals (2020academic year) special  - その他

  • Research in Medical Sciences I (2020academic year) Year-round  - その他

  • Research in Medical Sciences II (2020academic year) Year-round  - その他

  • Research Projects (2020academic year) Year-round  - その他

  • Project-based Learning in Molecular Pathogenesis (2020academic year) special  - その他

  • Biochemistry (2020academic year) Concentration  - その他

  • Practice in Biochemistry and Molecular Biology (2020academic year) special  - その他

▼display all

 

Media Coverage

  • 2023年度(入学生対象)O-NECUS秋季セミナー

    岡山大学HP  2022.11.14